

  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-8111665
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination of kinase inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Yi; Ren, Pingda; Jessen, Katayoun; Guo, Xin; Rommel, Christian;
Wilson, Troy Edward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014151147 A1 2014-09-25

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-6945175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM In one embodiment, compounds are synthesized by condensing a
functionalized heterocycle A-1 with formamide, to provide a
pyrazolopyrimidine A-2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination pharmaceutical compositions and uses for the treatment of
proliferative disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Yi; Ren, Pingda; Jessen, Katayoun; Guo, Xin; Rommel, Christian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012151562 A1 2012-11-08

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-14835057
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination of kinase inhibitors and uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Pingda; Liu, Yi; Jessen, Katayoun; Guo, Xin; Rommel, Christian;
Wilson, Troy Edward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012148540 A1 2012-11-01

$RFMT $RIREG SCHEME1 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyanopyrazole
C4H4N4
16617-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.7104 0.0 0
M  V30 2 N 5.4498 2.7104 0.0 0
M  V30 3 N 1.9406 0.0000 0.0 0
M  V30 4 C 2.3698 2.7104 0.0 0
M  V30 5 C 1.4645 1.4645 0.0 0
M  V30 6 C 1.4645 3.9563 0.0 0
M  V30 7 N 0.0000 1.9404 0.0 0
M  V30 8 N 0.0000 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazolo[3,4-d]pyrimidin-4-amine
C5H5N5
2380-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 C 2.1579 4.5864 0.0 0
M  V30 6 N 1.1444 0.7700 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 N 3.8119 0.7700 0.0 0
M  V30 9 N 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16617-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-13684840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Scheme 1 depicts the synthesis of
2-(4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl) iodide. Cyano substituted
aminopyrazole 1-1 is heated with formamide at 160 °C for 5 hours to yield
2-(4-amino-1H-pyrazolo[3,4-d]pyrimidine (compound 1-2) in 90% yield.
2-(4-amino-1H-pyrazolo[3,4-d]pyrimidine (compound 1-2), yield (90%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods and compositions for treatment of ophthalmic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wilson, Troy Edward; Rommel, Christian; Liu, Yi; Ren, Pingda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010059593 A1 2010-05-27

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23350460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of new apoptosis-inducing agents for breast cancer based on
ethyl 2-amino-4,5,6,7-tetra hydrobenzo[b]thiophene-3-carboxylate:
synthesis, in vitro, and in vivo activity evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gad, Emad M.; Nafie, Mohamed S.; Eltamany, Elsayed H.; Hammad, Magdy S.
A. G.; Barakat, Assem; Boraei, Ahmed T. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2020), 25(11), 2523

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15870797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12303702
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate
C11H15NO2S
4506-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.3321 0.0 0
M  V30 2 O 7.1954 2.8561 0.0 0
M  V30 3 O 5.4106 4.8383 0.0 0
M  V30 4 C 8.3398 3.8866 0.0 0
M  V30 5 C 9.8045 3.4108 0.0 0
M  V30 6 N 6.0810 0.0000 0.0 0
M  V30 7 C 3.0800 2.6217 0.0 0
M  V30 8 C 4.5864 2.3015 0.0 0
M  V30 9 C 2.3100 1.2880 0.0 0
M  V30 10 C 2.3100 3.9555 0.0 0
M  V30 11 C 4.7473 0.7700 0.0 0
M  V30 12 S 3.3405 0.1437 0.0 0
M  V30 13 C 0.7700 1.2880 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C10H10N2OS
14346-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.8322 2.0824 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3404 5.1455 0.0 0
M  V30 9 C 6.1542 5.1455 0.0 0
M  V30 10 C 7.2391 2.7087 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 7.4001 4.2403 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4506-71-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4854774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and anti-tumor activities of
N'-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lou, Jiangping; Liu, Zhen; Li, Yan; Zhou, Mi; Zhang, Zhengxi; Zheng, Shu;
Wang, Renxiao; Li, Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(22), 6662-6666

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-phenylthiophene-3-carboxylate
C13H13NO2S
4815-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 2.9016 0.0 0
M  V30 2 O 8.5965 4.3086 0.0 0
M  V30 3 O 8.8752 1.6557 0.0 0
M  V30 4 C 10.1280 4.4695 0.0 0
M  V30 5 C 10.7544 5.8763 0.0 0
M  V30 6 N 6.2949 0.0000 0.0 0
M  V30 7 C 4.0010 3.2587 0.0 0
M  V30 8 C 5.4080 3.8850 0.0 0
M  V30 9 S 4.1621 1.7271 0.0 0
M  V30 10 C 6.4384 2.7406 0.0 0
M  V30 11 C 5.6684 1.4070 0.0 0
M  V30 12 C 2.6673 4.0287 0.0 0
M  V30 13 C 2.6673 5.5688 0.0 0
M  V30 14 C 1.3337 3.2587 0.0 0
M  V30 15 C 1.3337 6.3388 0.0 0
M  V30 16 C 0.0000 4.0287 0.0 0
M  V30 17 C 0.0000 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Phenylthieno[2,3-d]pyrimidin-4(1H)-one
C12H8N2OS
35970-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 5.0371 3.0801 0.0 0
M  V30 3 C 4.1321 1.8342 0.0 0
M  V30 4 S 4.1321 4.3260 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0
M  V30 9 N 0.0000 2.3101 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 6.5772 3.0801 0.0 0
M  V30 12 C 7.3472 1.7464 0.0 0
M  V30 13 C 7.3472 4.4137 0.0 0
M  V30 14 C 8.8872 1.7464 0.0 0
M  V30 15 C 8.8872 4.4137 0.0 0
M  V30 16 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-34-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35970-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15957662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-phenylthiophene-3-carboxylate
C13H13NO2S
4815-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9700 2.9016 0.0 0
M  V30 2 O 8.5965 4.3086 0.0 0
M  V30 3 O 8.8752 1.6557 0.0 0
M  V30 4 C 10.1280 4.4695 0.0 0
M  V30 5 C 10.7544 5.8763 0.0 0
M  V30 6 N 6.2949 0.0000 0.0 0
M  V30 7 C 4.0010 3.2587 0.0 0
M  V30 8 C 5.4080 3.8850 0.0 0
M  V30 9 S 4.1621 1.7271 0.0 0
M  V30 10 C 6.4384 2.7406 0.0 0
M  V30 11 C 5.6684 1.4070 0.0 0
M  V30 12 C 2.6673 4.0287 0.0 0
M  V30 13 C 2.6673 5.5688 0.0 0
M  V30 14 C 1.3337 3.2587 0.0 0
M  V30 15 C 1.3337 6.3388 0.0 0
M  V30 16 C 0.0000 4.0287 0.0 0
M  V30 17 C 0.0000 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Phenylthieno[2,3-d]pyrimidin-4(1H)-one
C12H8N2OS
35970-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 5.0371 3.0801 0.0 0
M  V30 3 C 4.1321 1.8342 0.0 0
M  V30 4 S 4.1321 4.3260 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 2.6673 3.8501 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 N 1.3337 4.6201 0.0 0
M  V30 9 N 0.0000 2.3101 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 6.5772 3.0801 0.0 0
M  V30 12 C 7.3472 1.7464 0.0 0
M  V30 13 C 7.3472 4.4137 0.0 0
M  V30 14 C 8.8872 1.7464 0.0 0
M  V30 15 C 8.8872 4.4137 0.0 0
M  V30 16 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-34-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35970-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3481861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Aminosalicylic acid
C7H7NO3
570-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 O 2.6674 4.6200 0.0 0
M  V30 5 N 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Formylamino)-2-hydroxybenzoic acid
C8H7NO4
17968-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 4.0012 4.6201 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 570-23-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17968-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-9402843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7646-93-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Hydroxy-3-formylaminobenzoic acid (49). Aniline 48 (0.51 g, 3.31 mmol)
was suspended in formamide (3.0 mL under N2) and the mixture stirred at
150 °C for 0.5 h. The resulting solution was allowed to cool, dissolved
in 6% NaHCO3 (50 mL), acidified with 1 M KHSO4, and extracted with EtOAc
(3 x 50 mL). The combined extract was washed with 5 M NaCl (10 mL),
dried, and evaporated, and the residue was coevaporated with toluene (10
mL) to furnish 90% of phenol 49 as a greenish-gray solid: mp 168-169 °C;
TLC Rf 0.20 (95:5:1 DCM-MeOH-HOAc); 1H NMR (d 6-DMSO) δ 9.82 (1H, s),
8.38 (1H, d, J = 9.3 Hz), 7.55 (1H, d, J = 7.7 Hz), 6.92 (1H, t, J = 7.7
Hz); 13C NMR (d 6-DMSO) δ 172.3, 160.3, 151.2, 126.5, 125.7, 124.5,
118.6, 112.6.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antineoplastic Agents. 561. Total Synthesis of Respirantin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pettit, George R.; Smith, Thomas H.; Feng, Song; Knight, John C.; Tan,
Rui; Pettit, Robin K.; Hinrichs, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Natural Products (2007), 70(7), 1073-1083

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-amino-4-methoxy-5-(phenylmethoxy)-, methyl ester
C16H17NO4
855793-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 O 5.3900 1.3336 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 2.3100 6.6685 0.0 0
M  V30 6 O 0.7700 6.6685 0.0 0
M  V30 7 O 3.0800 8.0021 0.0 0
M  V30 8 C 0.0000 8.0021 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 14
M  V30 9 1 6 8
M  V30 10 1 9 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-6-(phenylmethoxy)-4(3H)-quinazolinone
C16H14N2O3
286371-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 8.0021 0.0 0
M  V30 2 O 5.3900 1.3336 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 O 6.9300 4.0011 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 5.3347 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 2.3100 6.6685 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 0.0000 5.3347 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 N 0.7700 6.6685 0.0 0
M  V30 16 C 9.2400 5.3347 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 18 C 10.0100 6.6685 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 855793-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 286371-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23726126
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel amide analogues of quinazoline carboxylate display selective
antiproliferative activity and potent EGFR inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Malhotra, Anjleena; Bansal, Ranju; Halim, Clarissa Esmeralda; Yap,
Celestial T.; Sethi, Gautam; Kumar, Alan Prem; Bishnoi, Mahendra; Yadav,
Kamalendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Medicinal Chemistry Research (2020), 29(12), 2112-2122

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38072373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11097-99-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated Starch: A Highly Efficient Catalyst for Transamidation of
Primary and Secondary Amines with Formamide and Acetamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wani, Rucha; Chaudhari, Hemchandra K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2024), 56(3), 277-288

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)formamide
C8H9NO2
5470-34-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5470-34-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-9024208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 95-14-7
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, alternative reaction condition gave lower yield, preparative
scale
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrogen bond organocatalysis of benzotriazole in transamidation of
carboxamides with amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nguyen, Thanh Binh; Ermolenko, Ludmila; Dau, Marie-Elise Tran Huu;
Al-Mourabit, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2014), 88(1), 403-416

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroaniline
C6H6ClN
106-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)formamide
C7H6ClNO
2617-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 Cl 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 106-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2617-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38072381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 11097-99-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfated Starch: A Highly Efficient Catalyst for Transamidation of
Primary and Secondary Amines with Formamide and Acetamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wani, Rucha; Chaudhari, Hemchandra K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Preparations and Procedures International (2024), 56(3), 277-288

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoroaniline
C6H6FN
371-40-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)formamide
C7H6FNO
459-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9301 2.6673 0.0 0
M  V30 3 O 8.4701 2.6673 0.0 0
M  V30 4 F 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 371-40-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 459-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25593765
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent,reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free Transamidation of Aromatic Amines with Formamide
Derivatives and Tertiary Amides with Aliphatic Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yin, Jiawen; Zhang, Jingyu; Cai, Changqun; Deng, Guo-Jun; Gong, Hang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(2), 387-392

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-methoxybenzoic acid
C8H9NO3
4294-95-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-4(3H)-quinazolinone
C9H8N2O2
16064-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 O 6.6686 4.6201 0.0 0
M  V30 3 C 8.0022 3.8500 0.0 0
M  V30 4 C 2.6675 3.8500 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 4.6201 0.0 0
M  V30 7 N 1.3337 4.6201 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4294-95-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-24-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21363022
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazolin-4(3H)-one-based hydroxamic acids: Design, synthesis and
evaluation of histone deacetylase inhibitory effects and cytotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hieu, Doan Thanh; Anh, Duong Tien; Hai, Pham-The; Thuan, Nguyen Thi;
Huong, Le-Thi-Thu; Park, Eun Jae; Young Ji, A.; Soon Kang, Jong; Phuong
Dung, Phan Thi; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biodiversity (2019), 16(4), n/a

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-fluorobenzoic acid
C7H6FNO2
446-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 F 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-4(3H)-quinazolinone
C8H5FN2O
16499-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 F 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21351049
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazolin-4(3H)-one-based hydroxamic acids: Design, synthesis and
evaluation of histone deacetylase inhibitory effects and cytotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hieu, Doan Thanh; Anh, Duong Tien; Hai, Pham-The; Thuan, Nguyen Thi;
Huong, Le-Thi-Thu; Park, Eun Jae; Young Ji, A.; Soon Kang, Jong; Phuong
Dung, Phan Thi; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biodiversity (2019), 16(4), n/a

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluorobenzoic acid
C7H6FNO2
446-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoroquinazolin-4(3H)-one
C8H5FN2O
16499-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 F 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16499-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21351369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazolin-4(3H)-one-based hydroxamic acids: Design, synthesis and
evaluation of histone deacetylase inhibitory effects and cytotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hieu, Doan Thanh; Anh, Duong Tien; Hai, Pham-The; Thuan, Nguyen Thi;
Huong, Le-Thi-Thu; Park, Eun Jae; Young Ji, A.; Soon Kang, Jong; Phuong
Dung, Phan Thi; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biodiversity (2019), 16(4), n/a

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5-dimethylthiophene-3-carboxylate
C9H13NO2S
4815-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 3.3320 0.0 0
M  V30 2 O 6.6363 2.5620 0.0 0
M  V30 3 O 5.3026 4.8721 0.0 0
M  V30 4 C 7.9700 3.3320 0.0 0
M  V30 5 C 9.3037 2.5620 0.0 0
M  V30 6 C 2.2418 4.6948 0.0 0
M  V30 7 N 4.9524 0.0000 0.0 0
M  V30 8 C 0.0000 2.2049 0.0 0
M  V30 9 C 3.9688 2.5620 0.0 0
M  V30 10 C 2.5620 3.1885 0.0 0
M  V30 11 C 3.8079 1.0304 0.0 0
M  V30 12 C 1.5316 2.0439 0.0 0
M  V30 13 S 2.3016 0.7103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 12
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-5,6-dimethylthieno[2,3-d]pyrimidine
C8H8N2OS
18593-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.3694 0.0 0
M  V30 2 O 1.3336 0.0000 0.0 0
M  V30 3 C 6.5770 3.0800 0.0 0
M  V30 4 C 2.6673 3.8500 0.0 0
M  V30 5 C 2.6673 2.3100 0.0 0
M  V30 6 S 4.1320 4.3259 0.0 0
M  V30 7 N 1.3336 4.6200 0.0 0
M  V30 8 C 4.1320 1.8341 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 5.0370 3.0800 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18593-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15956100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromonicotinic acid
C6H5BrN2O2
52833-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromopyrido[2,3-d]pyrimidin-4(3H)-one
C7H4BrN3O
155690-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 N 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52833-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 155690-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27852805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridopyrimidine derivatives as P2X3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bruno, Paolo; Biagetti, Matteo; Fiorelli, Claudio; Baker-Glenn, Charles;
Van de Poeel, Herve; Penrose, Stephen David; Lanaro, Roberta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020239953 A1 2020-12-03

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4,5-dimethoxybenzoic acid
C9H11NO4
5653-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 O 1.3337 6.9301 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 N 4.0011 6.9301 0.0 0
M  V30 5 O 4.0011 0.7700 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 O 6.6686 2.3100 0.0 0
M  V30 8 C 8.0022 3.0800 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 4.0011 5.3901 0.0 0
M  V30 11 C 2.6675 3.0800 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Dimethoxy-4(3H)-quinazolinone
C10H10N2O3
13794-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.6201 0.0 0
M  V30 2 O 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 O 4.0011 0.7700 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 C 4.0011 5.3901 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 4.0011 6.9301 0.0 0
M  V30 10 C 2.6675 3.0800 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 2.6675 7.7001 0.0 0
M  V30 14 C 4.0011 2.3100 0.0 0
M  V30 15 N 1.3337 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5653-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13794-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21363262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazolin-4(3H)-one-based hydroxamic acids: Design, synthesis and
evaluation of histone deacetylase inhibitory effects and cytotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hieu, Doan Thanh; Anh, Duong Tien; Hai, Pham-The; Thuan, Nguyen Thi;
Huong, Le-Thi-Thu; Park, Eun Jae; Young Ji, A.; Soon Kang, Jong; Phuong
Dung, Phan Thi; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biodiversity (2019), 16(4), n/a

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4032755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-bromo-3H-quinazolin-4-one 2-Amino-5-Bromo-benzoic acid (10.817 g, 50
mmol) was suspended in 70 ml formamide. The mixture was heated at 180°C.
for 7 hrs. The cooled solution was diluted with 100 ml cold water and
filtered. The tan solid was washed with di water and used for the next
step reaction without further purification. 10.2 g product was obtained.
Yield: 90%. 6-bromo-3H-quinazolin-4-one, Yield (10.2 g, 90%) 1H NMR (500
MHz, DMSO-d6): δ 7.61430- 7.63179 (d, J1=8.745 Hz, 1H), 7.94922-7.97149
(dd, J1=8.75 Hz, J2=2.385 Hz, 1H), 8.142421 (s, 1H), 8.19136-8.19609 (d,
J=2.365 Hz, 1H); ESI-MS: m/z 225, 227 (M++1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indoles, pteridines, pyridopyrazines, and benzotriazines as vasculostatic
agents, their preparation, pharmaceutical compositions and use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wrasidlo, Wolfgang; Doukas, John; Royston, Ivor; Noronha, Glenn; Hood,
John D.; Dneprovskaia, Elena; Gong, Xianchang; Splittgerber, Ute; Zhao,
Ningning
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050282814 A1 2005-12-22

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-bromobenzoic acid
C7H6BrNO2
5794-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4(3H)-quinazolinone
C8H5BrN2O
32084-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5794-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21074198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of vasculostatic agents and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wrasidlo, Wolfgang; Doukas, John; Royston, Ivor; Noronha, Glenn; Hood,
John D.; Dneprovskaia, Elena; Gong, Xianchang; Splittgerber, Ute; Zhao,
Ningning
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004030635 A2 2004-04-15

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-nitrobenzoic acid
C7H6N2O4
616-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Nitro-4(3H)-quinazolinone
C8H5N3O3
6943-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3336 0.0000 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 N 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 N 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 616-79-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6943-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5298905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (1-1) Preparation of 6-nitro-3H-quinazolin-4-one 150 g of
2-amino-5-nitro-benzoylic acid was added to 200 ml of formamide, the
resulting solution was heated to 170 °C for 4 hours, and cooled to 100°C.
500 ml of ice water was added thereto, stirred for 1 hour, and the
resulting mixture was filtered under a reduced pressure. The resulting
residue was washed with water to obtain a solid, which was dried at 40 °C
for 15 hours to obtain the title compound of formula (140 g, 90%). 1H-NMR
(DMSO-d6, 300MHz): δ 8.77 (d, J=2.7 Hz, 1H), 8.55 (dd, J=6.9 Hz, 1H),
8.36 (s, 1H), 7.84 (d, J=9 Hz, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline derivatives as inhibitors of epidermal growth
factor receptor and growth of cancer cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ham, Young Jin; Gong, Ji Hyeon; Cha, Mi Young; Kim, Jong Woo; Kim, Maeng
Sup; Kim, Eun Young; Song, Ji Yeon; Kim, Chang In; Kim, Se Young; Lee,
Gwan Sun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006071017 A1 2006-07-06

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-nitrobenzoic acid
C7H6N2O4
619-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 N 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Nitro-4(3H)-quinazolinone
C8H5N3O3
20872-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.8500 0.0 0
M  V30 2 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 4.0011 6.1600 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 2.6674 6.9300 0.0 0
M  V30 13 N 1.3336 6.1600 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 619-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20872-93-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21346402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazolin-4(3H)-one-based hydroxamic acids: Design, synthesis and
evaluation of histone deacetylase inhibitory effects and cytotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hieu, Doan Thanh; Anh, Duong Tien; Hai, Pham-The; Thuan, Nguyen Thi;
Huong, Le-Thi-Thu; Park, Eun Jae; Young Ji, A.; Soon Kang, Jong; Phuong
Dung, Phan Thi; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biodiversity (2019), 16(4), n/a

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzoic acid
C7H6ClNO2
635-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4(3H)-quinazolinone
C8H5ClN2O
16064-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21350639
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Niementowski condensation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazolin-4(3H)-one-based hydroxamic acids: Design, synthesis and
evaluation of histone deacetylase inhibitory effects and cytotoxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hieu, Doan Thanh; Anh, Duong Tien; Hai, Pham-The; Thuan, Nguyen Thi;
Huong, Le-Thi-Thu; Park, Eun Jae; Young Ji, A.; Soon Kang, Jong; Phuong
Dung, Phan Thi; Han, Sang-Bae; Nam, Nguyen-Hai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biodiversity (2019), 16(4), n/a

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-chlorobenzoic acid
C7H6ClNO2
635-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4(3H)-quinazolinone
C8H5ClN2O
16064-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 Cl 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16064-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5242110
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and SAR optimization of quinazolin-4(3H)-ones as
poly(ADP-ribose)polymerase-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kulkarni, Shridhar S.; Singh, Satyakam; Shah, Janki R.; Low, Woon-Kai;
Talele, Tanaji T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2012), 50264-273

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-methylthiophene-3-carboxylate
C8H11NO2S
4815-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7106 0.0 0
M  V30 2 O 5.9256 4.0442 0.0 0
M  V30 3 O 5.9256 1.3769 0.0 0
M  V30 4 C 7.4656 4.0442 0.0 0
M  V30 5 C 8.2357 5.3780 0.0 0
M  V30 6 N 3.1864 0.0000 0.0 0
M  V30 7 C 0.0000 4.3858 0.0 0
M  V30 8 C 3.6156 2.7106 0.0 0
M  V30 9 C 2.7104 1.4647 0.0 0
M  V30 10 C 2.7104 3.9564 0.0 0
M  V30 11 S 1.2459 1.9406 0.0 0
M  V30 12 C 1.2459 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methylthieno[2,3-d]pyrimidin-4(1H)-one
C7H6N2OS
108831-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 6.5771 3.0800 0.0 0
M  V30 3 C 2.6673 3.8500 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 S 4.1320 4.3259 0.0 0
M  V30 6 N 1.3337 4.6201 0.0 0
M  V30 7 C 4.1320 1.8342 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 5.0371 3.0800 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 11 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 108831-66-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15845951
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-methylthiophene-3-carboxylate
C8H11NO2S
4815-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7106 0.0 0
M  V30 2 O 5.9256 4.0442 0.0 0
M  V30 3 O 5.9256 1.3769 0.0 0
M  V30 4 C 7.4656 4.0442 0.0 0
M  V30 5 C 8.2357 5.3780 0.0 0
M  V30 6 N 3.1864 0.0000 0.0 0
M  V30 7 C 0.0000 4.3858 0.0 0
M  V30 8 C 3.6156 2.7106 0.0 0
M  V30 9 C 2.7104 1.4647 0.0 0
M  V30 10 C 2.7104 3.9564 0.0 0
M  V30 11 S 1.2459 1.9406 0.0 0
M  V30 12 C 1.2459 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methylthieno[2,3-d]pyrimidin-4(1H)-one
C7H6N2OS
108831-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 C 6.5771 3.0800 0.0 0
M  V30 3 C 2.6673 3.8500 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 S 4.1320 4.3259 0.0 0
M  V30 6 N 1.3337 4.6201 0.0 0
M  V30 7 C 4.1320 1.8342 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 5.0371 3.0800 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 11 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 108831-66-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10990561
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-(ethoxycarbonyl)-4-phenylthiophene
C13H13NO2S
4815-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6421 3.4209 0.0 0
M  V30 2 O 7.1485 3.1007 0.0 0
M  V30 3 O 5.1662 4.8856 0.0 0
M  V30 4 C 8.1789 4.2451 0.0 0
M  V30 5 C 9.6852 3.9249 0.0 0
M  V30 6 N 6.3386 0.1437 0.0 0
M  V30 7 C 3.0801 2.4374 0.0 0
M  V30 8 C 4.6116 2.2765 0.0 0
M  V30 9 C 2.4536 1.0306 0.0 0
M  V30 10 C 4.9318 0.7700 0.0 0
M  V30 11 S 3.5981 0.0000 0.0 0
M  V30 12 C 2.3100 3.7711 0.0 0
M  V30 13 C 3.0801 5.1049 0.0 0
M  V30 14 C 0.7700 3.7711 0.0 0
M  V30 15 C 2.3100 6.4386 0.0 0
M  V30 16 C 0.0000 5.1049 0.0 0
M  V30 17 C 0.7700 6.4386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Phenylthieno[2,3-d]pyrimidin-4(1H)-one
C12H8N2OS
35978-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5674 5.0873 0.0 0
M  V30 2 C 4.4197 1.8517 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 C 4.2588 0.3202 0.0 0
M  V30 5 C 1.9823 1.3337 0.0 0
M  V30 6 C 2.5369 3.9428 0.0 0
M  V30 7 S 2.7523 0.0000 0.0 0
M  V30 8 N 0.4760 1.6540 0.0 0
M  V30 9 N 1.0306 4.2631 0.0 0
M  V30 10 C 0.0000 3.1185 0.0 0
M  V30 11 C 5.7533 2.6217 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 7.0870 1.8517 0.0 0
M  V30 14 C 7.0870 4.9318 0.0 0
M  V30 15 C 8.4208 2.6217 0.0 0
M  V30 16 C 8.4208 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35978-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15885237
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-(ethoxycarbonyl)-4-phenylthiophene
C13H13NO2S
4815-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6421 3.4209 0.0 0
M  V30 2 O 7.1485 3.1007 0.0 0
M  V30 3 O 5.1662 4.8856 0.0 0
M  V30 4 C 8.1789 4.2451 0.0 0
M  V30 5 C 9.6852 3.9249 0.0 0
M  V30 6 N 6.3386 0.1437 0.0 0
M  V30 7 C 3.0801 2.4374 0.0 0
M  V30 8 C 4.6116 2.2765 0.0 0
M  V30 9 C 2.4536 1.0306 0.0 0
M  V30 10 C 4.9318 0.7700 0.0 0
M  V30 11 S 3.5981 0.0000 0.0 0
M  V30 12 C 2.3100 3.7711 0.0 0
M  V30 13 C 3.0801 5.1049 0.0 0
M  V30 14 C 0.7700 3.7711 0.0 0
M  V30 15 C 2.3100 6.4386 0.0 0
M  V30 16 C 0.0000 5.1049 0.0 0
M  V30 17 C 0.7700 6.4386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Phenylthieno[2,3-d]pyrimidin-4(1H)-one
C12H8N2OS
35978-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5674 5.0873 0.0 0
M  V30 2 C 4.4197 1.8517 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 C 4.2588 0.3202 0.0 0
M  V30 5 C 1.9823 1.3337 0.0 0
M  V30 6 C 2.5369 3.9428 0.0 0
M  V30 7 S 2.7523 0.0000 0.0 0
M  V30 8 N 0.4760 1.6540 0.0 0
M  V30 9 N 1.0306 4.2631 0.0 0
M  V30 10 C 0.0000 3.1185 0.0 0
M  V30 11 C 5.7533 2.6217 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 7.0870 1.8517 0.0 0
M  V30 14 C 7.0870 4.9318 0.0 0
M  V30 15 C 8.4208 2.6217 0.0 0
M  V30 16 C 8.4208 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35978-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7771768
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-N-phenyl-N-(phenylmethyl)-2-propenamide
C17H17NO
74480-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 O 3.0800 2.6674 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 6.9300 1.3338 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 7.7000 2.6674 0.0 0
M  V30 10 C 7.7000 5.3347 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 10.0100 4.0011 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-methyl-2-oxo-1-(phenylmethyl)-1H-indole-3-acetamide
C18H18N2O2
2080376-95-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1105 2.6673 0.0 0
M  V30 2 C 3.3405 1.3337 0.0 0
M  V30 3 N 4.1105 0.0000 0.0 0
M  V30 4 O 1.8005 1.3337 0.0 0
M  V30 5 C 2.0946 3.0959 0.0 0
M  V30 6 C 5.7309 7.1895 0.0 0
M  V30 7 O 6.0811 3.8575 0.0 0
M  V30 8 C 2.3101 5.1456 0.0 0
M  V30 9 C 3.0801 6.4792 0.0 0
M  V30 10 C 3.3405 4.0010 0.0 0
M  V30 11 C 0.7700 5.1456 0.0 0
M  V30 12 N 4.5864 6.1591 0.0 0
M  V30 13 C 2.3101 7.8129 0.0 0
M  V30 14 C 4.7473 4.6275 0.0 0
M  V30 15 C 0.0000 6.4792 0.0 0
M  V30 16 C 0.7700 7.8129 0.0 0
M  V30 17 C 7.1955 6.7136 0.0 0
M  V30 18 C 8.3401 7.7441 0.0 0
M  V30 19 C 7.5157 5.2073 0.0 0
M  V30 20 C 9.8046 7.2682 0.0 0
M  V30 21 C 8.9804 4.7313 0.0 0
M  V30 22 C 10.1248 5.7619 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 1 6 17
M  V30 8 2 7 14
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74480-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2080376-95-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29104166
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7782-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM continuous flow mode, Fenton reaction, irradiated with 450W Hg lamp
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nontraditional Application of the Photo-Fenton Process: A Novel Strategy
for Molecular Construction Using Formamide and Flow Chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanabria, Marialy N.; Hornink, Milene M.; Correia, Valquiria G.; Andrade,
Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2020), 24(10), 2288-2297

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-chlorobenzoic acid
C7H6ClNO2
89-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-4(3H)-quinazolinone
C8H5ClN2O
31374-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 Cl 6.9302 2.6673 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 0.7700 2.6673 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 2.3101 0.0000 0.0 0
M  V30 9 N 0.0000 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31374-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38331758
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Visible-light-promoted photoredox-catalyzed N-aminoalkylation of
quinazolinones with simple alkylamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gu, Yi-Jie; Cui, Wenwen; Jiang, De-Lu; Yuan, Hua; Liang, Xiao-Wei; Wang,
Shou-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2023), 132154801

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(3-fluorophenyl)methyl]-3-pyridinamine
C12H10ClFN2
1154722-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 Cl 1.3337 4.6201 0.0 0
M  V30 4 F 10.6697 2.3101 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 2.6673 0.7700 0.0 0
M  V30 8 N 0.0000 2.3101 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 8.0023 5.3901 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 6
M  V30 5 1 4 14
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3-Fluorophenyl)methyl]-1H-imidazo[4,5-b]pyridine
C13H10FN3
1365094-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 1.6414 0.0 0
M  V30 2 F 11.0882 1.6414 0.0 0
M  V30 3 C 3.0127 1.7849 0.0 0
M  V30 4 N 4.4197 2.4114 0.0 0
M  V30 5 C 1.9823 2.9294 0.0 0
M  V30 6 C 2.5369 0.3203 0.0 0
M  V30 7 C 4.2586 3.9429 0.0 0
M  V30 8 N 2.7523 4.2631 0.0 0
M  V30 9 N 0.4759 2.6091 0.0 0
M  V30 10 C 1.0304 0.0000 0.0 0
M  V30 11 C 0.0000 1.1445 0.0 0
M  V30 12 C 7.0870 2.4114 0.0 0
M  V30 13 C 8.4207 1.6414 0.0 0
M  V30 14 C 7.0870 3.9514 0.0 0
M  V30 15 C 9.7545 2.4114 0.0 0
M  V30 16 C 8.4207 4.7214 0.0 0
M  V30 17 C 9.7545 3.9514 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 12
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1154722-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-41-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3063158
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1160861-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-(3-Fluorobenzyl)-1H-imidazo[4,5-b]pyridine (3d) Following the general
experimental; 2-chloro-N-(3-fluorobenzyl)pyridin-3-amine (2d) (95 mg, 0.4
mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), t-BuBrettphos (9.7 mg, 0.02
mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.022 mL, 0.6 mmol) were
combined with 2.0 mL tert-butanol in a 25 mL Schlenk flask. After 4 h the
reaction was complete, the reaction cooled to RT, filtered through
Celite, concentrated and purified on a silica gel column (2.5 cm x 12
cm), eluting with 4% MeOH / CH2Cl2. 3d as 82 mg of a green solid (90%).
1H NMR (300 MHz, CDCl3) δ = 8.52 (dd, J = 4.8 Hz, 1.5 Hz, 1H), 8.17 (s,
1H), 7.53 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.28 (td, J = 7.8 Hz, 6 Hz, 1H),
7.13 (dd, J = 8.1 Hz, 4.8 Hz, 1H), 7.01-6.95 (m, 1H), 6.93-6.90 (m, 1H),
6.85-6.81 (m, 1H), 5.36 (s, 2H); 13C NMR (75.4 MHz, CDCl3) δ = 163.1 (d,
J C-F = 247 Hz), 156.4, 145.4, 145.2, 137.3 (d, J C-F = 7 Hz), 130.9 (d,
J C-F = 8 Hz), 126.1, 122.7 (d, J C-F = 3 Hz), 118.4, 118.4, 115.6 (d, J
C-F = 20 Hz), 114.2 (d, J C-F = 20 Hz), 48.9 (d, J C-F = 1.7 Hz); 19F NMR
(282.4 MHz, CDCl3) δ = -111.79 (td, J = 8.5 Hz, 5.6 Hz); FT-IR (NaCl,
thin film) ν = 1612, 1592, 1492, 1452, 1415, 1377, 1261, 1293, 1252, 780
cm-1. HRMS (ESI) Calc (C13H11N3F1): 228.0932, Found: 228.0929; MP:
117-121°C; Rf (4% MeOH / CH2Cl2): 0.23.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylboronic acid
C6H7BO2
98-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formanilide
C7H7NO
103-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 2.3101 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 103-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-10327135
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 6046-93-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (25) General Procedure for the Synthesis of Formanilides 2 To an open
flask containing a solution of arylboronic acid 1 (1.0 mmol) in formamide
(2 mL) were added Cu(OAc)2·H2O (19.9 mg, 10 mol%) and K2CO3 (138.2 mg, 1
mmol), and the mixture was stirred vigorously at r.t. under air (without
bubbling air) for 8-16 h (Table 2). After completion of the reaction
(indicated by TLC), the reaction mixture was treated with EtOAc (5 mL)
and H2O (5 mL). The organic layer was separated, and the aqueous layer
was extracted with EtOAc (3 × 5 mL). The combined organic phase was
washed with H2O (2 × 5 mL), dried over anhyd Na2SO4, and concentrated to
yield a residue, which was purified by flash chromatography (prepacked
silica cartridges). The clean product 2 as a mixture of rotamers.27 All
the products are known compounds and were characterized by comparison of
their melting points and spectral data with those reported in the
literature.14-17 N-Phenylformamide (2a, Table 2) Isolated as a pale
brownish solid (109 mg, 90%). Mp 48-49 °C [lit.17a 47-48 °C]. 1H NMR (400
MHz, CDCl3): δ = 9.12 (br s, 1 H, NH), 8.70 (d, J = 11.4 Hz, 1 H, CHO),
8.39 (s, 1 H, CHO), 8.10 (br s, 1 H, NH), 7.54 (d, J = 7.8 Hz, 2 H, ArH),
7.39-7.31 (m, 4 H, ArH), 7.20-7.14 (m, 2 H, ArH), 7.09 (d, J = 7.7 Hz, 2
H, ArH). 13C NMR (100 MHz, CDCl3): δ = 163.1, 159.5, 137.0, 136.7, 129.8,
128.9, 125.0, 124.6, 119.9, 118.6. IR (KBr): 3252, 3048, 1686, 1602,
1550, 1430, 1352, 758, 710, 696 cm-1. MS (EI): m/z = 122 [M+ + 1]. Anal.
Calcd for C7H7NO: C, 69.41; H, 5.82; N, 11.56. Found: C, 69.16; H, 5.96;
N, 11.48.
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, no solvent, optimization study, Chan-Lam coupling, optimized on
catalyst, base and solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed formamidation of arylboronic acids: direct access to
formanilides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srivastava, Vishnu P.; Yadav, Deepak K.; Yadav, Arvind K.; Watal, Geeta;
Yadav, Lal Dhar S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(11), 1423-1427

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl 5-amino-3-methylthiophene-2,4-dicarboxylate
C11H15NO4S
4815-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6445 4.0287 0.0 0
M  V30 2 O 9.9782 3.2587 0.0 0
M  V30 3 O 8.6445 5.5687 0.0 0
M  V30 4 C 11.3120 4.0287 0.0 0
M  V30 5 C 12.6456 3.2587 0.0 0
M  V30 6 C 5.5838 5.3914 0.0 0
M  V30 7 C 3.3420 2.9015 0.0 0
M  V30 8 O 2.4368 1.6557 0.0 0
M  V30 9 O 2.7156 4.3085 0.0 0
M  V30 10 C 0.9052 1.8166 0.0 0
M  V30 11 C 0.0000 0.5707 0.0 0
M  V30 12 N 5.0172 0.0000 0.0 0
M  V30 13 C 7.3109 3.2587 0.0 0
M  V30 14 C 5.9039 3.8850 0.0 0
M  V30 15 S 7.1499 1.7271 0.0 0
M  V30 16 C 4.8735 2.7406 0.0 0
M  V30 17 C 5.6435 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-methyl-4-oxothieno[2,3-d]pyrimidine-6-carboxylate
C10H10N2O3S
17417-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 S 4.5865 1.6538 0.0 0
M  V30 13 N 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17417-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31924275
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular design, synthesis and in vitro biological evaluation of
thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: a
challenging approach to combat cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abdel-Atty, Mona M.; Farag, Nahla A.; Serya, Rabah A. T.; Abouzid, Khaled
A. M.; Mowafy, Samar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Enzyme Inhibition and Medicinal Chemistry (2021), 36(1),
1290-1311

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl 5-amino-3-methylthiophene-2,4-dicarboxylate
C11H15NO4S
4815-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6445 4.0287 0.0 0
M  V30 2 O 9.9782 3.2587 0.0 0
M  V30 3 O 8.6445 5.5687 0.0 0
M  V30 4 C 11.3120 4.0287 0.0 0
M  V30 5 C 12.6456 3.2587 0.0 0
M  V30 6 C 5.5838 5.3914 0.0 0
M  V30 7 C 3.3420 2.9015 0.0 0
M  V30 8 O 2.4368 1.6557 0.0 0
M  V30 9 O 2.7156 4.3085 0.0 0
M  V30 10 C 0.9052 1.8166 0.0 0
M  V30 11 C 0.0000 0.5707 0.0 0
M  V30 12 N 5.0172 0.0000 0.0 0
M  V30 13 C 7.3109 3.2587 0.0 0
M  V30 14 C 5.9039 3.8850 0.0 0
M  V30 15 S 7.1499 1.7271 0.0 0
M  V30 16 C 4.8735 2.7406 0.0 0
M  V30 17 C 5.6435 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-methyl-4-oxothieno[2,3-d]pyrimidine-6-carboxylate
C10H10N2O3S
17417-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 S 4.5865 1.6538 0.0 0
M  V30 13 N 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17417-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15872566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl 5-amino-3-methylthiophene-2,4-dicarboxylate
C11H15NO4S
4815-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6445 4.0287 0.0 0
M  V30 2 O 9.9782 3.2587 0.0 0
M  V30 3 O 8.6445 5.5687 0.0 0
M  V30 4 C 11.3120 4.0287 0.0 0
M  V30 5 C 12.6456 3.2587 0.0 0
M  V30 6 C 5.5838 5.3914 0.0 0
M  V30 7 C 3.3420 2.9015 0.0 0
M  V30 8 O 2.4368 1.6557 0.0 0
M  V30 9 O 2.7156 4.3085 0.0 0
M  V30 10 C 0.9052 1.8166 0.0 0
M  V30 11 C 0.0000 0.5707 0.0 0
M  V30 12 N 5.0172 0.0000 0.0 0
M  V30 13 C 7.3109 3.2587 0.0 0
M  V30 14 C 5.9039 3.8850 0.0 0
M  V30 15 S 7.1499 1.7271 0.0 0
M  V30 16 C 4.8735 2.7406 0.0 0
M  V30 17 C 5.6435 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-methyl-4-oxothieno[2,3-d]pyrimidine-6-carboxylate
C10H10N2O3S
17417-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 S 4.5865 1.6538 0.0 0
M  V30 13 N 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17417-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13786134
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole
C16H12N4O
330792-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2420 3.9845 0.0 0
M  V30 2 N 1.9217 5.4908 0.0 0
M  V30 3 N 0.0000 1.4946 0.0 0
M  V30 4 O 9.3038 4.9318 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 C 2.5622 2.4781 0.0 0
M  V30 7 N 3.8080 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 N 2.3016 0.0000 0.0 0
M  V30 10 C 5.3026 2.6218 0.0 0
M  V30 11 C 6.6365 1.8517 0.0 0
M  V30 12 C 5.3026 4.1618 0.0 0
M  V30 13 C 7.9701 2.6218 0.0 0
M  V30 14 C 6.6365 4.9318 0.0 0
M  V30 15 C 7.9701 4.1618 0.0 0
M  V30 16 C 10.6375 4.1618 0.0 0
M  V30 17 C 10.6375 2.6218 0.0 0
M  V30 18 C 11.9713 4.9318 0.0 0
M  V30 19 C 11.9713 1.8517 0.0 0
M  V30 20 C 13.3050 4.1618 0.0 0
M  V30 21 C 13.3050 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 15
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 10
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C17H13N5O
330786-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.0873 0.0 0
M  V30 2 O 9.7544 4.9318 0.0 0
M  V30 3 C 4.4196 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 N 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 N 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0304 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 7.0871 1.8517 0.0 0
M  V30 14 C 5.7534 4.1618 0.0 0
M  V30 15 C 8.4208 2.6218 0.0 0
M  V30 16 C 7.0871 4.9318 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 18 C 11.0882 4.1618 0.0 0
M  V30 19 C 12.4219 4.9318 0.0 0
M  V30 20 C 11.0882 2.6218 0.0 0
M  V30 21 C 13.7556 4.1618 0.0 0
M  V30 22 C 12.4219 1.8517 0.0 0
M  V30 23 C 13.7556 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 17
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 6 8
M  V30 11 2 6 9
M  V30 12 1 7 10
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 330792-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330786-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-20358777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of stable amorphous ibrutinib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maier, Thomas; Karapetyan, Inna; Arakelyan, Alvard; Margaryan, Tamara;
Sargsyan, Vardan; Stepanyan, Heghine; Abovyan, Hermine; Gerber
Aeschbacher, Roman; Haferkamp, Sven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United Kingdom, GB2558514 A 2018-07-18

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole
C16H12N4O
330792-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2420 3.9845 0.0 0
M  V30 2 N 1.9217 5.4908 0.0 0
M  V30 3 N 0.0000 1.4946 0.0 0
M  V30 4 O 9.3038 4.9318 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0
M  V30 6 C 2.5622 2.4781 0.0 0
M  V30 7 N 3.8080 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 N 2.3016 0.0000 0.0 0
M  V30 10 C 5.3026 2.6218 0.0 0
M  V30 11 C 6.6365 1.8517 0.0 0
M  V30 12 C 5.3026 4.1618 0.0 0
M  V30 13 C 7.9701 2.6218 0.0 0
M  V30 14 C 6.6365 4.9318 0.0 0
M  V30 15 C 7.9701 4.1618 0.0 0
M  V30 16 C 10.6375 4.1618 0.0 0
M  V30 17 C 10.6375 2.6218 0.0 0
M  V30 18 C 11.9713 4.9318 0.0 0
M  V30 19 C 11.9713 1.8517 0.0 0
M  V30 20 C 13.3050 4.1618 0.0 0
M  V30 21 C 13.3050 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 15
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 10
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
C17H13N5O
330786-24-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.0873 0.0 0
M  V30 2 O 9.7544 4.9318 0.0 0
M  V30 3 C 4.4196 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 N 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 N 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0304 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 7.0871 1.8517 0.0 0
M  V30 14 C 5.7534 4.1618 0.0 0
M  V30 15 C 8.4208 2.6218 0.0 0
M  V30 16 C 7.0871 4.9318 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 18 C 11.0882 4.1618 0.0 0
M  V30 19 C 12.4219 4.9318 0.0 0
M  V30 20 C 11.0882 2.6218 0.0 0
M  V30 21 C 13.7556 4.1618 0.0 0
M  V30 22 C 12.4219 1.8517 0.0 0
M  V30 23 C 13.7556 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 17
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 6 8
M  V30 11 2 6 9
M  V30 12 1 7 10
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 330792-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 330786-24-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-17931000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of stable amorphous ibrutinib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maier, Thomas; Karapetyan, Inna; Arakelyan, Alvard; Margaryan, Tamara;
Sargsyan, Vardan; Stepanyan, Heghine; Abovyan, Hermine; Gerber
Aeschbacher, Roman; Haferkamp, Sven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017137446 A1 2017-08-17

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
B-(2,4-Dimethylphenyl)boronic acid
C8H11BO2
55499-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,4-Dimethylphenyl)formamide
C9H11NO
60397-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 4.0010 0.0 0
M  V30 3 O 8.4702 4.0010 0.0 0
M  V30 4 C 4.6201 0.0000 0.0 0
M  V30 5 C 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 1.3337 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55499-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60397-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-146-CAS-18145894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 86-93-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15158-11-9
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, nanopolystyrene anchored Cu(II) complex of
1-phenyl-1H-tetrazole-5-thiol used as catalyst, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization, antibacterial and catalytic activity of a
nanopolymer supported copper(II) complex as a highly active and
recyclable catalyst for the formamidation of arylboronic acids under
aerobic conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasrollahzadeh, Mahmoud; Zahraei, Ali; Ehsani, Ali; Khalaj, Mehdi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2014), 4(39), 20351-20357

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromodiphenyl ether
C12H9BrO
101-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 3.0800 0.0 0
M  V30 2 Br 9.3358 0.0000 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 0.7700 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 C 6.6684 0.0000 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 8
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Phenoxybenzonitrile
C13H9NO
3096-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 4.0011 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 N 10.7800 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 5.3900 5.3349 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 6.9300 5.3349 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 0.0000 1.3338 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 3 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101-55-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3096-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28988892
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cyanation of Aryl Halides Using Formamide and
Cyanuric Chloride as a New "CN" Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niknam, Esmaeil; Panahi, Farhad; Khalafi-Nezhad, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(18), 2699-2707

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-[3-(trifluoromethyl)phenyl]-3-thiophenecarboxylate
C14H12F3NO2S
1018830-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.7219 3.4208 0.0 0
M  V30 2 O 10.2284 3.1006 0.0 0
M  V30 3 O 8.2461 4.8855 0.0 0
M  V30 4 C 11.2588 4.2452 0.0 0
M  V30 5 C 12.7651 3.9250 0.0 0
M  V30 6 N 9.4185 0.1437 0.0 0
M  V30 7 C 1.5400 5.1048 0.0 0
M  V30 8 F 1.5400 6.6448 0.0 0
M  V30 9 F 0.0000 5.1048 0.0 0
M  V30 10 F 1.5400 3.5648 0.0 0
M  V30 11 C 6.1600 2.4374 0.0 0
M  V30 12 C 7.6915 2.2764 0.0 0
M  V30 13 C 5.5335 1.0306 0.0 0
M  V30 14 C 8.0117 0.7700 0.0 0
M  V30 15 S 6.6781 0.0000 0.0 0
M  V30 16 C 5.3900 3.7710 0.0 0
M  V30 17 C 3.8500 3.7710 0.0 0
M  V30 18 C 6.1600 5.1048 0.0 0
M  V30 19 C 3.0800 5.1048 0.0 0
M  V30 20 C 5.3900 6.4384 0.0 0
M  V30 21 C 3.8500 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 19
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[3-(Trifluoromethyl)phenyl]thieno[2,3-d]pyrimidin-4(1H)-one
C13H7F3N2OS
1929572-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 C 9.7545 1.8517 0.0 0
M  V30 3 F 10.5246 3.1855 0.0 0
M  V30 4 F 11.0882 1.0817 0.0 0
M  V30 5 F 8.9845 0.5181 0.0 0
M  V30 6 C 4.4197 1.8517 0.0 0
M  V30 7 C 3.0128 2.4782 0.0 0
M  V30 8 C 4.2586 0.3202 0.0 0
M  V30 9 C 1.9823 1.3337 0.0 0
M  V30 10 C 2.5369 3.9428 0.0 0
M  V30 11 S 2.7523 0.0000 0.0 0
M  V30 12 N 0.4759 1.6540 0.0 0
M  V30 13 N 1.0304 4.2631 0.0 0
M  V30 14 C 0.0000 3.1186 0.0 0
M  V30 15 C 5.7534 2.6217 0.0 0
M  V30 16 C 7.0871 1.8517 0.0 0
M  V30 17 C 5.7534 4.1618 0.0 0
M  V30 18 C 8.4207 2.6217 0.0 0
M  V30 19 C 7.0871 4.9318 0.0 0
M  V30 20 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1018830-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929572-32-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2919189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-acetyl-3-amino-4,7-dihydro-6-methyl-4-(3-nitrophenyl)thieno[2,3-b]pyr...
C19H19N3O5S
1021184-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6809 6.1600 0.0 0
M  V30 2 O 10.0145 6.9300 0.0 0
M  V30 3 O 8.6809 4.6200 0.0 0
M  V30 4 C 11.3483 6.1600 0.0 0
M  V30 5 C 12.6820 6.9300 0.0 0
M  V30 6 N 2.7394 4.9895 0.0 0
M  V30 7 C 8.6809 9.2400 0.0 0
M  V30 8 C 0.7700 7.7000 0.0 0
M  V30 9 C 0.0000 9.0337 0.0 0
M  V30 10 O 0.0000 6.3664 0.0 0
M  V30 11 N 3.3461 1.5400 0.0 0 VAL=5
M  V30 12 O 3.3461 0.0000 0.0 0
M  V30 13 O 2.0125 2.3100 0.0 0
M  V30 14 C 6.0136 6.1600 0.0 0
M  V30 15 C 4.6798 6.9300 0.0 0
M  V30 16 C 7.3472 6.9300 0.0 0
M  V30 17 C 4.6798 8.4700 0.0 0
M  V30 18 C 3.2152 6.4542 0.0 0
M  V30 19 C 7.3472 8.4700 0.0 0
M  V30 20 S 3.2152 8.9459 0.0 0
M  V30 21 N 6.0136 9.2400 0.0 0
M  V30 22 C 2.3100 7.7000 0.0 0
M  V30 23 C 6.0136 4.6200 0.0 0
M  V30 24 C 4.6798 3.8500 0.0 0
M  V30 25 C 7.3472 3.8500 0.0 0
M  V30 26 C 4.6798 2.3100 0.0 0
M  V30 27 C 7.3472 2.3100 0.0 0
M  V30 28 C 6.0136 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 18
M  V30 7 1 7 19
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 26
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 23
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4,7-dimethyl-9-(3-nitrophenyl)pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine-...
C20H16N4O4S
1021183-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8077 6.1600 0.0 0
M  V30 2 O 10.1414 6.9300 0.0 0
M  V30 3 O 8.8077 4.6200 0.0 0
M  V30 4 C 11.4750 6.1600 0.0 0
M  V30 5 C 12.8088 6.9300 0.0 0
M  V30 6 C 8.8077 9.2400 0.0 0
M  V30 7 C 0.0000 8.7850 0.0 0
M  V30 8 N 8.8077 1.5400 0.0 0 VAL=5
M  V30 9 O 10.1414 2.3100 0.0 0
M  V30 10 O 8.8077 0.0000 0.0 0
M  V30 11 C 4.8067 6.9300 0.0 0
M  V30 12 C 6.1403 6.1600 0.0 0
M  V30 13 C 3.3420 6.4542 0.0 0
M  V30 14 C 4.8067 8.4700 0.0 0
M  V30 15 C 7.4739 6.9300 0.0 0
M  V30 16 C 2.4369 7.7000 0.0 0
M  V30 17 N 2.7156 5.0472 0.0 0
M  V30 18 S 3.3420 8.9459 0.0 0
M  V30 19 N 6.1403 9.2400 0.0 0
M  V30 20 C 7.4739 8.4700 0.0 0
M  V30 21 C 0.9052 7.5391 0.0 0
M  V30 22 C 1.1841 4.8863 0.0 0
M  V30 23 N 0.2789 6.1321 0.0 0
M  V30 24 C 6.1403 4.6200 0.0 0
M  V30 25 C 7.4739 3.8500 0.0 0
M  V30 26 C 4.8067 3.8500 0.0 0
M  V30 27 C 7.4739 2.3100 0.0 0
M  V30 28 C 4.8067 2.3100 0.0 0
M  V30 29 C 6.1403 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 20
M  V30 7 1 7 21
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 27
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 24
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 2 15 20
M  V30 21 1 16 18
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 1 19 20
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1021184-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021183-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12640477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and reactions of some new pyridinethione and
dihydropyridinethione derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abbas-Temirek, H. H.; Harb, Abdel-Fattah A.; Fandy, Ragab F.; Abo-Bakr,
Ahmed M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Assiut University Journal of Chemistry (2006), 35(1), 17-35

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-b]pyridine-5-carboxylic acid, 2-acetyl-3-amino-6-methyl-4-(3-nitro...
C19H17N3O5S
1021184-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6809 6.1600 0.0 0
M  V30 2 O 10.0145 6.9300 0.0 0
M  V30 3 O 8.6809 4.6200 0.0 0
M  V30 4 C 11.3483 6.1600 0.0 0
M  V30 5 C 12.6820 6.9300 0.0 0
M  V30 6 N 2.7394 4.9895 0.0 0
M  V30 7 C 8.6809 9.2400 0.0 0
M  V30 8 C 0.7700 7.7000 0.0 0
M  V30 9 C 0.0000 9.0337 0.0 0
M  V30 10 O 0.0000 6.3664 0.0 0
M  V30 11 N 3.3461 1.5400 0.0 0 VAL=5
M  V30 12 O 3.3461 0.0000 0.0 0
M  V30 13 O 2.0125 2.3100 0.0 0
M  V30 14 C 6.0136 6.1600 0.0 0
M  V30 15 C 4.6798 6.9300 0.0 0
M  V30 16 C 7.3472 6.9300 0.0 0
M  V30 17 C 4.6798 8.4700 0.0 0
M  V30 18 C 3.2152 6.4542 0.0 0
M  V30 19 C 7.3472 8.4700 0.0 0
M  V30 20 S 3.2152 8.9459 0.0 0
M  V30 21 N 6.0136 9.2400 0.0 0
M  V30 22 C 2.3100 7.7000 0.0 0
M  V30 23 C 6.0136 4.6200 0.0 0
M  V30 24 C 4.6798 3.8500 0.0 0
M  V30 25 C 7.3472 3.8500 0.0 0
M  V30 26 C 4.6798 2.3100 0.0 0
M  V30 27 C 7.3472 2.3100 0.0 0
M  V30 28 C 6.0136 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 18
M  V30 7 1 7 19
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 22
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 26
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 23
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4,7-dimethyl-9-(3-nitrophenyl)pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine-...
C20H16N4O4S
1021183-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8077 6.1600 0.0 0
M  V30 2 O 10.1414 6.9300 0.0 0
M  V30 3 O 8.8077 4.6200 0.0 0
M  V30 4 C 11.4750 6.1600 0.0 0
M  V30 5 C 12.8088 6.9300 0.0 0
M  V30 6 C 8.8077 9.2400 0.0 0
M  V30 7 C 0.0000 8.7850 0.0 0
M  V30 8 N 8.8077 1.5400 0.0 0 VAL=5
M  V30 9 O 10.1414 2.3100 0.0 0
M  V30 10 O 8.8077 0.0000 0.0 0
M  V30 11 C 4.8067 6.9300 0.0 0
M  V30 12 C 6.1403 6.1600 0.0 0
M  V30 13 C 3.3420 6.4542 0.0 0
M  V30 14 C 4.8067 8.4700 0.0 0
M  V30 15 C 7.4739 6.9300 0.0 0
M  V30 16 C 2.4369 7.7000 0.0 0
M  V30 17 N 2.7156 5.0472 0.0 0
M  V30 18 S 3.3420 8.9459 0.0 0
M  V30 19 N 6.1403 9.2400 0.0 0
M  V30 20 C 7.4739 8.4700 0.0 0
M  V30 21 C 0.9052 7.5391 0.0 0
M  V30 22 C 1.1841 4.8863 0.0 0
M  V30 23 N 0.2789 6.1321 0.0 0
M  V30 24 C 6.1403 4.6200 0.0 0
M  V30 25 C 7.4739 3.8500 0.0 0
M  V30 26 C 4.8067 3.8500 0.0 0
M  V30 27 C 7.4739 2.3100 0.0 0
M  V30 28 C 4.8067 2.3100 0.0 0
M  V30 29 C 6.1403 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 20
M  V30 7 1 7 21
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 27
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 24
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 2 15 20
M  V30 21 1 16 18
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 1 19 20
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1021184-08-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1021183-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14790853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and reactions of some new pyridinethione and
dihydropyridinethione derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abbas-Temirek, H. H.; Harb, Abdel-Fattah A.; Fandy, Ragab F.; Abo-Bakr,
Ahmed M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Assiut University Journal of Chemistry (2006), 35(1), 17-35

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(2,4-difluorophenyl)-3-thiophenecarboxylate
C13H11F2NO2S
1036587-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2494 2.4581 0.0 0
M  V30 2 O 1.7849 1.9823 0.0 0
M  V30 3 O 4.3939 1.4277 0.0 0
M  V30 4 C 1.4647 0.4760 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 N 1.0076 4.9480 0.0 0
M  V30 7 F 7.6438 6.1309 0.0 0
M  V30 8 F 10.3112 1.5109 0.0 0
M  V30 9 C 3.5696 3.9646 0.0 0
M  V30 10 C 4.9765 4.5909 0.0 0
M  V30 11 C 2.5392 5.1089 0.0 0
M  V30 12 C 4.8156 6.1224 0.0 0
M  V30 13 S 3.3092 6.4427 0.0 0
M  V30 14 C 6.3102 3.8209 0.0 0
M  V30 15 C 7.6438 4.5909 0.0 0
M  V30 16 C 6.3102 2.2809 0.0 0
M  V30 17 C 8.9776 3.8209 0.0 0
M  V30 18 C 7.6438 1.5109 0.0 0
M  V30 19 C 8.9776 2.2809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 15
M  V30 8 1 8 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 10 14
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,4-Difluorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H6F2N2OS
1929572-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 F 7.0871 0.3117 0.0 0
M  V30 3 F 9.7545 4.9318 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.4197 1.8517 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 C 4.2586 0.3202 0.0 0
M  V30 9 S 2.7523 0.0000 0.0 0
M  V30 10 N 0.4759 1.6540 0.0 0
M  V30 11 N 1.0306 4.2631 0.0 0
M  V30 12 C 0.0000 3.1186 0.0 0
M  V30 13 C 5.7534 2.6217 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 5.7534 4.1618 0.0 0
M  V30 16 C 8.4207 2.6217 0.0 0
M  V30 17 C 7.0871 4.9318 0.0 0
M  V30 18 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 13
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 9
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1036587-77-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929572-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9637718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Thiophenecarboxylic acid, 2-amino-4-(3-chloro-4-fluorophenyl)-, ethyl ester
C13H11ClFNO2S
1036604-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1820 4.3513 0.0 0
M  V30 2 O 8.6885 4.6715 0.0 0
M  V30 3 O 6.7062 2.8866 0.0 0
M  V30 4 C 9.7189 3.5271 0.0 0
M  V30 5 C 11.2252 3.8473 0.0 0
M  V30 6 N 7.8786 7.6285 0.0 0
M  V30 7 Cl 0.0000 2.6675 0.0 0
M  V30 8 F 1.5400 0.0000 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 6.1516 5.4957 0.0 0
M  V30 11 C 3.9936 6.7417 0.0 0
M  V30 12 C 6.4718 7.0021 0.0 0
M  V30 13 S 5.1381 7.7722 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 18 C 3.8500 1.3337 0.0 0
M  V30 19 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 17
M  V30 8 1 8 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Chloro-4-fluorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H6ClFN2OS
1929572-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 Cl 9.7545 1.8517 0.0 0
M  V30 3 F 9.7545 4.9318 0.0 0
M  V30 4 C 4.4197 1.8517 0.0 0
M  V30 5 C 3.0128 2.4782 0.0 0
M  V30 6 C 4.2586 0.3202 0.0 0
M  V30 7 C 1.9823 1.3337 0.0 0
M  V30 8 C 2.5369 3.9428 0.0 0
M  V30 9 S 2.7523 0.0000 0.0 0
M  V30 10 N 0.4759 1.6540 0.0 0
M  V30 11 N 1.0306 4.2631 0.0 0
M  V30 12 C 0.0000 3.1186 0.0 0
M  V30 13 C 5.7534 2.6217 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 5.7534 4.1618 0.0 0
M  V30 16 C 8.4207 2.6217 0.0 0
M  V30 17 C 7.0871 4.9318 0.0 0
M  V30 18 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 16
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1036604-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929572-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9919043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME34 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azido-6-bromobenzaldehyde
C7H4BrN3O
2116536-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 2.3100 0.0 0
M  V30 2 N 6.6685 3.0800 0.0 0 CHG=1 VAL=4
M  V30 3 N 8.0021 3.8500 0.0 0 CHG=-1
M  V30 4 C 2.6674 0.7700 0.0 0
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 Br 0.0000 2.3100 0.0 0
M  V30 7 C 4.0011 3.0800 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 5.3900 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Toluenesulfonic acid
C7H8O3S
104-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-[(2-azido-6-bromophenyl)[(4-methylphenyl)sulfonyl]methyl]-
C15H13BrN4O3S
2983187-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 S 7.7000 4.0011 0.0 0 VAL=6
M  V30 3 N 5.3900 2.6674 0.0 0
M  V30 4 O 7.7000 5.5411 0.0 0
M  V30 5 O 7.7000 2.4611 0.0 0
M  V30 6 C 6.1600 1.3336 0.0 0
M  V30 7 O 5.3900 0.0000 0.0 0
M  V30 8 N 3.0800 4.0011 0.0 0
M  V30 9 N 1.5400 4.0011 0.0 0 CHG=1 VAL=4
M  V30 10 N 0.0000 4.0011 0.0 0 CHG=-1
M  V30 11 Br 7.7000 6.6685 0.0 0
M  V30 12 C 13.8600 4.0011 0.0 0
M  V30 13 C 5.3900 5.3347 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 6.1600 6.6685 0.0 0
M  V30 16 C 3.0800 6.6685 0.0 0
M  V30 17 C 5.3900 8.0021 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 10.0100 2.6674 0.0 0
M  V30 22 C 11.5500 5.3347 0.0 0
M  V30 23 C 11.5500 2.6674 0.0 0
M  V30 24 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 19
M  V30 7 1 3 6
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 14
M  V30 11 2 9 10
M  V30 12 1 11 15
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2116536-03-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2983187-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37740967
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1,2,3-Benzotriazine Synthesis by Heterocyclization of p-Tosylmethyl
Isocyanide Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maqueda-Zelaya, Francisco; Acena, Jose Luis; Merino, Estibaliz; Vaquero,
Juan J.; Sucunza, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2023), 88(19), 14131-14139

$RFMT $RIREG SCHEME35 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopentanone
C5H8O
120-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 1.2459 0.0 0
M  V30 2 C 2.3698 1.2459 0.0 0
M  V30 3 C 1.4645 2.4917 0.0 0
M  V30 4 C 1.4645 0.0000 0.0 0
M  V30 5 C 0.0000 2.0159 0.0 0
M  V30 6 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methoxyphenyl)amino]cyclopentanecarboxamide
C13H18N2O2
110817-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.4229 3.8119 0.0 0
M  V30 2 C 1.4070 3.3833 0.0 0
M  V30 3 N 1.5679 4.9150 0.0 0
M  V30 4 O 0.0000 2.7570 0.0 0
M  V30 5 O 9.5830 3.8119 0.0 0
M  V30 6 C 10.3530 5.1456 0.0 0
M  V30 7 C 2.6529 2.4782 0.0 0
M  V30 8 C 1.6224 1.3337 0.0 0
M  V30 9 C 4.0597 1.8517 0.0 0
M  V30 10 C 2.3924 0.0000 0.0 0
M  V30 11 C 3.8987 0.3202 0.0 0
M  V30 12 C 4.9629 3.8119 0.0 0
M  V30 13 C 5.7329 5.1456 0.0 0
M  V30 14 C 5.7329 2.4782 0.0 0
M  V30 15 C 7.2730 5.1456 0.0 0
M  V30 16 C 7.2730 2.4782 0.0 0
M  V30 17 C 8.0430 3.8119 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 7
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 120-92-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 110817-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28080431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of
quaternary α-aminoamides starting from aryl amines and ketones. A
homogeneous solution of formamide (10 mL) containing aryl amine (2 mmol),
cyclic (12 mmol) or acyclic ketone (24 mmol) and TiCl4 (2.5 mmol) was
well stirred at 0 °C under N2 atmosphere. After 30 minutes, Zn powder
(300 mg, ca. 5 mmol) was suspended in the reaction medium and an aqueous
35 wt % H2O2 solution (ca. 0.5 mL, 5 mmol), diluted in 4.5 mL of
formamide, was added dropwise over 3 hrs. The reaction looks like a
titration which proceeds with periodic changes of colour from orange to
violet, and H2O2 was added until a pale orange was barely maintained upon
further addition of Zn. At this point, the reaction was quenched with 5
mL of H2O and added with a 30 % aqueous NH3 solution until basic pH (a
white precipitate of Ti(IV) hydroxide was observed) and extracted with
EtOAc (3 x 50 mL). The combined organic layers were concentrated in vacuo
and the residue left was dissolved in CHCl3 (20 mL). The solution was
then washed twice with 5 mL of H2O in order to remove the formamide
leftover, which is insoluble in CHCl3 but very soluble in H2O. The
organic layers were then dried over Na2SO4 and concentrated in vacuum.
Purification by flash chromatography of the crude residue afforded the
α-aminoamides 3 as the last eluted products. Yields of isolated products
are based on the starting amine.
1-(4-methoxyphenylamino)cyclopentanecarboxamide (3j). Purification by FCC
(Hex:AcOEt 4:6) afforded 393 mg of a white crystalline solid; (84 %
isolated yield). m.p. 90-93°C. 1H and 13C NMR (DMSO) compared with the
literature: J. Chem. Soc. 1927, 486.
$DTYPE RXN:VAR(1):NOTES
$DATUM one-pot reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Free-Radical Addition to Ketimines Generated In Situ. New One-Pot
Synthesis of Quaternary α-Aminoamides Promoted by a H2O2/TiCl4-Zn/HCONH2
System
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pastori, Nadia; Greco, Cosimina; Clerici, Angelo; Punta, Carlo; Porta,
Ombretta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2010), 12(17), 3898-3901

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethylpyridine
C7H9N
108-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.0800 0.0 0
M  V30 2 C 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dimethyl-2-pyridinecarboxamide
C8H10N2O
72693-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 72693-02-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21158816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7727-21-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7761-88-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, Schlenk flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid-Free Silver-Catalyzed Cross-Dehydrogenative Carbamoylation of
Pyridines with Formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Wei; Jin, Fengli; Zhao, Qian; Du, Hongyan; Yao, Lifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(12), 1854-1859

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hexen-2-one
C6H10O
109-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methyl-4-penten-1-yl)formamide
C7H13NO
1314968-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 2.6675 2.3101 0.0 0
M  V30 4 C 4.0012 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0023 2.3101 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109-49-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1314968-55-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17943714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Artificial Macrocycles as Potent p53-MDM2 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Estrada-Ortiz, Natalia; Neochoritis, Constantinos G.; Twarda-Clapa,
Aleksandra; Musielak, Bogdan; Holak, Tad A.; Doemling, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2017), 8(10), 1025-1030

$RFMT $RIREG SCHEME38 STEP1
$RXN



  4  1
$MOL
Methyl 2,3-dihydro-6-nitro-2-oxo-1H-benzimidazole-5-carboxylate
C9H7N3O5
205259-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 O 1.5400 5.3347 0.0 0
M  V30 3 O 1.5400 2.6674 0.0 0
M  V30 4 C 0.0000 5.3347 0.0 0
M  V30 5 O 9.9312 6.6229 0.0 0
M  V30 6 N 3.8500 1.3338 0.0 0 VAL=5
M  V30 7 O 2.3100 1.3338 0.0 0
M  V30 8 O 4.6200 0.0000 0.0 0
M  V30 9 C 6.1600 5.3347 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 N 7.1906 6.4792 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 N 8.4364 4.3212 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 8.5974 5.8529 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 5 16
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iodoethane
C2H5I
75-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 I 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Piperazine
C4H10N2
110-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.3337 0.0 0
M  V30 2 C 0.7700 0.0000 0.0 0
M  V30 3 N 0.7700 2.6673 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Diethyl-1,3-dihydro-8-(1-piperazinyl)-2H-imidazo[4,5-g]quinazolin-2-one
C17H22N6O
205259-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6404 1.0304 0.0 0
M  V30 2 C 8.7850 0.0000 0.0 0
M  V30 3 C 10.3510 5.7252 0.0 0
M  V30 4 C 11.8158 5.2494 0.0 0
M  V30 5 O 10.7012 2.3932 0.0 0
M  V30 6 C 6.9302 3.6813 0.0 0
M  V30 7 C 7.7002 5.0150 0.0 0
M  V30 8 N 7.9607 2.5367 0.0 0
M  V30 9 C 5.3901 3.6813 0.0 0
M  V30 10 N 9.2066 4.6948 0.0 0
M  V30 11 C 6.9302 6.3486 0.0 0
M  V30 12 C 9.3676 3.1632 0.0 0
M  V30 13 C 4.6201 5.0150 0.0 0
M  V30 14 C 5.3901 6.3486 0.0 0
M  V30 15 C 3.0801 5.0150 0.0 0
M  V30 16 N 4.6201 7.6823 0.0 0
M  V30 17 N 2.3101 6.3486 0.0 0
M  V30 18 C 3.0801 7.6823 0.0 0
M  V30 19 N 2.3101 3.6813 0.0 0
M  V30 20 C 0.7700 3.6813 0.0 0
M  V30 21 C 3.0801 2.3475 0.0 0
M  V30 22 C 0.0000 2.3475 0.0 0
M  V30 23 C 2.3101 1.0138 0.0 0
M  V30 24 N 0.7700 1.0138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 12
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 205259-23-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-03-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 110-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 205259-28-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-3718098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To an ice-cooled solution of
1,3-dihydro-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid methyl ester
(7.78 g, 32.8 mmol) in DMF (100 mL) was added 60% sodium hydride (3.94 g,
98.5 mmol). The mixture was stirred for 15 min at the same temperature,
and iodomethane (6.13 mL, 98.5 mmol) was added. Then the reaction mixture
was stirred for 1.5 h at room temperature and poured into water. The
resulting precipitate was collected, washed with water, and dried to
provide
1,3-dihydro-1,3-dimethyl-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester (8.58 g, 32.5 mmol) in 99% yield. (3) A suspension of
1,3-dihydro-1,3-dimethyl-6-nitro-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester (8.58 g, 32.4 mmol) and 10% Pd/C (1.60 g, containing 50%
water) in ethanol (100 mL) was hydrogenated for 5.5 h under hydrogen
stream at room temperature. After removal of catalyst by filtration
through Celite, the filtrate was evaporated to provide
6-amino-1,3-dihydro-1,3-dimethyl-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester. This compound was used for the next reaction without
further purification. (4) A solution of
6-amino-1,3-dihydro-1,3-dimethyl-2-oxo-2H-benzimidazole-5-carboxylic acid
methyl ester in forma- mide (100 mL) was heated for 2 h at 190°C. The
reaction mixture was cooled to room temperature and poured into water,
and then NaCl was added. The resulting precipitate was collected, washed
with water, and dried to provide
1,3-dihydro-1,3-dimethyl-2H,7H-imidazo[4,5-g]quinazoline-2,8-di-one (4.73
g, 20.7 mmol) in 64% yield in two steps. Commercially available
4-hydroxyquinazoline (1.00 g, 6.85 mmol) was chlorinated with phosphorus
oxychloride (20 mL) by a known procedure. A mixture of
4-chloroquinazoline and anhydrous piperazine (5.89 g, 68.4 mmol) in
2-propanol (20 mL) was refluxed for 4 h. The reaction mixture was
evaporated, and the resulting residue was dissolved in brine, extracted
with chloroform, washed with brine, dried over anhydrous sodium sulfate,
and evaporated. yield 90%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Inhibitors of Platelet-Derived Growth Factor
Receptor Phosphorylation. 3. Replacement of Quinazoline Moiety and
Improvement of Metabolic Polymorphism of 4-[4-(N-Substituted
(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsuno, Kenji; Ushiki, Junko; Seishi, Takashi; Ichimura, Michio; Giese,
Neill A.; Yu, Jin-Chen; Takahashi, Shusuke; Oda, Shoji; Nomoto, Yuji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(23), 4910-4925

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetylpyridine
C7H7NO
1122-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetyl-2-pyridinecarboxamide
C8H8N2O2
135450-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 C 6.6686 3.0800 0.0 0
M  V30 5 N 6.6686 4.6201 0.0 0
M  V30 6 O 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 N 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-54-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 135450-71-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-21125556
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-53-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7727-21-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7761-88-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, Schlenk flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Acid-Free Silver-Catalyzed Cross-Dehydrogenative Carbamoylation of
Pyridines with Formamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Wei; Jin, Fengli; Zhao, Qian; Du, Hongyan; Yao, Lifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(12), 1854-1859

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-pyridinyl)-3-thiophenecarboxylate
C12H12N2O2S
117516-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6421 3.4209 0.0 0
M  V30 2 O 7.1485 3.1007 0.0 0
M  V30 3 O 5.1662 4.8856 0.0 0
M  V30 4 C 8.1789 4.2451 0.0 0
M  V30 5 C 9.6852 3.9249 0.0 0
M  V30 6 N 6.3386 0.1437 0.0 0
M  V30 7 C 3.0801 2.4374 0.0 0
M  V30 8 C 4.6116 2.2765 0.0 0
M  V30 9 C 2.4536 1.0306 0.0 0
M  V30 10 C 4.9318 0.7700 0.0 0
M  V30 11 S 3.5981 0.0000 0.0 0
M  V30 12 C 2.3100 3.7711 0.0 0
M  V30 13 C 3.0801 5.1049 0.0 0
M  V30 14 C 0.7700 3.7711 0.0 0
M  V30 15 C 2.3100 6.4386 0.0 0
M  V30 16 C 0.0000 5.1049 0.0 0
M  V30 17 N 0.7700 6.4386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Pyridinyl)thieno[2,3-d]pyrimidin-4(1H)-one
C11H7N3OS
1421263-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5674 5.0873 0.0 0
M  V30 2 C 4.4197 1.8517 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 C 4.2588 0.3202 0.0 0
M  V30 5 C 1.9823 1.3337 0.0 0
M  V30 6 C 2.5369 3.9428 0.0 0
M  V30 7 S 2.7523 0.0000 0.0 0
M  V30 8 N 0.4760 1.6540 0.0 0
M  V30 9 N 1.0306 4.2631 0.0 0
M  V30 10 C 0.0000 3.1185 0.0 0
M  V30 11 C 5.7533 2.6217 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 7.0870 1.8517 0.0 0
M  V30 14 C 7.0870 4.9318 0.0 0
M  V30 15 C 8.4208 2.6217 0.0 0
M  V30 16 N 8.4208 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117516-88-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1421263-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13527249
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME41 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′,N′′-Methylidynetris[formamide]
C4H7N3O3
4774-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 N 2.3100 5.3347 0.0 0
M  V30 3 N 4.6200 4.0011 0.0 0
M  V30 4 N 2.3100 2.6674 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 O 0.0000 6.6685 0.0 0
M  V30 9 O 6.9300 5.3347 0.0 0
M  V30 10 O 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5,6,7-Tetrahydro-1-phenyl-2-(phenylmethyl)-4H-isoindol-4-one
C21H19NO
1189363-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8690 6.0811 0.0 0
M  V30 2 O 5.9146 0.0000 0.0 0
M  V30 3 C 3.5673 4.5863 0.0 0
M  V30 4 C 3.2471 3.0800 0.0 0
M  V30 5 N 5.0990 4.7473 0.0 0
M  V30 6 C 4.5809 2.3100 0.0 0
M  V30 7 C 1.9135 2.3100 0.0 0
M  V30 8 C 5.7253 3.3405 0.0 0
M  V30 9 C 4.5809 0.7700 0.0 0
M  V30 10 C 1.9135 0.7700 0.0 0
M  V30 11 C 3.2471 0.0000 0.0 0
M  V30 12 C 2.5369 5.7307 0.0 0
M  V30 13 C 3.0127 7.1954 0.0 0
M  V30 14 C 1.0306 5.4105 0.0 0
M  V30 15 C 1.9823 8.3398 0.0 0
M  V30 16 C 0.0000 6.5551 0.0 0
M  V30 17 C 0.4760 8.0196 0.0 0
M  V30 18 C 7.4090 6.0811 0.0 0
M  V30 19 C 8.1790 4.7473 0.0 0
M  V30 20 C 8.1790 7.4147 0.0 0
M  V30 21 C 9.7190 4.7473 0.0 0
M  V30 22 C 9.7190 7.4147 0.0 0
M  V30 23 C 10.4891 6.0811 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 18
M  V30 3 2 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 2 6 8
M  V30 11 1 6 9
M  V30 12 1 7 10
M  V30 13 1 9 11
M  V30 14 1 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,8-Dihydro-7-phenyl-8-(phenylmethyl)-5H-pyrrolo[3,4-h]quinazoline
C23H19N3
1189364-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6229 4.0012 0.0 0
M  V30 2 C 6.4792 6.7418 0.0 0
M  V30 3 C 5.3348 7.7722 0.0 0
M  V30 4 N 5.8529 5.3348 0.0 0
M  V30 5 C 4.0010 7.0022 0.0 0
M  V30 6 C 5.3348 9.3123 0.0 0
M  V30 7 C 4.3212 5.4958 0.0 0
M  V30 8 C 2.6673 7.7722 0.0 0
M  V30 9 C 4.0010 10.0823 0.0 0
M  V30 10 C 2.6673 9.3123 0.0 0
M  V30 11 N 1.3337 7.0022 0.0 0
M  V30 12 C 1.3337 10.0823 0.0 0
M  V30 13 C 0.0000 7.7722 0.0 0
M  V30 14 N 0.0000 9.3123 0.0 0
M  V30 15 C 7.9855 7.0620 0.0 0
M  V30 16 C 9.0161 5.9174 0.0 0
M  V30 17 C 8.4616 8.5266 0.0 0
M  V30 18 C 10.5224 6.2376 0.0 0
M  V30 19 C 9.9679 8.8467 0.0 0
M  V30 20 C 10.9983 7.7023 0.0 0
M  V30 21 C 5.8529 2.6675 0.0 0
M  V30 22 C 6.6229 1.3337 0.0 0
M  V30 23 C 4.3129 2.6675 0.0 0
M  V30 24 C 5.8529 0.0000 0.0 0
M  V30 25 C 3.5428 1.3337 0.0 0
M  V30 26 C 4.3129 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 21
M  V30 3 2 2 3
M  V30 4 1 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 4 7
M  V30 9 2 5 7
M  V30 10 1 5 8
M  V30 11 1 6 9
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 10
M  V30 15 2 10 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 2 13 14
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4774-33-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1189363-88-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1189364-04-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25667239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of the new ring system 6,8-dihydro-5H-pyrrolo[3,4-h]quinazoline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barraja, Paola; Spano, Virginia; Diana, Patrizia; Carbone, Anna;
Cirrincione, Girolamo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(38), 5389-5391

$RFMT $RIREG SCHEME42 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isoquinoline
C9H7N
119-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 N 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dimethyl 2-[1-(formylamino)-2(1H)-isoquinolinyl]-2-butenedioate
C16H16N2O5
942481-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0
M  V30 2 C 6.6684 7.7000 0.0 0
M  V30 3 C 4.0011 7.7000 0.0 0
M  V30 4 C 8.0021 6.9300 0.0 0
M  V30 5 O 4.0011 9.2400 0.0 0
M  V30 6 O 2.6673 6.9300 0.0 0
M  V30 7 O 9.3358 7.7000 0.0 0
M  V30 8 O 8.0021 5.3900 0.0 0
M  V30 9 C 2.6673 10.0100 0.0 0
M  V30 10 C 10.6694 6.9300 0.0 0
M  V30 11 N 2.6673 5.3900 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 O 0.0000 5.3900 0.0 0
M  V30 14 N 5.3347 5.3900 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 4.0011 3.0800 0.0 0
M  V30 18 C 6.6684 3.0800 0.0 0
M  V30 19 C 5.3347 2.3100 0.0 0
M  V30 20 C 2.6673 2.3100 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 2.6673 0.7700 0.0 0
M  V30 23 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 15
M  V30 13 2 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 19
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-65-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942481-39-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26163579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile and clean synthesis of disubstituted-1,2-dihydroisoquinoline
derivatives via three-component reaction without catalyst at room
temperature
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sajjadifar, Sami; Rezayati, Sobhan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of ChemTech Research (2013), 5(1), 255-261

$RFMT $RIREG SCHEME42 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isoquinoline
C9H7N
119-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 N 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dimethyl 2-[1-(formylamino)-2(1H)-isoquinolinyl]-2-butenedioate
C16H16N2O5
942481-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.9300 0.0 0
M  V30 2 C 6.6684 7.7000 0.0 0
M  V30 3 C 4.0011 7.7000 0.0 0
M  V30 4 C 8.0021 6.9300 0.0 0
M  V30 5 O 4.0011 9.2400 0.0 0
M  V30 6 O 2.6673 6.9300 0.0 0
M  V30 7 O 9.3358 7.7000 0.0 0
M  V30 8 O 8.0021 5.3900 0.0 0
M  V30 9 C 2.6673 10.0100 0.0 0
M  V30 10 C 10.6694 6.9300 0.0 0
M  V30 11 N 2.6673 5.3900 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 O 0.0000 5.3900 0.0 0
M  V30 14 N 5.3347 5.3900 0.0 0
M  V30 15 C 4.0011 4.6200 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 4.0011 3.0800 0.0 0
M  V30 18 C 6.6684 3.0800 0.0 0
M  V30 19 C 5.3347 2.3100 0.0 0
M  V30 20 C 2.6673 2.3100 0.0 0
M  V30 21 C 5.3347 0.7700 0.0 0
M  V30 22 C 2.6673 0.7700 0.0 0
M  V30 23 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 15
M  V30 13 2 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 19
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-65-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942481-39-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24933805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of dimethyl 1,2-dihydroisoquinolines through the reaction of
isoquinoline and dimethyl acetylenedicarboxylate in the presence of
amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yavari, Issa; Ghazanfarpour-Darjani, Majid; Sabbaghan, Maryam; Hossaini,
Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2007), 48(21), 3749-3751

$RFMT $RIREG SCHEME43 STEP1
$RXN



  3  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isoquinoline
C9H7N
119-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 N 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl propiolate
C4H4O2
922-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 3.8500 1.3336 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-[1-(formylamino)-2(1H)-isoquinolinyl]-2-propenoate
C14H14N2O3
1947312-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 2.3100 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 O 2.6673 0.0000 0.0 0
M  V30 4 C 6.6684 3.8500 0.0 0
M  V30 5 C 8.0021 4.6200 0.0 0
M  V30 6 C 8.0021 6.1600 0.0 0
M  V30 7 O 9.3358 6.9300 0.0 0
M  V30 8 O 6.6684 6.9300 0.0 0
M  V30 9 C 10.6694 6.1600 0.0 0
M  V30 10 C 2.6673 4.6200 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0 CFG=3
M  V30 12 C 2.6673 6.1600 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 N 5.3347 4.6200 0.0 0
M  V30 15 C 4.0011 6.9300 0.0 0
M  V30 16 C 1.3336 6.9300 0.0 0
M  V30 17 C 0.0000 4.6200 0.0 0
M  V30 18 C 5.3347 6.1600 0.0 0
M  V30 19 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119-65-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 922-67-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1947312-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28531119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 30345-49-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyst-Induced Multicomponent Reaction: An Efficient Procedure
for the Activation of Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Samzadeh-Kermani, Alireza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(15), 2213-2216

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dimethoxy-2-nitrobenzaldehyde
C9H9NO5
1206-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 C 4.0011 6.1600 0.0 0
M  V30 5 O 5.3347 6.9300 0.0 0
M  V30 6 O 1.3336 1.5400 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 O 6.6685 4.6200 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-[(3,6-Dimethoxy-2-nitrophenyl)methylene]bis[formamide]
C11H13N3O6
19819-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 N 2.6673 3.8500 0.0 0
M  V30 3 N 4.0011 6.1600 0.0 0
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 C 2.6673 6.9300 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 2.6673 8.4700 0.0 0
M  V30 8 N 6.6684 6.1600 0.0 0 VAL=5
M  V30 9 O 5.3347 6.9300 0.0 0
M  V30 10 O 8.0021 6.9300 0.0 0
M  V30 11 O 4.0011 1.5400 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 O 9.3358 4.6200 0.0 0
M  V30 14 C 10.6694 3.8500 0.0 0
M  V30 15 C 5.3347 3.8500 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 5.3347 2.3100 0.0 0
M  V30 18 C 8.0021 3.8500 0.0 0
M  V30 19 C 6.6684 1.5400 0.0 0
M  V30 20 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 17
M  V30 13 1 13 14
M  V30 14 1 13 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1206-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19819-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-314-CAS-21119382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Novel Reactive Oxygen Species Inducers for the
Treatment of Pancreatic Ductal Adenocarcinoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuang, Yuting; Sechi, Mario; Nurra, Salvatore; Ljungman, Mats; Neamati,
Nouri
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(4), 1576-1594

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dimethoxy-2-nitrobenzaldehyde
C9H9NO5
1206-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 C 4.0011 6.1600 0.0 0
M  V30 5 O 5.3347 6.9300 0.0 0
M  V30 6 O 1.3336 1.5400 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 O 6.6685 4.6200 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-[(3,6-Dimethoxy-2-nitrophenyl)methylene]bis[formamide]
C11H13N3O6
19819-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 N 2.6673 3.8500 0.0 0
M  V30 3 N 4.0011 6.1600 0.0 0
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 C 2.6673 6.9300 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 2.6673 8.4700 0.0 0
M  V30 8 N 6.6684 6.1600 0.0 0 VAL=5
M  V30 9 O 5.3347 6.9300 0.0 0
M  V30 10 O 8.0021 6.9300 0.0 0
M  V30 11 O 4.0011 1.5400 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 O 9.3358 4.6200 0.0 0
M  V30 14 C 10.6694 3.8500 0.0 0
M  V30 15 C 5.3347 3.8500 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 5.3347 2.3100 0.0 0
M  V30 18 C 8.0021 3.8500 0.0 0
M  V30 19 C 6.6684 1.5400 0.0 0
M  V30 20 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 17
M  V30 13 1 13 14
M  V30 14 1 13 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1206-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19819-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-314-CAS-21165001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):NOTES
$DATUM HCl gas used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazoline derivatives as small molecule inducers of reactive oxygen
species and inhibitors of mitochondrial activity and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neamati, Nouri; Sechi, Mario
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017155991 A1 2017-09-14

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dimethoxy-2-nitrobenzaldehyde
C9H9NO5
1206-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 C 4.0011 6.1600 0.0 0
M  V30 5 O 5.3347 6.9300 0.0 0
M  V30 6 O 1.3336 1.5400 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 O 6.6685 4.6200 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-[(3,6-Dimethoxy-2-nitrophenyl)methylene]bis[formamide]
C11H13N3O6
19819-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 N 2.6673 3.8500 0.0 0
M  V30 3 N 4.0011 6.1600 0.0 0
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 C 2.6673 6.9300 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 2.6673 8.4700 0.0 0
M  V30 8 N 6.6684 6.1600 0.0 0 VAL=5
M  V30 9 O 5.3347 6.9300 0.0 0
M  V30 10 O 8.0021 6.9300 0.0 0
M  V30 11 O 4.0011 1.5400 0.0 0
M  V30 12 C 4.0011 0.0000 0.0 0
M  V30 13 O 9.3358 4.6200 0.0 0
M  V30 14 C 10.6694 3.8500 0.0 0
M  V30 15 C 5.3347 3.8500 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 5.3347 2.3100 0.0 0
M  V30 18 C 8.0021 3.8500 0.0 0
M  V30 19 C 6.6684 1.5400 0.0 0
M  V30 20 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 12
M  V30 12 1 11 17
M  V30 13 1 13 14
M  V30 14 1 13 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1206-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19819-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-314-CAS-21390030
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to
Pancreatic Cancer Cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sanna, Vanna; Nurra, Salvatore; Pala, Nicolino; Marceddu, Salvatore;
Pathania, Divya; Neamati, Nouri; Sechi, Mario
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(11), 5209-5220

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-(4-methylphenyl)-1-phenyl-1H-pyrrole-3-carbonitrile
C18H15N3
1207646-01-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.2459 3.9646 0.0 0
M  V30 2 C 1.2459 7.3150 0.0 0
M  V30 3 N 0.0000 8.2203 0.0 0
M  V30 4 C 11.0215 5.6398 0.0 0
M  V30 5 C 4.8615 5.6398 0.0 0
M  V30 6 N 3.9564 4.3940 0.0 0
M  V30 7 C 3.9564 6.8857 0.0 0
M  V30 8 C 2.4917 4.8698 0.0 0
M  V30 9 C 2.4917 6.4098 0.0 0
M  V30 10 C 6.4015 5.6398 0.0 0
M  V30 11 C 7.1715 4.3062 0.0 0
M  V30 12 C 7.1715 6.9735 0.0 0
M  V30 13 C 8.7115 4.3062 0.0 0
M  V30 14 C 8.7115 6.9735 0.0 0
M  V30 15 C 9.4815 5.6398 0.0 0
M  V30 16 C 4.4323 2.9292 0.0 0
M  V30 17 C 3.4017 1.7849 0.0 0
M  V30 18 C 5.9386 2.6091 0.0 0
M  V30 19 C 3.8777 0.3202 0.0 0
M  V30 20 C 6.4144 1.1445 0.0 0
M  V30 21 C 5.3840 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 3 2 3
M  V30 3 1 2 9
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Methylphenyl)-7-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
C19H16N4
1257392-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 8.7199 0.0 0
M  V30 2 C 11.1972 5.6398 0.0 0
M  V30 3 N 4.1320 4.3940 0.0 0
M  V30 4 C 5.0371 5.6398 0.0 0
M  V30 5 C 2.6673 4.8698 0.0 0
M  V30 6 C 4.1320 6.8857 0.0 0
M  V30 7 C 2.6673 6.4099 0.0 0
M  V30 8 N 1.3337 4.0998 0.0 0
M  V30 9 C 1.3337 7.1799 0.0 0
M  V30 10 C 0.0000 4.8698 0.0 0
M  V30 11 N 0.0000 6.4099 0.0 0
M  V30 12 C 4.6079 2.9293 0.0 0
M  V30 13 C 3.5773 1.7849 0.0 0
M  V30 14 C 6.1142 2.6091 0.0 0
M  V30 15 C 4.0533 0.3202 0.0 0
M  V30 16 C 6.5900 1.1445 0.0 0
M  V30 17 C 5.5596 0.0000 0.0 0
M  V30 18 C 6.5771 5.6398 0.0 0
M  V30 19 C 7.3471 4.3062 0.0 0
M  V30 20 C 7.3471 6.9735 0.0 0
M  V30 21 C 8.8871 4.3062 0.0 0
M  V30 22 C 8.8871 6.9735 0.0 0
M  V30 23 C 9.6571 5.6398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 23
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 7
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1207646-01-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1257392-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21258618
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial
and antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hassan Hilmy, Khalid Mohammed; Khalifa, Maha M. A.; Allah Hawata,
Mohammed Abd; AboAlzeen Keshk, Reda Mohammed; El-Torgman, Abd Almeneam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2010), 45(11), 5243-5250

$RFMT $RIREG SCHEME46 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Fluoren-9-ylmethyl N-[(1S)-2-mercapto-1-methylethyl]carbamate
C18H19NO2S
1231959-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4207 5.2310 0.0 0
M  V30 4 N 9.7543 4.4610 0.0 0
M  V30 5 O 8.4207 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0 CFG=1
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 C 11.0881 6.7710 0.0 0
M  V30 9 S 13.7554 5.2310 0.0 0
M  V30 10 C 4.4195 4.4610 0.0 0
M  V30 11 C 4.2586 2.9293 0.0 0
M  V30 12 C 3.0127 5.0873 0.0 0
M  V30 13 C 2.7523 2.6091 0.0 0
M  V30 14 C 5.2890 1.7849 0.0 0
M  V30 15 C 1.9823 3.9429 0.0 0
M  V30 16 C 2.5369 6.5520 0.0 0
M  V30 17 C 2.2763 1.1445 0.0 0
M  V30 18 C 4.8132 0.3202 0.0 0
M  V30 19 C 0.4759 4.2631 0.0 0
M  V30 20 C 1.0304 6.8722 0.0 0
M  V30 21 C 3.3069 0.0000 0.0 0
M  V30 22 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 15
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C20H22N2O3S
2602313-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2310 0.0 0
M  V30 2 O 7.0870 4.4610 0.0 0
M  V30 3 C 8.4208 5.2310 0.0 0
M  V30 4 N 9.7545 4.4610 0.0 0
M  V30 5 O 8.4208 6.7710 0.0 0
M  V30 6 C 11.0881 5.2310 0.0 0 CFG=1
M  V30 7 C 12.4218 4.4610 0.0 0
M  V30 8 C 11.0881 6.7710 0.0 0
M  V30 9 S 13.7556 5.2310 0.0 0
M  V30 10 C 15.0892 4.4610 0.0 0
M  V30 11 N 16.4229 5.2310 0.0 0
M  V30 12 C 17.7565 4.4610 0.0 0
M  V30 13 O 19.0904 5.2310 0.0 0
M  V30 14 C 4.4197 4.4610 0.0 0
M  V30 15 C 4.2588 2.9293 0.0 0
M  V30 16 C 3.0127 5.0873 0.0 0
M  V30 17 C 2.7523 2.6091 0.0 0
M  V30 18 C 5.2892 1.7849 0.0 0
M  V30 19 C 1.9823 3.9429 0.0 0
M  V30 20 C 2.5369 6.5520 0.0 0
M  V30 21 C 2.2765 1.1445 0.0 0
M  V30 22 C 4.8133 0.3202 0.0 0
M  V30 23 C 0.4760 4.2631 0.0 0
M  V30 24 C 1.0306 6.8722 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1231959-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602313-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23167003
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used, Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Nβ-Protected Amino Sulfenyl Methyl Formamides and Sulfonyl
Methyl Formamides: A Simple Protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasulu, Chinthaginjala; Sagar, Nagamangala R.; Vishwanatha,
Thimmalapura M.; Durgamma, Suram; Sureshbabu, Vommina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2021), 6(7), 4680-4686

$RFMT $RIREG SCHEME47 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9H-Fluoren-9-ylmethyl N-[(1S,2S)-1-(mercaptomethyl)-2-methylbutyl]carbamate
C21H25NO2S
1258407-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7532 5.2308 0.0 0
M  V30 2 O 7.0870 4.4608 0.0 0
M  V30 3 C 8.4207 5.2308 0.0 0
M  V30 4 N 9.7544 4.4608 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 11.0880 5.2308 0.0 0 CFG=2
M  V30 7 C 12.4218 4.4608 0.0 0 CFG=1
M  V30 8 C 11.0880 6.7709 0.0 0
M  V30 9 C 13.7555 5.2308 0.0 0
M  V30 10 C 12.4218 2.9208 0.0 0
M  V30 11 S 12.4218 7.5409 0.0 0
M  V30 12 C 15.0892 4.4608 0.0 0
M  V30 13 C 4.4196 4.4608 0.0 0
M  V30 14 C 3.0128 5.0873 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 1.9822 3.9428 0.0 0
M  V30 17 C 2.5369 6.5519 0.0 0
M  V30 18 C 2.7522 2.6091 0.0 0
M  V30 19 C 5.2891 1.7849 0.0 0
M  V30 20 C 0.4759 4.2629 0.0 0
M  V30 21 C 1.0304 6.8721 0.0 0
M  V30 22 C 2.2763 1.1444 0.0 0
M  V30 23 C 4.8132 0.3202 0.0 0
M  V30 24 C 0.0000 5.7277 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 7 10 CFG=3
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 2 23 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C23H28N2O3S
2602313-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 8.4702 0.0 0
M  V30 2 O 5.7533 6.9302 0.0 0
M  V30 3 C 7.0871 6.1601 0.0 0
M  V30 4 N 7.0871 4.6201 0.0 0
M  V30 5 O 8.4208 6.9302 0.0 0
M  V30 6 C 8.4208 3.8501 0.0 0 CFG=1
M  V30 7 C 9.7544 4.6201 0.0 0
M  V30 8 C 8.4208 2.3101 0.0 0 CFG=1
M  V30 9 S 11.0881 3.8501 0.0 0
M  V30 10 C 7.0871 1.5400 0.0 0
M  V30 11 C 9.7544 1.5400 0.0 0
M  V30 12 C 12.4219 4.6201 0.0 0
M  V30 13 C 7.0871 0.0000 0.0 0
M  V30 14 N 13.7556 3.8501 0.0 0
M  V30 15 C 15.0893 4.6201 0.0 0
M  V30 16 O 16.4229 3.8501 0.0 0
M  V30 17 C 4.4196 9.2402 0.0 0
M  V30 18 C 3.0128 8.6137 0.0 0
M  V30 19 C 4.2587 10.7718 0.0 0
M  V30 20 C 1.9822 9.7583 0.0 0
M  V30 21 C 2.5367 7.1491 0.0 0
M  V30 22 C 2.7522 11.0919 0.0 0
M  V30 23 C 5.2891 11.9162 0.0 0
M  V30 24 C 0.4759 9.4381 0.0 0
M  V30 25 C 1.0304 6.8290 0.0 0
M  V30 26 C 2.2763 12.5567 0.0 0
M  V30 27 C 4.8132 13.3809 0.0 0
M  V30 28 C 0.0000 7.9734 0.0 0
M  V30 29 C 3.3068 13.7011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11 CFG=1
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 2 15 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 22
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 25 28
M  V30 30 1 26 29
M  V30 31 2 27 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1258407-22-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602313-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23165306
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used, Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Nβ-Protected Amino Sulfenyl Methyl Formamides and Sulfonyl
Methyl Formamides: A Simple Protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasulu, Chinthaginjala; Sagar, Nagamangala R.; Vishwanatha,
Thimmalapura M.; Durgamma, Suram; Sureshbabu, Vommina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2021), 6(7), 4680-4686

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-[3,5-bis(trifluoromethyl)phenyl]-3-thiophenecarboxylate
C15H11F6NO2S
1263286-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.7220 5.6850 0.0 0
M  V30 2 O 10.2284 6.0051 0.0 0
M  V30 3 O 8.2461 4.2204 0.0 0
M  V30 4 C 11.2589 4.8607 0.0 0
M  V30 5 C 12.7652 5.1809 0.0 0
M  V30 6 N 9.4186 8.9621 0.0 0
M  V30 7 C 1.5400 4.0011 0.0 0
M  V30 8 F 1.5400 2.4611 0.0 0
M  V30 9 F 0.0000 4.0011 0.0 0
M  V30 10 F 1.5400 5.5411 0.0 0
M  V30 11 C 6.1600 1.3336 0.0 0
M  V30 12 F 4.8262 0.5636 0.0 0
M  V30 13 F 6.9300 0.0000 0.0 0
M  V30 14 F 7.4937 2.1037 0.0 0
M  V30 15 C 6.1600 6.6684 0.0 0
M  V30 16 C 7.6916 6.8295 0.0 0
M  V30 17 C 5.5336 8.0754 0.0 0
M  V30 18 C 8.0118 8.3358 0.0 0
M  V30 19 S 6.6781 9.1058 0.0 0
M  V30 20 C 5.3900 5.3348 0.0 0
M  V30 21 C 3.8500 5.3348 0.0 0
M  V30 22 C 6.1600 4.0011 0.0 0
M  V30 23 C 3.0800 4.0011 0.0 0
M  V30 24 C 5.3900 2.6673 0.0 0
M  V30 25 C 3.8500 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 23
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 24
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 20
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[3,5-Bis(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidin-4(1H)-one
C14H6F6N2OS
1929574-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.5208 2.9245 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 F 2.1037 7.4937 0.0 0
M  V30 4 F 0.0000 6.9300 0.0 0
M  V30 5 F 0.5636 4.8264 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 F 5.5411 1.5400 0.0 0
M  V30 8 F 4.0011 0.0000 0.0 0
M  V30 9 F 2.4611 1.5400 0.0 0
M  V30 10 C 6.6684 6.1600 0.0 0
M  V30 11 C 8.0754 5.5336 0.0 0
M  V30 12 C 6.8295 7.6916 0.0 0
M  V30 13 C 9.1058 6.6781 0.0 0
M  V30 14 C 8.5512 4.0690 0.0 0
M  V30 15 S 8.3358 8.0118 0.0 0
M  V30 16 N 10.6122 6.3579 0.0 0
M  V30 17 N 10.0577 3.7488 0.0 0
M  V30 18 C 11.0881 4.8932 0.0 0
M  V30 19 C 5.3348 5.3900 0.0 0
M  V30 20 C 4.0011 6.1600 0.0 0
M  V30 21 C 5.3348 3.8500 0.0 0
M  V30 22 C 2.6675 5.3900 0.0 0
M  V30 23 C 4.0011 3.0800 0.0 0
M  V30 24 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 22
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 23
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 19
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1263286-25-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929574-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7184262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4′Z)-4′,5′-Didehydro-5′-deoxy-2′,3′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]...
C29H45IN2O6Si2
1332757-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.4069 3.4333 0.0 0
M  V30 2 Si 6.3764 2.2889 0.0 0
M  V30 3 C 5.3460 1.1444 0.0 0
M  V30 4 C 5.2320 3.3193 0.0 0
M  V30 5 C 7.5209 1.2585 0.0 0
M  V30 6 C 4.2016 2.1749 0.0 0
M  V30 7 C 4.3155 0.0000 0.0 0
M  V30 8 C 6.4905 0.1140 0.0 0
M  V30 9 O 4.2205 4.4686 0.0 0
M  V30 10 Si 2.8136 5.0951 0.0 0
M  V30 11 C 1.4068 5.7214 0.0 0
M  V30 12 C 3.4401 6.5019 0.0 0
M  V30 13 C 2.1873 3.6881 0.0 0
M  V30 14 C 0.7805 4.3145 0.0 0
M  V30 15 C 0.0000 6.3477 0.0 0
M  V30 16 C 2.0331 7.1282 0.0 0
M  V30 17 C 4.2205 7.8190 0.0 0
M  V30 18 I 4.3815 9.3506 0.0 0
M  V30 19 O 9.3761 8.8113 0.0 0
M  V30 20 C 12.4561 8.8113 0.0 0
M  V30 21 O 13.9961 8.8113 0.0 0
M  V30 22 C 14.7661 10.1449 0.0 0
M  V30 23 O 13.9961 6.1438 0.0 0
M  V30 24 C 6.9311 4.8980 0.0 0 CFG=2
M  V30 25 C 7.8361 6.1438 0.0 0 CFG=2
M  V30 26 C 5.4664 5.3738 0.0 0 CFG=2
M  V30 27 O 6.9311 7.3897 0.0 0
M  V30 28 C 5.4664 6.9138 0.0 0
M  V30 29 N 9.3761 6.1438 0.0 0
M  V30 30 C 10.1461 7.4775 0.0 0
M  V30 31 C 10.1461 4.8102 0.0 0
M  V30 32 N 11.6861 7.4775 0.0 0
M  V30 33 C 11.6861 4.8102 0.0 0
M  V30 34 C 12.4561 6.1438 0.0 0
M  V30 35 C 16.3061 10.1449 0.0 0
M  V30 36 C 17.0761 11.4785 0.0 0
M  V30 37 C 17.0761 8.8113 0.0 0
M  V30 38 C 18.6161 11.4785 0.0 0
M  V30 39 C 18.6161 8.8113 0.0 0
M  V30 40 C 19.3861 10.1449 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 24 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 26 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 17 18
M  V30 18 2 17 28
M  V30 19 2 19 30
M  V30 20 1 20 21
M  V30 21 1 20 32
M  V30 22 1 21 22
M  V30 23 1 22 35
M  V30 24 2 23 34
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 25 29 CFG=1
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 1 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4′Z)-4′,5′-Didehydro-5′-deoxy-2′,3′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]...
C30H47N3O7Si2
1384963-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.4069 3.4334 0.0 0
M  V30 2 Si 6.3764 2.2889 0.0 0
M  V30 3 C 5.3460 1.1445 0.0 0
M  V30 4 C 7.5209 1.2585 0.0 0
M  V30 5 C 5.2320 3.3195 0.0 0
M  V30 6 C 6.4905 0.1141 0.0 0
M  V30 7 C 4.3155 0.0000 0.0 0
M  V30 8 C 4.2016 2.1749 0.0 0
M  V30 9 O 4.2205 4.4688 0.0 0
M  V30 10 Si 2.8136 5.0951 0.0 0
M  V30 11 C 1.4068 5.7214 0.0 0
M  V30 12 C 3.4401 6.5019 0.0 0
M  V30 13 C 2.1873 3.6883 0.0 0
M  V30 14 C 2.0331 7.1284 0.0 0
M  V30 15 C 0.0000 6.3479 0.0 0
M  V30 16 C 0.7805 4.3146 0.0 0
M  V30 17 C 4.2205 7.8190 0.0 0
M  V30 18 N 4.3815 9.3507 0.0 0
M  V30 19 C 3.1356 10.2558 0.0 0
M  V30 20 O 3.2965 11.7875 0.0 0
M  V30 21 O 9.3761 8.8113 0.0 0
M  V30 22 C 12.4561 8.8113 0.0 0
M  V30 23 O 13.9961 8.8113 0.0 0
M  V30 24 C 14.7661 10.1449 0.0 0
M  V30 25 O 13.9961 6.1438 0.0 0
M  V30 26 C 6.9311 4.8980 0.0 0 CFG=2
M  V30 27 C 7.8361 6.1438 0.0 0 CFG=2
M  V30 28 C 5.4664 5.3738 0.0 0 CFG=2
M  V30 29 O 6.9311 7.3898 0.0 0
M  V30 30 C 5.4664 6.9138 0.0 0
M  V30 31 N 9.3761 6.1438 0.0 0
M  V30 32 C 10.1461 7.4776 0.0 0
M  V30 33 C 10.1461 4.8102 0.0 0
M  V30 34 N 11.6861 7.4776 0.0 0
M  V30 35 C 11.6861 4.8102 0.0 0
M  V30 36 C 12.4561 6.1438 0.0 0
M  V30 37 C 16.3061 10.1449 0.0 0
M  V30 38 C 17.0761 8.8113 0.0 0
M  V30 39 C 17.0761 11.4785 0.0 0
M  V30 40 C 18.6161 8.8113 0.0 0
M  V30 41 C 18.6161 11.4785 0.0 0
M  V30 42 C 19.3861 10.1449 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 26 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 28 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 17 18
M  V30 18 2 17 30
M  V30 19 1 18 19
M  V30 20 2 19 20
M  V30 21 2 21 32
M  V30 22 1 22 23
M  V30 23 1 22 34
M  V30 24 1 23 24
M  V30 25 1 24 37
M  V30 26 2 25 36
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 27 31 CFG=1
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 1 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 1 34 36
M  V30 38 1 35 36
M  V30 39 2 37 38
M  V30 40 1 37 39
M  V30 41 1 38 40
M  V30 42 2 39 41
M  V30 43 2 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 26 27 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1332757-98-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1384963-27-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-14569869
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 107-15-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pacidamycin analogues via an Ugi-multicomponent reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okamoto, Kazuya; Sakagami, Masahiro; Feng, Fei; Takahashi, Fumiyo;
Uotani, Kouichi; Togame, Hiroko; Takemoto, Hiroshi; Ichikawa, Satoshi;
Matsuda, Akira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2012), 22(14), 4810-4815

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)-N,2-dimethyl-2-propenamide
C11H12FNO
1353568-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 C 4.0011 0.0000 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 O 2.6674 3.8500 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 F 9.3358 4.6200 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 6.6684 4.6200 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-2,3-dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetamide
C12H13FN2O2
2080376-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1264 3.6643 0.0 0
M  V30 2 C 6.8964 4.9979 0.0 0
M  V30 3 N 8.4364 4.9979 0.0 0
M  V30 4 O 6.1264 6.3317 0.0 0
M  V30 5 C 4.7474 5.1958 0.0 0
M  V30 6 O 6.0810 1.3627 0.0 0
M  V30 7 C 3.0202 0.0000 0.0 0
M  V30 8 F 0.0000 6.6519 0.0 0
M  V30 9 C 3.0800 3.9844 0.0 0
M  V30 10 C 4.5864 3.6643 0.0 0
M  V30 11 C 2.3100 2.6508 0.0 0
M  V30 12 C 2.3100 5.3182 0.0 0
M  V30 13 C 4.7474 2.1327 0.0 0
M  V30 14 N 3.3406 1.5064 0.0 0
M  V30 15 C 0.7700 2.6508 0.0 0
M  V30 16 C 0.7700 5.3182 0.0 0
M  V30 17 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 10
M  V30 6 2 6 13
M  V30 7 1 7 14
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353568-73-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2080376-86-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26319118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iron-Catalyzed Synthesis of Oxindoles: Application to the Preparation of
Pyrroloindolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Correia, Valquirio G.; Abreu, Juliana C.; Barata, Caio A. E.; Andrade,
Leandro H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(5), 1060-1063

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(phenylmethyl)-3-pyridinamine
C12H11ClN2
142670-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 Cl 3.0800 0.0000 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 N 0.7700 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.0000 2.6674 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 7.7000 5.3349 0.0 0
M  V30 13 C 9.2400 2.6674 0.0 0
M  V30 14 C 9.2400 5.3349 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 10
M  V30 4 1 3 5
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenylmethyl)-1H-imidazo[4,5-b]pyridine
C13H11N3
105942-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 1.3338 0.0 0
M  V30 2 C 2.9292 2.8284 0.0 0
M  V30 3 N 4.4608 2.6674 0.0 0
M  V30 4 C 2.6091 4.3348 0.0 0
M  V30 5 C 1.7849 1.7980 0.0 0
M  V30 6 C 5.0872 4.0742 0.0 0
M  V30 7 N 3.9427 5.1048 0.0 0
M  V30 8 N 1.1444 4.8107 0.0 0
M  V30 9 C 0.3202 2.2738 0.0 0
M  V30 10 C 0.0000 3.7801 0.0 0
M  V30 11 C 6.7708 1.3338 0.0 0
M  V30 12 C 7.5408 0.0000 0.0 0
M  V30 13 C 7.5408 2.6674 0.0 0
M  V30 14 C 9.0808 0.0000 0.0 0
M  V30 15 C 9.0808 2.6674 0.0 0
M  V30 16 C 9.8508 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 2 6 7
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 142670-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 105942-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10083593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1160861-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-Benzyl-1H-imidazo[4,5-b]pyridine (3b)11 Following the general
experimental; N-benzyl-2-chloropyridin-3-amine (3a) (87.5 mg, 0.4 mmol),
Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), t-BuBrettPhos (9.7 mg, 0.02 mmol),
K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) were combined
with 2 mL tert-butanol in a 25 mL Schlenk flask. After 4h TLC analysis
indicated the reaction was complete. The reaction was cooled to RT,
filtered through Celite, concentrated and purified on a silica gel column
(2.5 cm x 12 cm), eluting with 4% MeOH / CH2Cl2. 3b as 75 mg of a yellow
solid (90%). 1H NMR (300 MHz, CDCl3) δ = 8.50 (dd, J = 4.5 Hz, 1.5 Hz,
1H), 8.14 (s, 1H), 7.53 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.34-7.24 (m, 3H),
7.18-7.08 (m, 3H), 5.34 (s, 2H); MP: 118-120°C; Rf (4% MeOH / CH2Cl2):
0.24.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-(4-methoxyphenyl)-4-phenyl-3-furancarbonitrile
C18H14N2O2
14774-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5315 2.9015 0.0 0
M  V30 2 N 0.0000 3.0625 0.0 0
M  V30 3 N 3.2068 0.0000 0.0 0
M  V30 4 O 10.8353 6.3387 0.0 0
M  V30 5 C 12.1689 5.5687 0.0 0
M  V30 6 C 4.0937 3.8850 0.0 0
M  V30 7 C 5.5005 3.2587 0.0 0
M  V30 8 C 3.0631 2.7406 0.0 0
M  V30 9 O 5.3395 1.7271 0.0 0
M  V30 10 C 3.8331 1.4070 0.0 0
M  V30 11 C 3.7733 5.3914 0.0 0
M  V30 12 C 4.9179 6.4219 0.0 0
M  V30 13 C 2.3088 5.8673 0.0 0
M  V30 14 C 4.5977 7.9283 0.0 0
M  V30 15 C 1.9886 7.3736 0.0 0
M  V30 16 C 3.1330 8.4042 0.0 0
M  V30 17 C 6.8341 4.0287 0.0 0
M  V30 18 C 8.1678 3.2587 0.0 0
M  V30 19 C 6.8341 5.5687 0.0 0
M  V30 20 C 9.5016 4.0287 0.0 0
M  V30 21 C 8.1678 6.3387 0.0 0
M  V30 22 C 9.5016 5.5687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Methoxyphenyl)-5-phenylfuro[2,3-d]pyrimidin-4-amine
C19H15N3O2
14774-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.5598 0.0 0
M  V30 2 O 11.1973 5.6399 0.0 0
M  V30 3 C 11.9673 6.9736 0.0 0
M  V30 4 C 4.1321 4.3940 0.0 0
M  V30 5 C 5.0371 5.6399 0.0 0
M  V30 6 C 2.6673 4.8699 0.0 0
M  V30 7 O 4.1321 6.8858 0.0 0
M  V30 8 C 2.6673 6.4099 0.0 0
M  V30 9 C 1.3337 4.0999 0.0 0
M  V30 10 N 1.3337 7.1799 0.0 0
M  V30 11 N 0.0000 4.8699 0.0 0
M  V30 12 C 0.0000 6.4099 0.0 0
M  V30 13 C 4.6079 2.9293 0.0 0
M  V30 14 C 6.1142 2.6091 0.0 0
M  V30 15 C 3.5773 1.7849 0.0 0
M  V30 16 C 6.5901 1.1446 0.0 0
M  V30 17 C 4.0534 0.3202 0.0 0
M  V30 18 C 5.5597 0.0000 0.0 0
M  V30 19 C 6.5772 5.6399 0.0 0
M  V30 20 C 7.3472 4.3062 0.0 0
M  V30 21 C 7.3472 6.9736 0.0 0
M  V30 22 C 8.8872 4.3062 0.0 0
M  V30 23 C 8.8872 6.9736 0.0 0
M  V30 24 C 9.6572 5.6399 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 24
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 5 19
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 8
M  V30 12 2 8 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14774-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14774-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21289930
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 6: Preparation of 4-amino
furopyrimidine-based compound
4-amino-6-(4-chlorophenyl)furo[2,3,d]Pyrimidine(Vla) 20ml of formamide
was applied dropwisely to the 4.37 g (20 mmol) of 2-
amino-3-cyano-5-(4-chlorophenyl)furan (IVa) obtained in Example 5, which
was heated and refluxed for 12 hours and then cooled at a room
temperature. 100 ml of water was added thereto, and a generated solid was
filtered, which was washed with water and n-hexane sufficiently, and
then, dried. Thereafter, the resultant material was re-crystallized with
acetone and ethylalcohol to obtain a brown-colored solid product of
4-amino-6-(4-chlorophenyl)furo[2,3,d]pyrimidine (VIa). Compounds Vlb to
VIy of table 4 were also obtained, respectively, according to the same
method. [Table 4] VIx, yield 90% Table 4 shows analysis results of the
obtained 4-amino furopyrimidine based compound VIa to VIy 1H NMR (400 MHz
DMSO-d6) δ (ppm) : 8.25 (s. 1H), 7.60-7.46 (m, 5H), 7.36 (d, J= 8.8 Hz,
2H), 6.92 (d, J= 8.8 Hz, 2H), 3.75 (s, 3H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furo[2,3-d]pyrimidines as inhibitors of DDR2 (discoidin
domain receptor 2) tyrosine kinase.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Beom-Seok; Yang, Kyung-Mi; Kim, Hae-Jong; Park, In-Sung; Park,
Sung-Dae; Lee, Jang-Hyuk; Kwon, Hyuk-Man; Woo, Byoung-Young
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005092896 A1 2005-10-06

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-phenyl-3-pyridinamine
C11H9ClN2
1565870-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 Cl 1.3336 0.0000 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 N 1.3336 4.6200 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 4
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Phenyl-3H-imidazo[4,5-c]pyridine
C12H9N3
1393178-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4196 1.8517 0.0 0
M  V30 2 C 3.0127 2.4782 0.0 0
M  V30 3 C 4.2587 0.3202 0.0 0
M  V30 4 C 1.9823 1.3336 0.0 0
M  V30 5 C 2.5368 3.9427 0.0 0
M  V30 6 N 2.7523 0.0000 0.0 0
M  V30 7 C 0.4760 1.6538 0.0 0
M  V30 8 N 1.0306 4.2629 0.0 0
M  V30 9 C 0.0000 3.1185 0.0 0
M  V30 10 C 5.7533 2.6217 0.0 0
M  V30 11 C 7.0869 1.8517 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 8.4207 2.6217 0.0 0
M  V30 14 C 7.0869 4.9317 0.0 0
M  V30 15 C 8.4207 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1565870-60-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393178-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2070730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1359986-21-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 1359986-22-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Experimental D: Palladium Amidation of
3-Amino-4-chloropyridines. To an oven-dried 25 mL Schlenk tube equipped
with a stirbar were added Pd2(dba)3·CHCl3 (1 mol %), Me3(OMe)t-BuXPhos (5
mol %), K3PO4 (1.5 equiv), and pyridine 3 (1 equiv). The reaction vessel
was evacuated under vacuum and refilled with Ar(g).t-BuOH (0.2 M) and
formamide (1.5 equiv) were then added via syringe, and the reaction
mixture was degassed by three vacuum/Ar(g) purge cycles. The reaction
vessel was then equipped with a coldfinger condenser, placed in a
preheated 110°C oil bath, and stirred for the specified time. Upon
consumption of pyridine 3 (as judged by TLC analysis), the reaction
mixture was allowed to cool to room temperature. The reaction mixture was
diluted with methanol and passed through a Celite plug. The crude mixture
was concentrated in vacuo and applied to a silica gel column eluted with
the indicated solvent mixture(s) to give the desired product.
3-Benzyl-3H-imidazo[4,5-c]pyridine (4a). 37 Following general procedure
D: Pyridine 3a (88 mg, 0.4 mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol),
Me3(OMe)-tert-butyl-XPhos26 (10 mg, 0.02 mmol), K3PO4 (128 mg, 0.6 mmol),
and formamide (0.024 mL, 0.6 mmol) were combined with 2 mL of tert-butyl
alcohol in a 25 mL Schlenk tube. After 4 h, TLC analysis indicated the
reaction was complete. The reaction mixture was cooled to rt, filtered
through Celite, concentrated in vacuo, and purified on a silica gel
column, eluted with 3% MeOH/DCM. 3-Phenyl-3H-imidazo[4,5-c]pyridine (4h).
Following general procedure D: Pyridine 3h (82 mg, 0.4 mmol),
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)-tert-butyl-XPhos26 (10 mg,
0.02 mmol), K3PO4 (128 mg, 0.6 mmol), and formamide (0.024 mL, 0.6 mmol)
were combined with 2 mL of tert-butyl alcohol in a 25 mL Schlenk tube.
After 6.5 h, TLC analysis indicated the reaction was complete. The
reaction mixture was cooled to rt,filtered through Celite, concentrated
in vacuo, and purified on a silica gel column, eluted with 3% MeOH/DCM.
70 mg of pyridine 4h (85%) as a light brown solid. Mp 149-150°C; R f =
0.26 (EtOAc); 1H NMR (300 MHz, CDCl3 ) δ = 8.91 (s, 1H), 8.46 (d, J = 5.7
Hz, 1H), 8.19 (s, 1H), 7.72 (dd, J = 5.4 Hz, 0.6 Hz, 1H), 7.61-7.41 (m,
5H); 13C NMR (75.4 MHz, CDCl3) δ = 149.1, 144.8, 142.5, 135.4, 134.2,
131.4, 130.3, 128.7, 123.8, 115.2; FT-IR (NaCl, thinfilm) ν = 3177, 1597,
1503, 1480, 1304, 1233, 761, 696 cm-1 . Anal. Calcd for C12H9N3 : C,
73.83; H, 4.65; N, 21.52. Found: C, 73.80; H, 4.90; N, 21.28.
$DTYPE RXN:VAR(1):NOTES
$DATUM optimized on ligand, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper- and Palladium-Catalyzed Amidation Reactions for the Synthesis of
Substituted Imidazo[4,5-c]pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wilson, Robert J.; Rosenberg, Adam J.; Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(5), 2203-2212

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(3,5-dimethylphenyl)-3-pyridinamine
C13H13ClN2
1565870-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6200 0.0 0
M  V30 2 C 9.3358 4.6200 0.0 0
M  V30 3 C 6.6684 0.0000 0.0 0
M  V30 4 Cl 1.3336 6.1600 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 8.0021 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 N 1.3336 1.5400 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 8
M  V30 4 1 3 9
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3,5-Dimethylphenyl)-3H-imidazo[4,5-c]pyridine
C14H13N3
1565870-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0870 0.0000 0.0 0
M  V30 2 C 9.7545 4.6201 0.0 0
M  V30 3 N 4.4197 4.6201 0.0 0
M  V30 4 C 3.0127 3.9936 0.0 0
M  V30 5 C 4.2586 6.1516 0.0 0
M  V30 6 C 1.9823 5.1381 0.0 0
M  V30 7 C 2.5369 2.5290 0.0 0
M  V30 8 N 2.7523 6.4718 0.0 0
M  V30 9 C 0.4759 4.8180 0.0 0
M  V30 10 N 1.0306 2.2089 0.0 0
M  V30 11 C 0.0000 3.3532 0.0 0
M  V30 12 C 5.7534 3.8501 0.0 0
M  V30 13 C 5.7534 2.3100 0.0 0
M  V30 14 C 7.0870 4.6201 0.0 0
M  V30 15 C 7.0870 1.5400 0.0 0
M  V30 16 C 8.4207 3.8501 0.0 0
M  V30 17 C 8.4207 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1565870-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1565870-75-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12727595
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1359986-21-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 1359986-22-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Experimental D: Palladium Amidation of
3-Amino-4-chloropyridines. To an oven-dried 25 mL Schlenk tube equipped
with a stirbar were added Pd2(dba)3·CHCl3 (1 mol %), Me3(OMe)t-BuXPhos (5
mol %), K3PO4 (1.5 equiv), and pyridine 3 (1 equiv). The reaction vessel
was evacuated under vacuum and refilled with Ar(g).t-BuOH (0.2 M) and
formamide (1.5 equiv) were then added via syringe, and the reaction
mixture was degassed by three vacuum/Ar(g) purge cycles. The reaction
vessel was then equipped with a coldfinger condenser, placed in a
preheated 110°C oil bath, and stirred for the specified time. Upon
consumption of pyridine 3 (as judged by TLC analysis), the reaction
mixture was allowed to cool to room temperature. The reaction mixture was
diluted with methanol and passed through a Celite plug. The crude mixture
was concentrated in vacuo and applied to a silica gel column eluted with
the indicated solvent mixture(s) to give the desired product.
3-Benzyl-3H-imidazo[4,5-c]pyridine (4a). 37 Following general procedure
D: Pyridine 3a (88 mg, 0.4 mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol),
Me3(OMe)-tert-butyl-XPhos26 (10 mg, 0.02 mmol), K3PO4 (128 mg, 0.6 mmol),
and formamide (0.024 mL, 0.6 mmol) were combined with 2 mL of tert-butyl
alcohol in a 25 mL Schlenk tube. After 4 h, TLC analysis indicated the
reaction was complete. The reaction mixture was cooled to rt, filtered
through Celite, concentrated in vacuo, and purified on a silica gel
column, eluted with 3% MeOH/DCM.
3-(3,5-Dimethylphenyl)-3H-imidazo[4,5-c]pyridine (4m). Following general
procedure D: Pyridine 3m (93 mg, 0.4 mmol), Pd2(dba)3 · CHCl3 (4 mg,
0.004 mmol), Me3(OMe)-tert-butyl-XPhos26 (10 mg, 0.02 mmol), K3PO4 (128
mg, 0.6 mmol), and formamide (0.024 mL, 0.6 mmol) were combined with 2 mL
of tert-butyl alcohol in a 25 mL Schlenk tube. After 4 h, TLC analysis
indicated the reaction was complete. The reaction mixture was cooled to
rt, filtered through Celite, concentrated in vacuo, and purified on a
silica gel column, eluted with 4% MeOH/DCM. 80 mg of pyridine 4m (90%) as
a pale yellow solid. Mp 144-146°C; R f = 0.33 (5% MeOH/DCM); 1H NMR (400
MHz, CDCl3) δ = 8.96 (s, 1H), 8.51 (d, J = 5.4 Hz, 1H), 8.19 (s, 1H),
7.77 (d, J = 5.6 Hz, 1H), 7.14 (s, 3H), 2.43 (s, 6H); 13C NMR (100 MHz,
CDCl3 ) δ = 149.2, 144.9, 142.6, 140.5, 135.4, 134.6, 131.6, 130.5,
121.7, 115.3, 21.5; FT-IR (NaCl, thinfilm) ν = 3060, 2919, 1602, 1494,
1231 cm-1 . Anal. Calcd for C14H13N3 :C, 75.31; H, 5.87; N, 18.82. Found:
C, 75.64; H, 5.59; N, 18.66.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper- and Palladium-Catalyzed Amidation Reactions for the Synthesis of
Substituted Imidazo[4,5-c]pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wilson, Robert J.; Rosenberg, Adam J.; Kaminsky, Lauren; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2014), 79(5), 2203-2212

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-methylphenyl)-3-thiophenecarboxylate
C14H15NO2S
15854-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 C 10.3115 4.9318 0.0 0
M  V30 8 C 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 S 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 6.3103 4.1618 0.0 0
M  V30 15 C 7.6440 1.8517 0.0 0
M  V30 16 C 7.6440 4.9318 0.0 0
M  V30 17 C 8.9778 2.6218 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C13H10N2OS
17509-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 C 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15854-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17509-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15886849
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-methylphenyl)-3-thiophenecarboxylate
C14H15NO2S
15854-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 C 10.3115 4.9318 0.0 0
M  V30 8 C 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 S 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 6.3103 4.1618 0.0 0
M  V30 15 C 7.6440 1.8517 0.0 0
M  V30 16 C 7.6440 4.9318 0.0 0
M  V30 17 C 8.9778 2.6218 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C13H10N2OS
17509-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 C 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15854-08-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17509-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3445839
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-methoxyphenyl)-3-thiophenecarboxylate
C14H15NO3S
15854-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 O 10.3114 4.9318 0.0 0
M  V30 8 C 11.6451 4.1618 0.0 0
M  V30 9 C 4.9766 1.8517 0.0 0
M  V30 10 C 3.5696 2.4781 0.0 0
M  V30 11 C 4.8155 0.3202 0.0 0
M  V30 12 C 2.5392 1.3337 0.0 0
M  V30 13 S 3.3092 0.0000 0.0 0
M  V30 14 C 6.3103 2.6218 0.0 0
M  V30 15 C 6.3103 4.1618 0.0 0
M  V30 16 C 7.6440 1.8517 0.0 0
M  V30 17 C 7.6440 4.9318 0.0 0
M  V30 18 C 8.9778 2.6218 0.0 0
M  V30 19 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Methoxyphenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C13H10N2O2S
17537-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 O 9.7545 4.9318 0.0 0
M  V30 3 C 11.0882 4.1618 0.0 0
M  V30 4 C 4.4197 1.8517 0.0 0
M  V30 5 C 3.0128 2.4782 0.0 0
M  V30 6 C 4.2586 0.3202 0.0 0
M  V30 7 C 1.9823 1.3337 0.0 0
M  V30 8 C 2.5369 3.9428 0.0 0
M  V30 9 S 2.7523 0.0000 0.0 0
M  V30 10 N 0.4759 1.6540 0.0 0
M  V30 11 N 1.0304 4.2631 0.0 0
M  V30 12 C 0.0000 3.1186 0.0 0
M  V30 13 C 5.7534 2.6217 0.0 0
M  V30 14 C 5.7534 4.1618 0.0 0
M  V30 15 C 7.0871 1.8517 0.0 0
M  V30 16 C 7.0871 4.9318 0.0 0
M  V30 17 C 8.4207 2.6217 0.0 0
M  V30 18 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15854-11-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17537-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7458631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(3,4-dimethoxyphenyl)-3-thiophenecarboxylate
C15H17NO4S
15854-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 5.6850 0.0 0
M  V30 2 O 9.4586 6.0052 0.0 0
M  V30 3 O 7.4762 4.2205 0.0 0
M  V30 4 C 10.4890 4.8608 0.0 0
M  V30 5 C 11.9953 5.1810 0.0 0
M  V30 6 N 8.6487 8.9622 0.0 0
M  V30 7 O 0.7700 4.0012 0.0 0
M  V30 8 C 0.0000 5.3348 0.0 0
M  V30 9 O 2.3101 1.3337 0.0 0
M  V30 10 C 3.0801 0.0000 0.0 0
M  V30 11 C 5.3901 6.6685 0.0 0
M  V30 12 C 6.9217 6.8296 0.0 0
M  V30 13 C 4.7636 8.0755 0.0 0
M  V30 14 C 7.2419 8.3359 0.0 0
M  V30 15 S 5.9082 9.1059 0.0 0
M  V30 16 C 4.6201 5.3348 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0
M  V30 18 C 5.3901 4.0012 0.0 0
M  V30 19 C 2.3101 4.0012 0.0 0
M  V30 20 C 4.6201 2.6673 0.0 0
M  V30 21 C 3.0801 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3,4-Dimethoxyphenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C14H12N2O3S
14346-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3939 7.2292 0.0 0
M  V30 2 O 8.1343 1.3336 0.0 0
M  V30 3 C 7.3643 0.0000 0.0 0
M  V30 4 O 9.6743 4.0011 0.0 0
M  V30 5 C 10.4443 5.3347 0.0 0
M  V30 6 C 2.6091 5.2469 0.0 0
M  V30 7 C 3.5143 4.0011 0.0 0
M  V30 8 C 1.1445 4.7711 0.0 0
M  V30 9 C 2.9292 6.7534 0.0 0
M  V30 10 C 2.6091 2.7552 0.0 0
M  V30 11 S 1.1445 3.2311 0.0 0
M  V30 12 N 0.0000 5.8015 0.0 0
M  V30 13 N 1.7849 7.7838 0.0 0
M  V30 14 C 0.3202 7.3079 0.0 0
M  V30 15 C 5.0543 4.0011 0.0 0
M  V30 16 C 5.8243 2.6674 0.0 0
M  V30 17 C 5.8243 5.3347 0.0 0
M  V30 18 C 7.3643 2.6674 0.0 0
M  V30 19 C 7.3643 5.3347 0.0 0
M  V30 20 C 8.1343 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 4 5
M  V30 5 1 4 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 15
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15854-12-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-26-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15822054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-8-quinolinylbenzamide
C16H11FN2O
159090-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 6.6684 0.7700 0.0 0
M  V30 4 F 12.0032 5.3901 0.0 0
M  V30 5 C 2.6673 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 1.3337 2.3100 0.0 0
M  V30 8 N 2.6673 4.6201 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 C 9.3359 2.3100 0.0 0
M  V30 17 C 8.0021 4.6201 0.0 0
M  V30 18 C 10.6695 3.0800 0.0 0
M  V30 19 C 9.3359 5.3901 0.0 0
M  V30 20 C 10.6695 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 20
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-3-(8-quinolinyl)-4(3H)-quinazolinone
C17H10FN3O
2352672-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.7700 0.0 0
M  V30 2 F 12.0033 5.3901 0.0 0
M  V30 3 C 4.0012 2.3101 0.0 0
M  V30 4 C 2.6673 3.0801 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 C 1.3337 2.3101 0.0 0
M  V30 7 N 2.6673 4.6201 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 C 1.3337 0.7700 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 1.3337 5.3901 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 N 5.3348 3.0801 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 N 6.6685 5.3901 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3360 2.3101 0.0 0
M  V30 20 C 9.3360 5.3901 0.0 0
M  V30 21 C 10.6697 3.0801 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 22
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 9
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 18
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 159090-73-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2352672-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30205786
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-89-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM aerobic, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Catalyzed Tandem C-H/N-H Activation, Cyclization[4+2] and
Dehydration of Arylamides with Formamide: Synthesis of
4(3H)-Quinazolinones Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Jian; Wang, Guodong; Hao, Liqiang; Han, Junfen; Li, Hongshuang;
Duan, Guiyun; You, Guirong; Li, Furong; Xia, Chengcai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2019), 11(12), 2799-2802

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-cyanophenyl)-3-thiophenecarboxylate
C14H12N2O2S
1639250-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9847 0.0 0
M  V30 2 O 1.7849 4.4605 0.0 0
M  V30 3 O 4.3940 5.0151 0.0 0
M  V30 4 C 1.4647 5.9668 0.0 0
M  V30 5 C 0.0000 6.4429 0.0 0
M  V30 6 N 1.0076 1.4948 0.0 0
M  V30 7 C 10.3114 4.9319 0.0 0
M  V30 8 N 11.6451 5.7020 0.0 0
M  V30 9 C 4.9766 1.8519 0.0 0
M  V30 10 C 3.5696 2.4782 0.0 0
M  V30 11 C 4.8155 0.3203 0.0 0
M  V30 12 C 2.5392 1.3338 0.0 0
M  V30 13 S 3.3092 0.0000 0.0 0
M  V30 14 C 6.3103 2.6219 0.0 0
M  V30 15 C 6.3103 4.1619 0.0 0
M  V30 16 C 7.6439 1.8519 0.0 0
M  V30 17 C 7.6439 4.9319 0.0 0
M  V30 18 C 8.9777 2.6219 0.0 0
M  V30 19 C 8.9777 4.1619 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 3 7 8
M  V30 8 1 7 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,4-Dihydro-4-oxothieno[2,3-d]pyrimidin-5-yl)benzonitrile
C13H7N3OS
1929574-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 C 9.7545 4.9318 0.0 0
M  V30 3 N 11.0882 5.7018 0.0 0
M  V30 4 C 4.4197 1.8517 0.0 0
M  V30 5 C 3.0128 2.4782 0.0 0
M  V30 6 C 4.2586 0.3202 0.0 0
M  V30 7 C 1.9823 1.3337 0.0 0
M  V30 8 C 2.5369 3.9428 0.0 0
M  V30 9 S 2.7523 0.0000 0.0 0
M  V30 10 N 0.4759 1.6538 0.0 0
M  V30 11 N 1.0304 4.2630 0.0 0
M  V30 12 C 0.0000 3.1186 0.0 0
M  V30 13 C 5.7534 2.6217 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 5.7534 4.1618 0.0 0
M  V30 16 C 8.4207 2.6217 0.0 0
M  V30 17 C 7.0871 4.9318 0.0 0
M  V30 18 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 3 2 3
M  V30 3 1 2 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1639250-62-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929574-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13844674
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-amino-6,7-dihydro-5H-cyclopenta[b]thieno[3,2-e]pyridine-2-carboxylate
C13H14N2O2S
166113-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9778 0.0000 0.0 0
M  V30 2 C 8.9471 2.7106 0.0 0
M  V30 3 O 9.7171 4.0442 0.0 0
M  V30 4 O 9.7171 1.3769 0.0 0
M  V30 5 C 11.2571 4.0442 0.0 0
M  V30 6 C 12.0271 5.3780 0.0 0
M  V30 7 C 5.0372 3.4806 0.0 0
M  V30 8 C 5.0372 1.9406 0.0 0
M  V30 9 S 6.5019 3.9564 0.0 0
M  V30 10 N 3.7036 4.2506 0.0 0
M  V30 11 C 6.5019 1.4647 0.0 0
M  V30 12 C 3.7036 1.1706 0.0 0
M  V30 13 C 7.4071 2.7106 0.0 0
M  V30 14 C 2.3699 3.4806 0.0 0
M  V30 15 C 2.3699 1.9406 0.0 0
M  V30 16 C 0.9052 3.9564 0.0 0
M  V30 17 C 0.9052 1.4647 0.0 0
M  V30 18 C 0.0000 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 13
M  V30 15 2 12 15
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7,8,9-Tetrahydro-4H-cyclopenta[5′,6′]pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidi...
C12H9N3OS
2527818-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 4.5865 1.6538 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 4.7474 3.1854 0.0 0
M  V30 5 C 5.8323 0.7486 0.0 0
M  V30 6 C 2.3100 2.6673 0.0 0
M  V30 7 N 2.3100 0.0000 0.0 0
M  V30 8 S 3.3404 3.8118 0.0 0
M  V30 9 N 6.1542 3.8118 0.0 0
M  V30 10 C 7.2392 1.3751 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 7.4001 2.9066 0.0 0
M  V30 14 C 8.6461 0.7486 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 8.9065 3.2268 0.0 0
M  V30 17 C 9.6765 1.8931 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 2 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 14 17
M  V30 20 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 166113-89-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2527818-90-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22833824
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Neurotropic Activity of Novel Condensed
Cyclopentanopyrido[3',2':4,5]-thieno[3,2-D]pyrimidine Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dabaeva, V. V.; Bagdasaryan, M. R.; Paronikyan, E. G.; Dashyan, Sh. Sh.;
Paronikyan, R. G.; Nazaryan, I. M.; Akopyan, A. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2020), 54(7), 707-713

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Hydroxyphthalide
C8H6O3
16859-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7307 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 3.0800 3.9845 0.0 0
M  V30 4 C 2.3100 2.6508 0.0 0
M  V30 5 C 4.5863 3.6643 0.0 0
M  V30 6 C 2.3100 5.3183 0.0 0
M  V30 7 C 3.3405 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 O 4.7473 2.1328 0.0 0
M  V30 10 C 0.7700 5.3183 0.0 0
M  V30 11 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1,3-Dihydro-3-oxo-1-isobenzofuranyl)formamide
C9H7NO3
113951-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.7306 4.6948 0.0 0
M  V30 2 C 7.1953 4.2188 0.0 0
M  V30 3 O 8.3397 5.2494 0.0 0
M  V30 4 O 3.0202 0.0000 0.0 0
M  V30 5 C 3.0800 3.9844 0.0 0
M  V30 6 C 2.3100 2.6508 0.0 0
M  V30 7 C 4.5863 3.6643 0.0 0
M  V30 8 C 2.3100 5.3182 0.0 0
M  V30 9 C 3.3404 1.5064 0.0 0
M  V30 10 C 0.7700 2.6508 0.0 0
M  V30 11 O 4.7472 2.1327 0.0 0
M  V30 12 C 0.7700 5.3182 0.0 0
M  V30 13 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16859-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 113951-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29751192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM formamide as reactant and solvent, optimized with solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Rearrangement, and Hauser Annulation of 3-Isocyanophthalides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mal, Dipakranjan; Ghosh, Ketaki; Chakraborty, Soumen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2015), 47(16), 2473-2484

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
C9H11NO2S
184174-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1779 3.3320 0.0 0
M  V30 2 O 6.5116 2.5620 0.0 0
M  V30 3 O 5.1779 4.8721 0.0 0
M  V30 4 C 7.8452 3.3320 0.0 0
M  V30 5 N 4.8277 0.0000 0.0 0
M  V30 6 C 2.4373 3.1885 0.0 0
M  V30 7 C 3.8442 2.5620 0.0 0
M  V30 8 C 1.4068 2.0439 0.0 0
M  V30 9 C 1.6672 4.5222 0.0 0
M  V30 10 C 3.6831 1.0304 0.0 0
M  V30 11 S 2.1768 0.7103 0.0 0
M  V30 12 C 0.0000 2.6704 0.0 0
M  V30 13 C 0.1609 4.2020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,7-Tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one
C9H8N2OS
14346-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9876 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7474 4.5192 0.0 0
M  V30 5 C 5.9933 2.3612 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3337 0.0 0
M  V30 8 S 3.3405 5.1455 0.0 0
M  V30 9 C 6.2537 4.8394 0.0 0
M  V30 10 C 7.0237 3.5057 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3337 0.0 0
M  V30 13 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 184174-80-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14346-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11348831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis And Bioevaluation Of Thieno[2,3-d]Pyrimidinone Derivatives As
Potential Tumor Cell Growth Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Huangyong; Chen, Changshui; Xu, Shengzhen; Cao, Xiufang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemistry (2013), 692074, 7 pp.

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-[4-[(methylsulfonyl)oxy]phenyl]-3-thiophenecarboxylate
C14H15NO5S2
1929571-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4646 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 O 10.3115 4.9318 0.0 0
M  V30 8 S 11.6451 4.1618 0.0 0 VAL=6
M  V30 9 C 12.4151 5.4955 0.0 0
M  V30 10 O 12.9788 3.3918 0.0 0
M  V30 11 O 10.8751 2.8281 0.0 0
M  V30 12 C 4.9766 1.8517 0.0 0
M  V30 13 C 3.5696 2.4781 0.0 0
M  V30 14 C 4.8155 0.3202 0.0 0
M  V30 15 C 2.5392 1.3337 0.0 0
M  V30 16 S 3.3092 0.0000 0.0 0
M  V30 17 C 6.3103 2.6218 0.0 0
M  V30 18 C 6.3103 4.1618 0.0 0
M  V30 19 C 7.6440 1.8517 0.0 0
M  V30 20 C 7.6440 4.9318 0.0 0
M  V30 21 C 8.9776 2.6218 0.0 0
M  V30 22 C 8.9776 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 17
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[4-[(Methylsulfonyl)oxy]phenyl]thieno[2,3-d]pyrimidin-4(1H)-one
C13H10N2O4S2
1929574-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0872 0.0 0
M  V30 2 O 9.7544 4.9318 0.0 0
M  V30 3 S 11.0882 4.1618 0.0 0 VAL=6
M  V30 4 C 11.8583 5.4955 0.0 0
M  V30 5 O 12.4219 3.3918 0.0 0
M  V30 6 O 10.3182 2.8281 0.0 0
M  V30 7 C 4.4196 1.8517 0.0 0
M  V30 8 C 3.0128 2.4781 0.0 0
M  V30 9 C 4.2587 0.3202 0.0 0
M  V30 10 C 1.9823 1.3337 0.0 0
M  V30 11 C 2.5369 3.9428 0.0 0
M  V30 12 S 2.7523 0.0000 0.0 0
M  V30 13 N 0.4759 1.6538 0.0 0
M  V30 14 N 1.0304 4.2630 0.0 0
M  V30 15 C 0.0000 3.1186 0.0 0
M  V30 16 C 5.7534 2.6218 0.0 0
M  V30 17 C 7.0871 1.8517 0.0 0
M  V30 18 C 5.7534 4.1618 0.0 0
M  V30 19 C 8.4208 2.6218 0.0 0
M  V30 20 C 7.0871 4.9318 0.0 0
M  V30 21 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1929571-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929574-59-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11723531
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-4,7-dihydro-4-(4-methoxyphenyl)-3-phenyl-1H-pyrazolo[3,4-b]pyridine-5...
C20H17N5O
1946004-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1457 1.5400 0.0 0
M  V30 2 N 6.4794 0.7700 0.0 0
M  V30 3 N 2.4782 0.0000 0.0 0
M  V30 4 O 9.1467 6.9302 0.0 0
M  V30 5 C 10.4805 6.1601 0.0 0
M  V30 6 C 2.4782 4.6201 0.0 0
M  V30 7 C 3.8119 3.8501 0.0 0
M  V30 8 C 2.1580 6.1264 0.0 0
M  V30 9 C 1.1446 3.8501 0.0 0
M  V30 10 C 3.8119 2.3101 0.0 0
M  V30 11 N 0.6265 6.2873 0.0 0
M  V30 12 N 0.0000 4.8805 0.0 0
M  V30 13 N 1.1446 2.3101 0.0 0
M  V30 14 C 2.4782 1.5400 0.0 0
M  V30 15 C 5.1457 4.6201 0.0 0
M  V30 16 C 6.4794 3.8501 0.0 0
M  V30 17 C 5.1457 6.1601 0.0 0
M  V30 18 C 7.8131 4.6201 0.0 0
M  V30 19 C 6.4794 6.9302 0.0 0
M  V30 20 C 7.8131 6.1601 0.0 0
M  V30 21 C 3.1885 7.2708 0.0 0
M  V30 22 C 4.6949 6.9506 0.0 0
M  V30 23 C 2.7126 8.7355 0.0 0
M  V30 24 C 5.7254 8.0952 0.0 0
M  V30 25 C 3.7431 9.8799 0.0 0
M  V30 26 C 5.2495 9.5598 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 1 4 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 7 15
M  V30 11 2 8 11
M  V30 12 1 8 21
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 2 10 14
M  V30 16 1 11 12
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenyl)-3-phenyl-1H-pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidin-5-a...
C21H16N6O
1946004-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5699 4.0011 0.0 0
M  V30 2 O 2.9498 1.3338 0.0 0
M  V30 3 C 3.7198 0.0000 0.0 0
M  V30 4 C 6.0298 6.6686 0.0 0
M  V30 5 C 5.2598 8.0023 0.0 0
M  V30 6 C 7.5699 6.6686 0.0 0
M  V30 7 C 3.7535 8.3225 0.0 0
M  V30 8 C 6.0298 9.3360 0.0 0
M  V30 9 C 8.3399 8.0023 0.0 0
M  V30 10 C 8.3399 5.3348 0.0 0
M  V30 11 N 3.5926 9.8540 0.0 0
M  V30 12 N 7.5699 9.3360 0.0 0
M  V30 13 N 4.9994 10.4805 0.0 0
M  V30 14 N 9.8799 8.0023 0.0 0
M  V30 15 N 9.8799 5.3348 0.0 0
M  V30 16 C 10.6499 6.6686 0.0 0
M  V30 17 C 5.2598 5.3348 0.0 0
M  V30 18 C 6.0298 4.0011 0.0 0
M  V30 19 C 3.7198 5.3348 0.0 0
M  V30 20 C 5.2598 2.6675 0.0 0
M  V30 21 C 2.9498 4.0011 0.0 0
M  V30 22 C 3.7198 2.6675 0.0 0
M  V30 23 C 2.6091 7.2920 0.0 0
M  V30 24 C 2.9293 5.7856 0.0 0
M  V30 25 C 1.1444 7.7679 0.0 0
M  V30 26 C 1.7847 4.7551 0.0 0
M  V30 27 C 0.0000 6.7375 0.0 0
M  V30 28 C 0.3202 5.2310 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 2 7 11
M  V30 12 1 7 23
M  V30 13 1 8 12
M  V30 14 2 8 13
M  V30 15 1 9 12
M  V30 16 2 9 14
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 1 14 16
M  V30 20 2 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1946004-03-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1946004-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25726239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, molecular modeling and biological evaluation of novel
1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eissa, Ibrahim H.; El-Naggar, Abeer M.; El-Hashash, Maher A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2016), 6743-56

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzoyl chloride
C8H7ClO2
21615-34-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 Cl 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzamide
C8H9NO2
2439-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 N 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21615-34-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2439-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9568393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for Amination All the
experiments were carried out in a parallel synthesizer from REDLEYS
Discovery Technologies, UK. A solution of acid chloride 1a (1.0 gm 7.11
mmol) in formamide (10 ml) was heated to 100-120 °C and maintained at
same temperature for 5 to 6 hours, the reaction mixture was cooled to
room temperature. The reaction mass quenched in excess water and
extracted with dichloromethane. The combined organic solvent was washed
with saturated NaHCO3 aqueous solution and dried over anhydrous Na2SO4.
The solvent was evaporated under reduced pressure to give the residue
which was purified by column chromatography using silica gel and EtOAc=
hexane as eluent. An amount of 0.77 g (6.4 mmol, 90%) of 2a was obtained
as crystals. Compound 2d. Yield 90% Mp in °C (Lit): 127-128; Mp in °C
(Obs.): 125-126
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1E)-N′-(3-Cyano-5,6-dihydro-8-methoxy-4-phenyl-4H-naphtho[1,2-b]pyran-2-yl)-...
C24H23N3O2
2361266-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 N 5.3348 3.0801 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 N 6.6685 0.7700 0.0 0
M  V30 6 C 8.0022 0.0000 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 O 12.0033 10.0102 0.0 0
M  V30 9 C 13.3370 9.2402 0.0 0
M  V30 10 C 4.0010 6.9302 0.0 0 CFG=3
M  V30 11 C 5.3348 7.7002 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 6.6685 6.9302 0.0 0
M  V30 14 C 5.3348 9.2402 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 8.0022 7.7002 0.0 0
M  V30 17 O 6.6685 5.3901 0.0 0
M  V30 18 C 6.6685 10.0102 0.0 0
M  V30 19 C 8.0022 9.2402 0.0 0
M  V30 20 C 9.3360 6.9302 0.0 0
M  V30 21 C 9.3360 10.0102 0.0 0
M  V30 22 C 10.6697 7.7002 0.0 0
M  V30 23 C 10.6697 9.2402 0.0 0
M  V30 24 C 2.6673 7.7002 0.0 0
M  V30 25 C 1.3337 6.9302 0.0 0
M  V30 26 C 2.6673 9.2402 0.0 0
M  V30 27 C 0.0000 7.7002 0.0 0
M  V30 28 C 1.3337 10.0102 0.0 0
M  V30 29 C 0.0000 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 12
M  V30 3 2 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 23
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 24
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 18 19
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,7-Dihydro-3-methoxy-7-phenyl-6H-naphtho[2′,1′:5,6]pyrano[2,3-d]pyrimidin-8-...
C22H19N3O2
2361266-53-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0801 0.0 0
M  V30 2 O 12.0033 7.7002 0.0 0
M  V30 3 C 13.3370 6.9302 0.0 0
M  V30 4 C 4.0010 4.6201 0.0 0
M  V30 5 C 5.3348 5.3901 0.0 0
M  V30 6 C 4.0010 3.0801 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 5.3348 6.9302 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 O 6.6685 3.0801 0.0 0
M  V30 13 C 6.6685 7.7002 0.0 0
M  V30 14 N 5.3348 0.7700 0.0 0
M  V30 15 N 2.6673 0.7700 0.0 0
M  V30 16 C 8.0022 6.9302 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 4.0010 0.0000 0.0 0
M  V30 19 C 9.3360 7.7002 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 10.6697 6.9302 0.0 0
M  V30 22 C 2.6673 5.3901 0.0 0
M  V30 23 C 1.3337 4.6201 0.0 0
M  V30 24 C 2.6673 6.9302 0.0 0
M  V30 25 C 0.0000 5.3901 0.0 0
M  V30 26 C 1.3337 7.7002 0.0 0
M  V30 27 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 22
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 2 9 14
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 2 11 17
M  V30 19 1 13 16
M  V30 20 1 14 18
M  V30 21 2 15 18
M  V30 22 2 16 19
M  V30 23 1 17 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2361266-52-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2361266-53-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26667311
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):NOTES
$DATUM formamide also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and easy synthesis of new benzo[h]chromene and
benzo[h]quinoline derivatives as a new class of cytotoxic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Haiba, Mogedda E.; Al-Abdullah, Ebtehal S.; Ahmed, Nesreen S.; Ghabbour,
Hazem A.; Awad, Hanem M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2019), 1195702-711

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzylamine
C8H11NO
2393-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)methyl]formamide
C9H11NO2
17061-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2393-23-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17061-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-11653458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1291-32-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-82-7
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed carousel tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of primary amides with amines catalyzed by zirconocene
dichloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Benjamin N.; Chhatwal, A. Rosie; Lomax, Helen V.; Walton, James
W.; Williams, Jonathan M. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2012), 48(95),
11626-11628

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H15N3O7S
2413011-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7035 0.7700 0.0 0
M  V30 2 C 2.3698 0.0000 0.0 0
M  V30 3 C 6.9777 1.1394 0.0 0
M  V30 4 O 3.7035 6.9300 0.0 0
M  V30 5 C 2.3698 7.7000 0.0 0
M  V30 6 C 8.9469 3.8500 0.0 0
M  V30 7 N 9.7169 5.1836 0.0 0
M  V30 8 O 9.7169 2.5164 0.0 0
M  V30 9 O 14.3369 2.5164 0.0 0
M  V30 10 O 16.9877 4.4734 0.0 0
M  V30 11 C 5.0372 3.0800 0.0 0
M  V30 12 C 5.0372 4.6200 0.0 0
M  V30 13 C 3.7035 2.3100 0.0 0
M  V30 14 C 6.5017 2.6041 0.0 0
M  V30 15 C 3.7035 5.3900 0.0 0
M  V30 16 O 6.5017 5.0959 0.0 0
M  V30 17 C 2.3698 3.0800 0.0 0
M  V30 18 C 7.4069 3.8500 0.0 0
M  V30 19 C 2.3698 4.6200 0.0 0
M  V30 20 C 0.9052 2.6041 0.0 0
M  V30 21 O 0.9052 5.0959 0.0 0
M  V30 22 C 0.0000 3.8500 0.0 0
M  V30 23 C 11.2569 5.1836 0.0 0
M  V30 24 N 12.0269 6.5174 0.0 0
M  V30 25 C 12.0269 3.8500 0.0 0
M  V30 26 C 13.5669 6.5174 0.0 0
M  V30 27 C 13.5669 3.8500 0.0 0
M  V30 28 N 14.3369 5.1836 0.0 0
M  V30 29 S 14.5975 7.6618 0.0 0
M  V30 30 C 15.8434 5.5038 0.0 0
M  V30 31 C 16.0043 7.0355 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 23
M  V30 10 2 9 27
M  V30 11 2 10 30
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 27 28
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H16N4O6S
2413012-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7035 6.9300 0.0 0
M  V30 2 C 2.3698 7.7000 0.0 0
M  V30 3 O 3.7035 0.7700 0.0 0
M  V30 4 C 2.3698 0.0000 0.0 0
M  V30 5 C 6.9777 1.1394 0.0 0
M  V30 6 O 14.3369 7.8509 0.0 0
M  V30 7 O 16.9877 5.8939 0.0 0
M  V30 8 C 5.0372 4.6200 0.0 0
M  V30 9 C 5.0372 3.0800 0.0 0
M  V30 10 C 3.7035 5.3900 0.0 0
M  V30 11 O 6.5017 5.0959 0.0 0
M  V30 12 C 3.7035 2.3100 0.0 0
M  V30 13 C 6.5017 2.6040 0.0 0
M  V30 14 C 2.3698 4.6200 0.0 0
M  V30 15 C 7.4069 3.8500 0.0 0
M  V30 16 C 2.3698 3.0800 0.0 0
M  V30 17 O 0.9052 5.0959 0.0 0
M  V30 18 C 0.9052 2.6040 0.0 0
M  V30 19 C 0.0000 3.8500 0.0 0
M  V30 20 C 8.9469 3.8500 0.0 0
M  V30 21 N 9.7169 5.1836 0.0 0
M  V30 22 N 9.7169 2.5162 0.0 0
M  V30 23 C 11.2569 5.1836 0.0 0
M  V30 24 C 11.2569 2.5162 0.0 0
M  V30 25 N 12.0269 3.8500 0.0 0
M  V30 26 C 12.0269 6.5173 0.0 0
M  V30 27 C 13.5669 3.8500 0.0 0
M  V30 28 C 13.5669 6.5173 0.0 0
M  V30 29 N 14.3369 5.1836 0.0 0
M  V30 30 S 14.5975 2.7055 0.0 0
M  V30 31 C 15.8434 4.8635 0.0 0
M  V30 32 C 16.0043 3.3319 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 13
M  V30 6 2 6 28
M  V30 7 2 7 31
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 14 17
M  V30 19 1 15 20
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 2 23 26
M  V30 29 1 24 25
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 27 30
M  V30 34 1 28 29
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2413011-90-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413012-02-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29048188
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel benzodifuranyl; 1,3,5-triazines; 1,3,5-oxadiazepines;
and thiazolopyrimidines derived from visnaginone and khellinone as
anti-inflammatory and analgesic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abu-Hashem, Ameen Ali; Al-Hussain, Sami A.; Zaki, Magdi E. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2020), 25(1), 220pp.

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methylene-4-[methyl(4-methylphenyl)amino]-4-oxobutanoate
C14H17NO3
2529933-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 O 6.6685 3.8501 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 9.3360 3.8501 0.0 0
M  V30 9 O 12.0033 2.3101 0.0 0
M  V30 10 O 10.6697 0.0000 0.0 0
M  V30 11 C 13.3370 1.5400 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 2.6673 1.5400 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1′,6′-Dimethylspiro[pyrrolidine-3,4′(1′H)-quinoline]-2,2′,5(3′H)-trione
C14H14N2O3
2529933-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.7173 0.7102 0.0 0
M  V30 2 O 0.0000 3.7710 0.0 0
M  V30 3 O 7.1086 0.1437 0.0 0
M  V30 4 C 1.5400 6.4384 0.0 0
M  V30 5 C 8.4700 5.1048 0.0 0
M  V30 6 C 3.8500 2.4374 0.0 0
M  V30 7 C 4.6200 3.7710 0.0 0
M  V30 8 C 2.3100 2.4374 0.0 0
M  V30 9 C 5.3815 2.2764 0.0 0
M  V30 10 C 3.2237 1.0306 0.0 0
M  V30 11 C 3.8500 5.1048 0.0 0
M  V30 12 C 6.1600 3.7710 0.0 0
M  V30 13 C 1.5400 3.7710 0.0 0
M  V30 14 C 5.7017 0.7700 0.0 0
M  V30 15 N 4.3681 0.0000 0.0 0
M  V30 16 N 2.3100 5.1048 0.0 0
M  V30 17 C 4.6200 6.4384 0.0 0
M  V30 18 C 6.9300 5.1048 0.0 0
M  V30 19 C 6.1600 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 13
M  V30 3 2 3 14
M  V30 4 1 4 16
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 16
M  V30 19 1 14 15
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2529933-56-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529933-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22929330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical (Hg lamp (450W) used (stage 1)), Fenton reaction (stage 1),
continuous flow mode (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biobased Spiroimides from Itaconic Acid and Formamides: Molecular Targets
for a Novel Synthetic Application of Renewable Chemicals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hornink, Milene Macedo; Lopes, Alice Uva; Andrade, Leandro Helgueira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2021), 53(2), 296-308

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(2-furanyl)-3-thiophenecarboxylate
C11H11NO3S
256506-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4902 3.7711 0.0 0
M  V30 2 O 7.0302 3.7711 0.0 0
M  V30 3 O 4.7202 5.1047 0.0 0
M  V30 4 C 7.8002 5.1047 0.0 0
M  V30 5 C 9.3402 5.1047 0.0 0
M  V30 6 N 6.8528 0.7103 0.0 0
M  V30 7 C 3.1885 2.2763 0.0 0
M  V30 8 C 4.7202 2.4374 0.0 0
M  V30 9 C 2.8683 0.7700 0.0 0
M  V30 10 C 5.3465 1.0304 0.0 0
M  V30 11 S 4.2019 0.0000 0.0 0
M  V30 12 C 2.1580 3.4209 0.0 0
M  V30 13 C 0.6265 3.2598 0.0 0
M  V30 14 O 2.4782 4.9271 0.0 0
M  V30 15 C 0.0000 4.6667 0.0 0
M  V30 16 C 1.1445 5.6972 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Furanyl)thieno[2,3-d]pyrimidin-4(1H)-one
C10H6N2O2S
256507-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 5.1455 0.0 0
M  V30 2 C 4.5863 2.1579 0.0 0
M  V30 3 C 3.0800 2.4780 0.0 0
M  V30 4 C 4.7474 0.6263 0.0 0
M  V30 5 C 2.3100 1.1444 0.0 0
M  V30 6 C 2.3100 3.8119 0.0 0
M  V30 7 S 3.3405 0.0000 0.0 0
M  V30 8 N 0.7700 1.1444 0.0 0
M  V30 9 N 0.7700 3.8119 0.0 0
M  V30 10 C 0.0000 2.4780 0.0 0
M  V30 11 C 5.7309 3.1885 0.0 0
M  V30 12 C 7.2372 2.8683 0.0 0
M  V30 13 O 5.5698 4.7200 0.0 0
M  V30 14 C 8.0072 4.2020 0.0 0
M  V30 15 C 6.9768 5.3463 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 256506-99-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 256507-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4955486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-(4-chlorophenyl)-3-furancarbonitrile
C11H7ClN2O
26454-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.2459 0.9052 0.0 0
M  V30 2 N 0.0000 0.0000 0.0 0
M  V30 3 N 1.2459 4.2557 0.0 0
M  V30 4 Cl 11.0215 2.5804 0.0 0
M  V30 5 C 4.8615 2.5804 0.0 0
M  V30 6 C 3.9564 1.3346 0.0 0
M  V30 7 O 3.9564 3.8263 0.0 0
M  V30 8 C 2.4917 1.8104 0.0 0
M  V30 9 C 2.4917 3.3504 0.0 0
M  V30 10 C 6.4015 2.5804 0.0 0
M  V30 11 C 7.1715 3.9141 0.0 0
M  V30 12 C 7.1715 1.2468 0.0 0
M  V30 13 C 8.7115 3.9141 0.0 0
M  V30 14 C 8.7115 1.2468 0.0 0
M  V30 15 C 9.4815 2.5804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 9
M  V30 4 1 4 15
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenyl)furo[2,3-d]pyrimidin-4-amine
C12H8ClN3O
744255-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 0.0000 0.0 0
M  V30 2 Cl 11.1973 3.0801 0.0 0
M  V30 3 C 5.0371 3.0801 0.0 0
M  V30 4 C 4.1321 1.8342 0.0 0
M  V30 5 O 4.1321 4.3260 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 N 1.3337 4.6201 0.0 0
M  V30 10 N 0.0000 2.3101 0.0 0
M  V30 11 C 0.0000 3.8501 0.0 0
M  V30 12 C 6.5772 3.0801 0.0 0
M  V30 13 C 7.3472 1.7464 0.0 0
M  V30 14 C 7.3472 4.4137 0.0 0
M  V30 15 C 8.8872 1.7464 0.0 0
M  V30 16 C 8.8872 4.4137 0.0 0
M  V30 17 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 17
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26454-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 744255-24-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-21323384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 6: Preparation of 4-amino furopyrimidine-based compound
4-amino-6-(4-chlorophenyl)furo[2,3,d]Pyrimidine(Vla) 20ml of formamide
was applied dropwisely to the 4.37 g (20 mmol) of 2-
amino-3-cyano-5-(4-chlorophenyl)furan (IVa) obtained in Example 5, which
was heated and refluxed for 12 hours and then cooled at a room
temperature. 100 ml of water was added thereto, and a generated solid was
filtered, which was washed with water and n-hexane sufficiently, and
then, dried. Thereafter, the resultant material was re-crystallized with
acetone and ethylalcohol to obtain a brown-colored solid product of
4-amino-6-(4-chlorophenyl)furo[2,3,d]pyrimidine (VIa). Compounds Vlb to
VIy of table 4 were also obtained, respectively, according to the same
method. 4-amino-6-(4-chlorophenyl)furo[2,3,d]Pyrimidine(Vla), yield 90%
1H NMR (400 MHz DMSO-d6) δ (ppm) : 8.18 (s, 1H), 7.77 (d, J = 8.8 Hz,
2H), 7.52-7.62 (m, 4H), 7.34 (s. 1H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furo[2,3-d]pyrimidines as inhibitors of DDR2 (discoidin
domain receptor 2) tyrosine kinase.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Beom-Seok; Yang, Kyung-Mi; Kim, Hae-Jong; Park, In-Sung; Park,
Sung-Dae; Lee, Jang-Hyuk; Kwon, Hyuk-Man; Woo, Byoung-Young
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005092896 A1 2005-10-06

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isosteviol
C20H30O3
27975-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0711 4.9113 0.0 0
M  V30 2 C 10.9087 5.0439 0.0 0
M  V30 3 O 11.1448 2.3913 0.0 0
M  V30 4 C 1.1798 1.5166 0.0 0
M  V30 5 O 0.0000 2.5065 0.0 0
M  V30 6 O 0.9123 0.0000 0.0 0
M  V30 7 C 2.8943 0.5268 0.0 0
M  V30 8 C 6.4768 3.3771 0.0 0 CFG=1
M  V30 9 C 7.2469 2.0434 0.0 0 CFG=2
M  V30 10 C 4.9368 3.3771 0.0 0 CFG=1
M  V30 11 C 6.9897 4.6452 0.0 0
M  V30 12 C 8.0794 3.5790 0.0 0
M  V30 13 C 6.4768 0.7096 0.0 0
M  V30 14 C 8.5964 1.8622 0.0 0
M  V30 15 C 4.1668 2.0434 0.0 0 CFG=1
M  V30 16 C 4.1668 4.7108 0.0 0
M  V30 17 C 8.4638 5.0694 0.0 0
M  V30 18 C 9.5738 4.2760 0.0 0 CFG=2
M  V30 19 C 4.9368 0.7096 0.0 0
M  V30 20 C 9.7009 2.9266 0.0 0
M  V30 21 C 2.6268 2.0434 0.0 0 CFG=2
M  V30 22 C 2.6268 4.7108 0.0 0
M  V30 23 C 1.8568 3.3771 0.0 0
M  V30 24 H 5.9757 4.8333 0.0 0
M  V30 25 H 3.3968 0.7096 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=3
M  V30 2 1 2 18
M  V30 3 2 3 20
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 21 4 CFG=3
M  V30 7 1 21 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 24 CFG=1
M  V30 12 1 9 12 CFG=1
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 18 12 CFG=1
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 15 19
M  V30 22 1 15 21
M  V30 23 1 15 25 CFG=1
M  V30 24 1 16 22
M  V30 25 1 17 18
M  V30 26 1 18 20
M  V30 27 1 21 23
M  V30 28 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 8 9 10 15 18 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4α,8β,13β)-16-(Formylamino)-13-methyl-17-norkauran-18-oic acid
C21H33NO3
953017-96-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0712 4.9113 0.0 0
M  V30 2 C 10.9088 5.0439 0.0 0
M  V30 3 N 11.1449 2.3914 0.0 0
M  V30 4 C 11.4033 0.8732 0.0 0
M  V30 5 O 12.8472 0.3379 0.0 0
M  V30 6 C 1.1797 1.5166 0.0 0
M  V30 7 O 0.0000 2.5066 0.0 0
M  V30 8 O 0.9123 0.0000 0.0 0
M  V30 9 C 2.8943 0.5268 0.0 0
M  V30 10 C 6.4769 3.3771 0.0 0 CFG=1
M  V30 11 C 7.2469 2.0435 0.0 0 CFG=1
M  V30 12 C 4.9369 3.3771 0.0 0 CFG=1
M  V30 13 C 6.9897 4.6452 0.0 0
M  V30 14 C 8.0795 3.5790 0.0 0
M  V30 15 C 8.5964 1.8622 0.0 0
M  V30 16 C 6.4769 0.7096 0.0 0
M  V30 17 C 4.1669 2.0435 0.0 0 CFG=1
M  V30 18 C 4.1669 4.7108 0.0 0
M  V30 19 C 8.4637 5.0695 0.0 0
M  V30 20 C 9.5739 4.2760 0.0 0 CFG=2
M  V30 21 C 9.7008 2.9267 0.0 0 CFG=3
M  V30 22 C 4.9369 0.7096 0.0 0
M  V30 23 C 2.6268 2.0435 0.0 0 CFG=2
M  V30 24 C 2.6268 4.7108 0.0 0
M  V30 25 C 1.8568 3.3771 0.0 0
M  V30 26 H 5.9758 4.8334 0.0 0
M  V30 27 H 3.3968 0.7096 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 23 6 CFG=3
M  V30 9 1 23 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 26 CFG=1
M  V30 14 1 11 14 CFG=1
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 13 19
M  V30 20 1 20 14 CFG=1
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 1 17 22
M  V30 24 1 17 23
M  V30 25 1 17 27 CFG=1
M  V30 26 1 18 24
M  V30 27 1 19 20
M  V30 28 1 20 21
M  V30 29 1 23 25
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 10 11 12 17 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27975-19-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 953017-96-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5179801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM ent-16-Formamidobeieran-19-oic acid (XIII). A mixture of 0.3 g of
isosteviol I, 2 g of formamide and 1 g of 90% formic acid was heated for
18 h at a bath temperature of 170°C. After cooling, crystal formed and
were washed with petroleum ether. Yield 0.3 g (90%). mp 284-287°C. IR
spectrum, ν , cm-1: 1541, 1644, 1665 (O=C-N), 1697 (COOH), 3334 (NH). 1H
NMR spectrum (CD3OD), δ , ppm (J, Hz): 0.78 1.95 m (19H, isosteviol
frame), 0.78 s (3H, 20-CH3), 0.81 s (3H, 17-CH3), 1.10 s (3H, 18-H3),
2.12 d (1H, 3-He, J 14.1), 3.42 3.58 m (2H, H215), 3.97 d.d (1H, H16, J
11.4, 6.0), 7.98 s (1H, O=CH). Mass spectrum, [M]+: m/zexp 347.2493,
m/zcalc 347.2460 (C21H33NO3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Schiff bases on the basis of the isosteviol terpenoid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Militsina, O. I.; Strobykina, I. Yu.; Kovylyaeva, G. I.; Bakaleinik, G.
A.; Kataev, V. E.; Gubaidullin, A. T.; Musin, R. Z.; Tolstikov, A. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of General Chemistry (2007), 77(2), 285-296

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5-bis(4-methoxyphenyl)-1-[3-(trifluoromethyl)phenyl]-1H-pyrro...
C28H25F3N2O4
2886732-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.9621 3.8987 0.0 0
M  V30 2 O 8.0569 2.6528 0.0 0
M  V30 3 O 10.4937 3.7376 0.0 0
M  V30 4 C 8.6834 1.2459 0.0 0
M  V30 5 C 7.7782 0.0000 0.0 0
M  V30 6 N 5.6850 4.5953 0.0 0
M  V30 7 C 1.3337 7.1574 0.0 0
M  V30 8 F 0.5636 8.4910 0.0 0
M  V30 9 F 0.0000 6.3874 0.0 0
M  V30 10 F 2.1037 5.8236 0.0 0
M  V30 11 O 9.3561 13.8092 0.0 0
M  V30 12 C 8.2115 14.8396 0.0 0
M  V30 13 O 15.2321 7.2832 0.0 0
M  V30 14 C 16.1372 6.0372 0.0 0
M  V30 15 C 8.0752 7.7837 0.0 0
M  V30 16 C 9.1058 6.6392 0.0 0
M  V30 17 N 6.6684 7.1574 0.0 0
M  V30 18 C 8.3358 5.3055 0.0 0
M  V30 19 C 6.8293 5.6257 0.0 0
M  V30 20 C 8.3954 9.2900 0.0 0
M  V30 21 C 9.8601 9.7660 0.0 0
M  V30 22 C 7.2510 10.3206 0.0 0
M  V30 23 C 10.1803 11.2723 0.0 0
M  V30 24 C 7.5712 11.8269 0.0 0
M  V30 25 C 9.0359 12.3027 0.0 0
M  V30 26 C 10.6373 6.8002 0.0 0
M  V30 27 C 11.5426 5.5544 0.0 0
M  V30 28 C 11.2637 8.2070 0.0 0
M  V30 29 C 13.0741 5.7153 0.0 0
M  V30 30 C 12.7952 8.3680 0.0 0
M  V30 31 C 13.7004 7.1221 0.0 0
M  V30 32 C 5.3348 7.9274 0.0 0
M  V30 33 C 4.0010 7.1574 0.0 0
M  V30 34 C 5.3348 9.4674 0.0 0
M  V30 35 C 2.6673 7.9274 0.0 0
M  V30 36 C 4.0010 10.2374 0.0 0
M  V30 37 C 2.6673 9.4674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 19
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 35
M  V30 11 1 11 12
M  V30 12 1 11 25
M  V30 13 1 13 14
M  V30 14 1 13 31
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20
M  V30 18 1 16 18
M  V30 19 1 16 26
M  V30 20 1 17 19
M  V30 21 1 17 32
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Dihydro-5,6-bis(4-methoxyphenyl)-7-[3-(trifluoromethyl)phenyl]-4H-pyrrolo...
C27H20F3N3O3
2886732-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.6885 10.6334 0.0 0
M  V30 2 C 1.1445 8.9443 0.0 0
M  V30 3 F 2.1749 10.0887 0.0 0
M  V30 4 F 0.0000 9.9747 0.0 0
M  V30 5 F 0.1140 7.7998 0.0 0
M  V30 6 O 7.6085 0.7700 0.0 0
M  V30 7 C 6.2749 0.0000 0.0 0
M  V30 8 O 14.7129 5.9316 0.0 0
M  V30 9 C 15.8574 6.9620 0.0 0
M  V30 10 C 7.6085 6.9300 0.0 0
M  V30 11 N 6.3627 7.8351 0.0 0
M  V30 12 C 8.8544 7.8351 0.0 0
M  V30 13 C 6.8385 9.2998 0.0 0
M  V30 14 C 8.3785 9.2998 0.0 0
M  V30 15 N 6.0685 10.6334 0.0 0
M  V30 16 C 9.1485 10.6334 0.0 0
M  V30 17 C 6.8385 11.9670 0.0 0
M  V30 18 N 8.3785 11.9670 0.0 0
M  V30 19 C 7.6085 5.3900 0.0 0
M  V30 20 C 6.2749 4.6200 0.0 0
M  V30 21 C 8.9422 4.6200 0.0 0
M  V30 22 C 6.2749 3.0800 0.0 0
M  V30 23 C 8.9422 3.0800 0.0 0
M  V30 24 C 7.6085 2.3100 0.0 0
M  V30 25 C 4.8980 7.3592 0.0 0
M  V30 26 C 3.7536 8.3898 0.0 0
M  V30 27 C 4.5778 5.8529 0.0 0
M  V30 28 C 2.2889 7.9138 0.0 0
M  V30 29 C 3.1131 5.3771 0.0 0
M  V30 30 C 1.9687 6.4075 0.0 0
M  V30 31 C 10.3191 7.3592 0.0 0
M  V30 32 C 11.4635 8.3898 0.0 0
M  V30 33 C 10.6392 5.8529 0.0 0
M  V30 34 C 12.9281 7.9138 0.0 0
M  V30 35 C 12.1038 5.3771 0.0 0
M  V30 36 C 13.2483 6.4075 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 28
M  V30 6 1 6 7
M  V30 7 1 6 24
M  V30 8 1 8 9
M  V30 9 1 8 36
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 19
M  V30 13 1 11 13
M  V30 14 1 11 25
M  V30 15 1 12 14
M  V30 16 1 12 31
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2886732-65-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2886732-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35242041
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anti-Inflammatory activity of some synthesized novel pyrrolo[2,3-D]
pyrimidines derivatives using ethyl 2-amino-4,5-bis(4-methoxyphenyi)-1-
(3-(trifluoromethyl)phenyi)-1 h-pyrrole- 3-carboxylate as synthon
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM El-Shehry, Mohamed F.; Hosni, Hanaa M.; Amr, Abd El-Galil E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Computational and Theoretical Nanoscience (2017), 14(7),
3191-3197

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-[1,1′-biphenyl]-4-yl-3-thiophenecarboxylate
C19H17NO2S
307343-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4646 5.9669 0.0 0
M  V30 5 C 0.0000 6.4427 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 C 4.9766 1.8517 0.0 0
M  V30 8 C 3.5696 2.4782 0.0 0
M  V30 9 C 4.8155 0.3202 0.0 0
M  V30 10 C 2.5392 1.3337 0.0 0
M  V30 11 S 3.3092 0.0000 0.0 0
M  V30 12 C 6.3103 2.6218 0.0 0
M  V30 13 C 7.6440 1.8517 0.0 0
M  V30 14 C 6.3103 4.1618 0.0 0
M  V30 15 C 8.9776 2.6218 0.0 0
M  V30 16 C 7.6440 4.9318 0.0 0
M  V30 17 C 8.9776 4.1618 0.0 0
M  V30 18 C 10.3115 4.9318 0.0 0
M  V30 19 C 10.3115 6.4718 0.0 0
M  V30 20 C 11.6451 4.1618 0.0 0
M  V30 21 C 11.6451 7.2419 0.0 0
M  V30 22 C 12.9788 4.9318 0.0 0
M  V30 23 C 12.9788 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[1,1′-Biphenyl]-4-ylthieno[2,3-d]pyrimidin-4(1H)-one
C18H12N2OS
307512-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3939 0.5547 0.0 0
M  V30 2 C 3.5143 3.7827 0.0 0
M  V30 3 C 2.6091 2.5368 0.0 0
M  V30 4 C 2.6091 5.0287 0.0 0
M  V30 5 C 1.1445 3.0127 0.0 0
M  V30 6 C 2.9292 1.0306 0.0 0
M  V30 7 S 1.1445 4.5527 0.0 0
M  V30 8 N 0.0000 1.9823 0.0 0
M  V30 9 N 1.7849 0.0000 0.0 0
M  V30 10 C 0.3202 0.4760 0.0 0
M  V30 11 C 5.0543 3.7827 0.0 0
M  V30 12 C 5.8243 2.4491 0.0 0
M  V30 13 C 5.8243 5.1165 0.0 0
M  V30 14 C 7.3643 2.4491 0.0 0
M  V30 15 C 7.3643 5.1165 0.0 0
M  V30 16 C 8.1343 3.7827 0.0 0
M  V30 17 C 9.6743 3.7827 0.0 0
M  V30 18 C 10.4443 2.4491 0.0 0
M  V30 19 C 10.4443 5.1165 0.0 0
M  V30 20 C 11.9843 2.4491 0.0 0
M  V30 21 C 11.9843 5.1165 0.0 0
M  V30 22 C 12.7543 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 307343-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 307512-30-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1783867
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(3,4-dimethylphenyl)-3-thiophenecarboxylate
C15H17NO2S
307511-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1820 4.3513 0.0 0
M  V30 2 O 8.6885 4.6715 0.0 0
M  V30 3 O 6.7062 2.8866 0.0 0
M  V30 4 C 9.7189 3.5271 0.0 0
M  V30 5 C 11.2252 3.8473 0.0 0
M  V30 6 N 7.8786 7.6285 0.0 0
M  V30 7 C 0.0000 2.6675 0.0 0
M  V30 8 C 1.5400 0.0000 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 6.1516 5.4957 0.0 0
M  V30 11 C 3.9936 6.7417 0.0 0
M  V30 12 C 6.4718 7.0021 0.0 0
M  V30 13 S 5.1381 7.7722 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 18 C 3.8500 1.3337 0.0 0
M  V30 19 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 17
M  V30 8 1 8 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3,4-Dimethylphenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C14H12N2OS
433949-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 C 9.7545 1.8517 0.0 0
M  V30 3 C 9.7545 4.9318 0.0 0
M  V30 4 C 4.4197 1.8517 0.0 0
M  V30 5 C 3.0128 2.4782 0.0 0
M  V30 6 C 4.2586 0.3202 0.0 0
M  V30 7 C 1.9823 1.3337 0.0 0
M  V30 8 C 2.5369 3.9428 0.0 0
M  V30 9 S 2.7523 0.0000 0.0 0
M  V30 10 N 0.4759 1.6540 0.0 0
M  V30 11 N 1.0306 4.2631 0.0 0
M  V30 12 C 0.0000 3.1186 0.0 0
M  V30 13 C 5.7534 2.6217 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 5.7534 4.1618 0.0 0
M  V30 16 C 8.4207 2.6217 0.0 0
M  V30 17 C 7.0871 4.9318 0.0 0
M  V30 18 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 16
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 307511-65-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 433949-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15954994
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-[4-(1,1-dimethylethyl)phenyl]-3-thiophenecarboxylate
C17H21NO2S
307511-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0149 0.0 0
M  V30 4 C 1.4647 5.9668 0.0 0
M  V30 5 C 0.0000 6.4427 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 C 10.3114 4.9318 0.0 0
M  V30 8 C 11.6451 4.1618 0.0 0
M  V30 9 C 11.6451 5.7018 0.0 0
M  V30 10 C 10.3114 6.4718 0.0 0
M  V30 11 C 4.9766 1.8517 0.0 0
M  V30 12 C 3.5696 2.4782 0.0 0
M  V30 13 C 4.8155 0.3202 0.0 0
M  V30 14 C 2.5392 1.3337 0.0 0
M  V30 15 S 3.3092 0.0000 0.0 0
M  V30 16 C 6.3103 2.6217 0.0 0
M  V30 17 C 7.6439 1.8517 0.0 0
M  V30 18 C 6.3103 4.1618 0.0 0
M  V30 19 C 8.9777 2.6217 0.0 0
M  V30 20 C 7.6439 4.9318 0.0 0
M  V30 21 C 8.9777 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 21
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[4-(1,1-Dimethylethyl)phenyl]thieno[2,3-d]pyrimidin-4(1H)-one
C16H16N2OS
1056054-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 C 9.7545 4.9318 0.0 0
M  V30 3 C 9.7545 6.4718 0.0 0
M  V30 4 C 11.0882 5.7018 0.0 0
M  V30 5 C 11.0882 4.1618 0.0 0
M  V30 6 C 4.4197 1.8517 0.0 0
M  V30 7 C 3.0128 2.4782 0.0 0
M  V30 8 C 4.2586 0.3202 0.0 0
M  V30 9 C 1.9823 1.3337 0.0 0
M  V30 10 C 2.5369 3.9428 0.0 0
M  V30 11 S 2.7523 0.0000 0.0 0
M  V30 12 N 0.4759 1.6538 0.0 0
M  V30 13 N 1.0304 4.2630 0.0 0
M  V30 14 C 0.0000 3.1186 0.0 0
M  V30 15 C 5.7534 2.6217 0.0 0
M  V30 16 C 5.7534 4.1618 0.0 0
M  V30 17 C 7.0871 1.8517 0.0 0
M  V30 18 C 7.0871 4.9318 0.0 0
M  V30 19 C 8.4207 2.6217 0.0 0
M  V30 20 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 307511-84-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1056054-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14835477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethyl 1-amino-3-methyl-1H-pyrrole-2,4-dicarboxylate
C9H12N2O4
310431-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 1.3337 2.3100 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 5.7281 0.1773 0.0 0
M  V30 6 N 3.0177 4.8720 0.0 0
M  V30 7 C 7.9701 2.6672 0.0 0
M  V30 8 O 8.8753 3.9130 0.0 0
M  V30 9 O 8.5964 1.2602 0.0 0
M  V30 10 C 10.4069 3.7520 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.4079 1.6836 0.0 0
M  V30 13 N 4.1621 3.8416 0.0 0
M  V30 14 C 6.4385 2.8281 0.0 0
M  V30 15 C 5.6685 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,4-dihydro-5-methyl-4-oxopyrrolo[2,1-f][1,2,4]triazine-6-carboxylate
C9H9N3O3
310431-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6079 0.3695 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 C 6.5771 3.0800 0.0 0
M  V30 4 O 7.3471 4.4137 0.0 0
M  V30 5 O 7.3471 1.7464 0.0 0
M  V30 6 C 8.8871 4.4137 0.0 0
M  V30 7 N 2.6673 3.8500 0.0 0
M  V30 8 C 2.6673 2.3100 0.0 0
M  V30 9 C 4.1320 4.3259 0.0 0
M  V30 10 N 1.3337 4.6201 0.0 0
M  V30 11 C 4.1320 1.8342 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 5.0371 3.0800 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 310431-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 310431-29-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4603913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM D. 5-Methylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one-6-carboxylic acid
methyl ester. Compound C (38 g, 179 mmol) was combined with formamide
(400 mL) and heated to 165°C for 6 hr. The reaction was diluted with
water (5 mL), extracted with EtOAc (3 × 1 0 mL), dried (Na2SO4), and
concentrated. The crude material was purified by washing with
ether/hexanes (7/3). 33.4 g (90%) of Compound D as a white solid. ESI
MS:[M-H]- = 206.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolo[2,1-f][1,2,4]triazine carboxylic acid derivatives
for use in treating p38 kinase-associated conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leftheris, Katerina; Barrish, Joel; Hynes, John; Wrobleski, Stephen T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002040486 A2 2002-05-23

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dimethyl 1-amino-3-methyl-1H-pyrrole-2,4-dicarboxylate
C9H12N2O4
310431-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 1.3337 2.3100 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 5.7281 0.1773 0.0 0
M  V30 6 N 3.0177 4.8720 0.0 0
M  V30 7 C 7.9701 2.6672 0.0 0
M  V30 8 O 8.8753 3.9130 0.0 0
M  V30 9 O 8.5964 1.2602 0.0 0
M  V30 10 C 10.4069 3.7520 0.0 0
M  V30 11 C 4.0011 2.3100 0.0 0
M  V30 12 C 5.4079 1.6836 0.0 0
M  V30 13 N 4.1621 3.8416 0.0 0
M  V30 14 C 6.4385 2.8281 0.0 0
M  V30 15 C 5.6685 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,4-dihydro-5-methyl-4-oxopyrrolo[2,1-f][1,2,4]triazine-6-carboxylate
C9H9N3O3
310431-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6079 0.3695 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 C 6.5771 3.0800 0.0 0
M  V30 4 O 7.3471 4.4137 0.0 0
M  V30 5 O 7.3471 1.7464 0.0 0
M  V30 6 C 8.8871 4.4137 0.0 0
M  V30 7 N 2.6673 3.8500 0.0 0
M  V30 8 C 2.6673 2.3100 0.0 0
M  V30 9 C 4.1320 4.3259 0.0 0
M  V30 10 N 1.3337 4.6201 0.0 0
M  V30 11 C 4.1320 1.8342 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 5.0371 3.0800 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 310431-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 310431-29-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8919534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM C. 5-Methylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-one-6-carboxylic acid
methyl ester, Compound B (38 g, 179 mmol) was combined with formamide
(400 mL) and heated to 165°C for 6 hr. The reaction was diluted with
water (5 mL), extracted with ethyl acetate (3 ×10 mL), dried (Na2SO4) and
concentrated. The crude material was purified by washing with
ether/hexanes (7/3). 33.4 g (90%) of Compound C as a white solid. ESI
MS:[M-H]-= 206.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolotriazines as kinases inhibitors for treating
inflammation, cancer, and proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hunt, John T.; Bhide, Rajeev S.; Borzilleri, Robert M.; Qian, Ligang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000071129 A1 2000-11-30

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-[4-(1-methylethyl)phenyl]-3-thiophenecarboxylate
C16H19NO2S
315683-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2494 3.9844 0.0 0
M  V30 2 O 1.7849 4.4603 0.0 0
M  V30 3 O 4.3939 5.0149 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 C 10.3112 4.9317 0.0 0
M  V30 8 C 10.3112 6.4717 0.0 0
M  V30 9 C 11.6449 4.1617 0.0 0
M  V30 10 C 4.9765 1.8517 0.0 0
M  V30 11 C 3.5696 2.4782 0.0 0
M  V30 12 C 4.8156 0.3202 0.0 0
M  V30 13 C 2.5392 1.3336 0.0 0
M  V30 14 S 3.3092 0.0000 0.0 0
M  V30 15 C 6.3102 2.6217 0.0 0
M  V30 16 C 6.3102 4.1617 0.0 0
M  V30 17 C 7.6438 1.8517 0.0 0
M  V30 18 C 7.6438 4.9317 0.0 0
M  V30 19 C 8.9776 2.6217 0.0 0
M  V30 20 C 8.9776 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 20
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[4-(1-Methylethyl)phenyl]thieno[2,3-d]pyrimidin-4(1H)-one
C15H14N2OS
315684-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 1.3845 0.0 0
M  V30 2 C 9.7545 1.5400 0.0 0
M  V30 3 C 11.0882 2.3100 0.0 0
M  V30 4 C 9.7545 0.0000 0.0 0
M  V30 5 C 4.4197 4.6201 0.0 0
M  V30 6 C 3.0127 3.9936 0.0 0
M  V30 7 C 4.2586 6.1516 0.0 0
M  V30 8 C 1.9823 5.1381 0.0 0
M  V30 9 C 2.5369 2.5290 0.0 0
M  V30 10 S 2.7523 6.4718 0.0 0
M  V30 11 N 0.4759 4.8180 0.0 0
M  V30 12 N 1.0304 2.2089 0.0 0
M  V30 13 C 0.0000 3.3532 0.0 0
M  V30 14 C 5.7534 3.8501 0.0 0
M  V30 15 C 5.7534 2.3100 0.0 0
M  V30 16 C 7.0870 4.6201 0.0 0
M  V30 17 C 7.0870 1.5400 0.0 0
M  V30 18 C 8.4207 3.8501 0.0 0
M  V30 19 C 8.4207 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 19
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 315683-17-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 315684-18-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8452005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-ethoxyphenyl)-3-thiophenecarboxylate
C15H17NO3S
315684-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9847 0.0 0
M  V30 2 O 1.7849 4.4606 0.0 0
M  V30 3 O 4.3940 5.0151 0.0 0
M  V30 4 C 1.4646 5.9669 0.0 0
M  V30 5 C 0.0000 6.4429 0.0 0
M  V30 6 N 1.0076 1.4948 0.0 0
M  V30 7 O 10.3115 4.9320 0.0 0
M  V30 8 C 11.6451 4.1619 0.0 0
M  V30 9 C 12.9788 4.9320 0.0 0
M  V30 10 C 4.9766 1.8519 0.0 0
M  V30 11 C 3.5696 2.4782 0.0 0
M  V30 12 C 4.8155 0.3203 0.0 0
M  V30 13 C 2.5392 1.3338 0.0 0
M  V30 14 S 3.3092 0.0000 0.0 0
M  V30 15 C 6.3103 2.6219 0.0 0
M  V30 16 C 6.3103 4.1619 0.0 0
M  V30 17 C 7.6440 1.8519 0.0 0
M  V30 18 C 7.6440 4.9320 0.0 0
M  V30 19 C 8.9776 2.6219 0.0 0
M  V30 20 C 8.9776 4.1619 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 15
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Ethoxyphenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C14H12N2O2S
455897-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 O 9.7544 4.9318 0.0 0
M  V30 3 C 11.0882 4.1618 0.0 0
M  V30 4 C 12.4219 4.9318 0.0 0
M  V30 5 C 4.4196 1.8517 0.0 0
M  V30 6 C 3.0128 2.4782 0.0 0
M  V30 7 C 4.2587 0.3202 0.0 0
M  V30 8 C 1.9823 1.3337 0.0 0
M  V30 9 C 2.5369 3.9428 0.0 0
M  V30 10 S 2.7523 0.0000 0.0 0
M  V30 11 N 0.4759 1.6540 0.0 0
M  V30 12 N 1.0304 4.2631 0.0 0
M  V30 13 C 0.0000 3.1186 0.0 0
M  V30 14 C 5.7534 2.6218 0.0 0
M  V30 15 C 7.0871 1.8517 0.0 0
M  V30 16 C 5.7534 4.1618 0.0 0
M  V30 17 C 8.4208 2.6218 0.0 0
M  V30 18 C 7.0871 4.9318 0.0 0
M  V30 19 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 315684-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 455897-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11301332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-3-(trifluoromethyl)-5-pyrazolone
C10H7F3N2O
321-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0177 5.6420 0.0 0
M  V30 2 C 7.9701 3.4372 0.0 0
M  V30 3 F 8.1310 4.9687 0.0 0
M  V30 4 F 9.5016 3.2761 0.0 0
M  V30 5 F 7.8090 1.9055 0.0 0
M  V30 6 N 4.0011 3.0800 0.0 0
M  V30 7 N 5.4079 2.4536 0.0 0
M  V30 8 C 4.1621 4.6116 0.0 0
M  V30 9 C 6.4385 3.5981 0.0 0
M  V30 10 C 5.6685 4.9318 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 1.3337 3.0800 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 14 C 0.0000 2.3100 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 9
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dihydro-4-[[5-hydroxy-1-phenyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl...
C21H12F6N4O2
1311144-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3083 7.9700 0.0 0
M  V30 2 C 1.4068 6.2948 0.0 0
M  V30 3 F 0.7805 4.8878 0.0 0
M  V30 4 F 0.0000 6.9211 0.0 0
M  V30 5 F 2.0333 7.7016 0.0 0
M  V30 6 O 6.7982 5.7281 0.0 0
M  V30 7 C 5.0050 11.2472 0.0 0
M  V30 8 F 3.8605 10.2166 0.0 0
M  V30 9 F 3.9745 12.3915 0.0 0
M  V30 10 F 6.1494 12.2776 0.0 0
M  V30 11 O 7.2099 6.2948 0.0 0
M  V30 12 C 4.1474 6.4383 0.0 0
M  V30 13 C 2.8138 5.6683 0.0 0
M  V30 14 C 5.2919 5.4079 0.0 0
M  V30 15 N 3.1339 4.1620 0.0 0
M  V30 16 N 4.6655 4.0011 0.0 0
M  V30 17 C 5.7153 8.5963 0.0 0
M  V30 18 C 6.0355 10.1026 0.0 0
M  V30 19 C 7.0489 7.8263 0.0 0
M  V30 20 N 7.5670 10.2637 0.0 0
M  V30 21 N 8.1935 8.8568 0.0 0
M  V30 22 C 5.4355 2.6673 0.0 0
M  V30 23 C 6.9755 2.6673 0.0 0
M  V30 24 C 4.6655 1.3336 0.0 0
M  V30 25 C 7.7455 1.3336 0.0 0
M  V30 26 C 5.4355 0.0000 0.0 0
M  V30 27 C 6.9755 0.0000 0.0 0
M  V30 28 C 9.6998 8.5366 0.0 0
M  V30 29 C 10.1756 7.0719 0.0 0
M  V30 30 C 10.7302 9.6811 0.0 0
M  V30 31 C 11.6821 6.7517 0.0 0
M  V30 32 C 12.2366 9.3608 0.0 0
M  V30 33 C 12.7125 7.8963 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 1 17 CFG=2
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 13
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 7 18
M  V30 12 2 11 19
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 16 22
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 21 28
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1311144-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-329-CAS-1308511
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Vilsmeier-type methylenation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Vilsmeier-type methylenation for synthesis of dipyrazolylmethane
derivatives using formamide or N-methylformamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wong, Fung Fuh; Huang, Yu-Ying
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(21), 3863-3867

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Thiophenecarboxylic acid, 2-amino-4-(2-chlorophenyl)-, ethyl ester
C13H12ClNO2S
325724-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6421 3.4209 0.0 0
M  V30 2 O 7.1485 3.1007 0.0 0
M  V30 3 O 5.1662 4.8856 0.0 0
M  V30 4 C 8.1790 4.2451 0.0 0
M  V30 5 C 9.6853 3.9249 0.0 0
M  V30 6 N 6.3386 0.1437 0.0 0
M  V30 7 Cl 0.0000 2.4374 0.0 0
M  V30 8 C 3.0801 2.4374 0.0 0
M  V30 9 C 4.6116 2.2765 0.0 0
M  V30 10 C 2.4536 1.0306 0.0 0
M  V30 11 C 4.9318 0.7700 0.0 0
M  V30 12 S 3.5981 0.0000 0.0 0
M  V30 13 C 2.3101 3.7711 0.0 0
M  V30 14 C 0.7700 3.7711 0.0 0
M  V30 15 C 3.0801 5.1049 0.0 0
M  V30 16 C 0.0000 5.1049 0.0 0
M  V30 17 C 2.3101 6.4386 0.0 0
M  V30 18 C 0.7700 6.4386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Chlorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H7ClN2OS
315684-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.8533 5.0872 0.0 0
M  V30 2 Cl 1.3338 0.3117 0.0 0
M  V30 3 C 4.0011 1.8517 0.0 0
M  V30 4 C 5.4080 2.4782 0.0 0
M  V30 5 C 4.1620 0.3202 0.0 0
M  V30 6 C 6.4384 1.3336 0.0 0
M  V30 7 C 5.8839 3.9427 0.0 0
M  V30 8 S 5.6684 0.0000 0.0 0
M  V30 9 N 7.9447 1.6540 0.0 0
M  V30 10 N 7.3902 4.2630 0.0 0
M  V30 11 C 8.4207 3.1185 0.0 0
M  V30 12 C 2.6674 2.6217 0.0 0
M  V30 13 C 1.3338 1.8517 0.0 0
M  V30 14 C 2.6674 4.1617 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 16 C 1.3338 4.9317 0.0 0
M  V30 17 C 0.0000 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 325724-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 315684-36-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1124742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(3-pyridinyl)-3-thiophenecarboxylate
C12H12N2O2S
331975-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6421 3.4209 0.0 0
M  V30 2 O 7.1485 3.1007 0.0 0
M  V30 3 O 5.1662 4.8856 0.0 0
M  V30 4 C 8.1789 4.2451 0.0 0
M  V30 5 C 9.6852 3.9249 0.0 0
M  V30 6 N 6.3386 0.1437 0.0 0
M  V30 7 C 3.0801 2.4374 0.0 0
M  V30 8 C 4.6116 2.2765 0.0 0
M  V30 9 C 2.4536 1.0306 0.0 0
M  V30 10 C 4.9318 0.7700 0.0 0
M  V30 11 S 3.5981 0.0000 0.0 0
M  V30 12 C 2.3100 3.7711 0.0 0
M  V30 13 C 3.0801 5.1049 0.0 0
M  V30 14 C 0.7700 3.7711 0.0 0
M  V30 15 C 2.3100 6.4386 0.0 0
M  V30 16 N 0.0000 5.1049 0.0 0
M  V30 17 C 0.7700 6.4386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Pyridinyl)thieno[2,3-d]pyrimidin-4(1H)-one
C11H7N3OS
1929574-64-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5674 5.0873 0.0 0
M  V30 2 C 4.4197 1.8517 0.0 0
M  V30 3 C 3.0127 2.4782 0.0 0
M  V30 4 C 4.2588 0.3202 0.0 0
M  V30 5 C 1.9823 1.3337 0.0 0
M  V30 6 C 2.5369 3.9428 0.0 0
M  V30 7 S 2.7523 0.0000 0.0 0
M  V30 8 N 0.4760 1.6540 0.0 0
M  V30 9 N 1.0306 4.2631 0.0 0
M  V30 10 C 0.0000 3.1185 0.0 0
M  V30 11 C 5.7533 2.6217 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 7.0870 1.8517 0.0 0
M  V30 14 C 7.0870 4.9318 0.0 0
M  V30 15 N 8.4208 2.6217 0.0 0
M  V30 16 C 8.4208 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 331975-81-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929574-64-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7126167
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-(2,4-dimethylphenyl)benzamide
C15H14BrNO
348153-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 N 5.3901 2.6675 0.0 0
M  V30 3 O 5.3901 5.3348 0.0 0
M  V30 4 Br 3.0801 6.6687 0.0 0
M  V30 5 C 6.9302 0.0000 0.0 0
M  V30 6 C 11.5503 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 2.3101 5.3348 0.0 0
M  V30 9 C 2.3101 2.6675 0.0 0
M  V30 10 C 0.7700 5.3348 0.0 0
M  V30 11 C 0.7700 2.6675 0.0 0
M  V30 12 C 0.0000 4.0012 0.0 0
M  V30 13 C 6.9302 2.6675 0.0 0
M  V30 14 C 7.7002 1.3338 0.0 0
M  V30 15 C 7.7002 4.0012 0.0 0
M  V30 16 C 9.2402 1.3338 0.0 0
M  V30 17 C 9.2402 4.0012 0.0 0
M  V30 18 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 4 8
M  V30 6 1 5 14
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2,4-Dimethylphenyl)-4(3H)-quinazolinone
C16H14N2O
24122-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 C 6.9300 0.0000 0.0 0
M  V30 3 C 11.5500 2.6674 0.0 0
M  V30 4 N 5.3900 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 4.6200 1.3338 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 7.7000 1.3338 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 1.3338 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 15
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 348153-91-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 24122-43-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-778237
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for CuI-catalyzed formation
of 3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline. 3-(2,4-Dimethylphenyl)quinazolin-4(3H)-one
(11k). 56 mg, 90% yield. 1H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 7.2 Hz,
1H), 7.99 (s, 1H), 7.83-7.77 (m, 2H), 7.57-7.53 (m, 1H), 7.20 (s, 1H),
7.17-7.11 (m, 2H), 2.40 (s, 3H), 2.15 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
160.70, 148.21, 146.73, 139.89, 135.48, 134.60, 134.16, 132.12 (2C),
128.07, 127.66 (2C), 127.28, 122.54, 21.25, 17.73; HRMS-ESI: m/z calcd
for C16H15N2O [M + H]+: 251.1184, found 251.1182.
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst formed in-situ; Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(3,4-dichlorophenyl)-3-thiophenecarboxylate
C13H11Cl2NO2S
351156-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1820 4.3513 0.0 0
M  V30 2 O 8.6885 4.6715 0.0 0
M  V30 3 O 6.7062 2.8866 0.0 0
M  V30 4 C 9.7189 3.5271 0.0 0
M  V30 5 C 11.2252 3.8473 0.0 0
M  V30 6 N 7.8786 7.6285 0.0 0
M  V30 7 Cl 0.0000 2.6675 0.0 0
M  V30 8 Cl 1.5400 0.0000 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 6.1516 5.4957 0.0 0
M  V30 11 C 3.9936 6.7417 0.0 0
M  V30 12 C 6.4718 7.0021 0.0 0
M  V30 13 S 5.1381 7.7722 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 18 C 3.8500 1.3337 0.0 0
M  V30 19 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 17
M  V30 8 1 8 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3,4-Dichlorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H6Cl2N2OS
1082410-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 Cl 9.7545 1.8517 0.0 0
M  V30 3 Cl 9.7545 4.9318 0.0 0
M  V30 4 C 4.4197 1.8517 0.0 0
M  V30 5 C 3.0128 2.4782 0.0 0
M  V30 6 C 4.2586 0.3202 0.0 0
M  V30 7 C 1.9823 1.3337 0.0 0
M  V30 8 C 2.5369 3.9428 0.0 0
M  V30 9 S 2.7523 0.0000 0.0 0
M  V30 10 N 0.4759 1.6540 0.0 0
M  V30 11 N 1.0306 4.2631 0.0 0
M  V30 12 C 0.0000 3.1186 0.0 0
M  V30 13 C 5.7534 2.6217 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 5.7534 4.1618 0.0 0
M  V30 16 C 8.4207 2.6217 0.0 0
M  V30 17 C 7.0871 4.9318 0.0 0
M  V30 18 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 16
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351156-69-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1082410-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5653707
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(2,4-dichlorophenyl)-3-thiophenecarboxylate
C13H11Cl2NO2S
351977-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2494 2.4581 0.0 0
M  V30 2 O 1.7849 1.9823 0.0 0
M  V30 3 O 4.3939 1.4277 0.0 0
M  V30 4 C 1.4647 0.4760 0.0 0
M  V30 5 C 0.0000 0.0000 0.0 0
M  V30 6 N 1.0076 4.9480 0.0 0
M  V30 7 Cl 7.6438 6.1309 0.0 0
M  V30 8 Cl 10.3112 1.5109 0.0 0
M  V30 9 C 3.5696 3.9646 0.0 0
M  V30 10 C 4.9765 4.5909 0.0 0
M  V30 11 C 2.5392 5.1089 0.0 0
M  V30 12 C 4.8156 6.1224 0.0 0
M  V30 13 S 3.3092 6.4427 0.0 0
M  V30 14 C 6.3102 3.8209 0.0 0
M  V30 15 C 7.6438 4.5909 0.0 0
M  V30 16 C 6.3102 2.2809 0.0 0
M  V30 17 C 8.9776 3.8209 0.0 0
M  V30 18 C 7.6438 1.5109 0.0 0
M  V30 19 C 8.9776 2.2809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 15
M  V30 8 1 8 19
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 10 14
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,4-Dichlorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H6Cl2N2OS
339369-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 Cl 7.0871 0.3117 0.0 0
M  V30 3 Cl 9.7545 4.9318 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.4197 1.8517 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 C 4.2586 0.3202 0.0 0
M  V30 9 S 2.7523 0.0000 0.0 0
M  V30 10 N 0.4759 1.6540 0.0 0
M  V30 11 N 1.0306 4.2631 0.0 0
M  V30 12 C 0.0000 3.1186 0.0 0
M  V30 13 C 5.7534 2.6217 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 5.7534 4.1618 0.0 0
M  V30 16 C 8.4207 2.6217 0.0 0
M  V30 17 C 7.0871 4.9318 0.0 0
M  V30 18 C 8.4207 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 13
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 9
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351977-69-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 339369-75-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3232077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-fluorophenyl)thiophene-3-carboxylate
C13H12FNO2S
35978-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 F 10.3115 4.9318 0.0 0
M  V30 8 C 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 S 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 6.3103 4.1618 0.0 0
M  V30 15 C 7.6440 1.8517 0.0 0
M  V30 16 C 7.6440 4.9318 0.0 0
M  V30 17 C 8.9778 2.6218 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H7FN2OS
35978-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 F 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35978-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35978-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15932258
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-fluorophenyl)thiophene-3-carboxylate
C13H12FNO2S
35978-33-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 F 10.3115 4.9318 0.0 0
M  V30 8 C 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 S 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 6.3103 4.1618 0.0 0
M  V30 15 C 7.6440 1.8517 0.0 0
M  V30 16 C 7.6440 4.9318 0.0 0
M  V30 17 C 8.9778 2.6218 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H7FN2OS
35978-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 F 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35978-33-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35978-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1448901
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinemethanamine
C6H8N2
3731-51-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Pyridinylmethyl)formamide
C7H8N2O
56625-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 N 5.3348 2.3100 0.0 0
M  V30 3 C 6.6686 3.0800 0.0 0
M  V30 4 O 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 N 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3731-51-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56625-03-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30614706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1817778-31-6
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Efficient Heterobimetallic Lanthanide Alkoxide Catalyst for
Transamidation of Amides under Solvent-Free Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sheng, Hongting; Zeng, Ruijie; Wang, Wenjuan; Luo, Shuwen; Feng, Yan;
Liu, Jing; Chen, Weijian; Zhu, Manzhou; Guo, Qingxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2017), 359(2), 302-313

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Cyclohepta[b]thiophene-3-carboxylic acid, 2-amino-5,6,7,8-tetrahydro-, eth...
C12H17NO2S
40106-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1947 3.3320 0.0 0
M  V30 2 O 7.5286 2.5620 0.0 0
M  V30 3 O 6.1947 4.8720 0.0 0
M  V30 4 C 8.8622 3.3320 0.0 0
M  V30 5 C 10.1959 2.5620 0.0 0
M  V30 6 N 5.8445 0.0000 0.0 0
M  V30 7 C 3.4543 3.1885 0.0 0
M  V30 8 C 4.8611 2.5620 0.0 0
M  V30 9 C 2.4237 2.0439 0.0 0
M  V30 10 C 3.2019 4.7075 0.0 0
M  V30 11 C 4.7002 1.0304 0.0 0
M  V30 12 S 3.1937 0.7103 0.0 0
M  V30 13 C 0.8864 2.1360 0.0 0
M  V30 14 C 1.8568 5.4575 0.0 0
M  V30 15 C 0.0000 3.3953 0.0 0
M  V30 16 C 0.4318 4.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,7,8,9-Hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-one
C11H12N2OS
40106-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9874 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7472 4.5191 0.0 0
M  V30 5 C 5.6834 1.9067 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 S 3.3404 5.1454 0.0 0
M  V30 9 C 6.0451 5.3481 0.0 0
M  V30 10 C 7.2123 2.0906 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3336 0.0 0
M  V30 13 C 7.5024 4.8504 0.0 0
M  V30 14 C 8.0219 3.4006 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40106-13-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40106-31-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14763735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Cyclohepta[b]thiophene-3-carboxylic acid, 2-amino-5,6,7,8-tetrahydro-, eth...
C12H17NO2S
40106-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1947 3.3320 0.0 0
M  V30 2 O 7.5286 2.5620 0.0 0
M  V30 3 O 6.1947 4.8720 0.0 0
M  V30 4 C 8.8622 3.3320 0.0 0
M  V30 5 C 10.1959 2.5620 0.0 0
M  V30 6 N 5.8445 0.0000 0.0 0
M  V30 7 C 3.4543 3.1885 0.0 0
M  V30 8 C 4.8611 2.5620 0.0 0
M  V30 9 C 2.4237 2.0439 0.0 0
M  V30 10 C 3.2019 4.7075 0.0 0
M  V30 11 C 4.7002 1.0304 0.0 0
M  V30 12 S 3.1937 0.7103 0.0 0
M  V30 13 C 0.8864 2.1360 0.0 0
M  V30 14 C 1.8568 5.4575 0.0 0
M  V30 15 C 0.0000 3.3953 0.0 0
M  V30 16 C 0.4318 4.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,7,8,9-Hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-one
C11H12N2OS
40106-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9874 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7472 4.5191 0.0 0
M  V30 5 C 5.6834 1.9067 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 S 3.3404 5.1454 0.0 0
M  V30 9 C 6.0451 5.3481 0.0 0
M  V30 10 C 7.2123 2.0906 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3336 0.0 0
M  V30 13 C 7.5024 4.8504 0.0 0
M  V30 14 C 8.0219 3.4006 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40106-13-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40106-31-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9994808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and biological studies of some novel
thieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Taisan, Khulud M.; Al-Hazimi, Hassan M. A.; Al-Shihry, Shar S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2010), 153932-3957

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Cyclohepta[b]thiophene-3-carboxylic acid, 2-amino-5,6,7,8-tetrahydro-, eth...
C12H17NO2S
40106-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1947 3.3320 0.0 0
M  V30 2 O 7.5286 2.5620 0.0 0
M  V30 3 O 6.1947 4.8720 0.0 0
M  V30 4 C 8.8622 3.3320 0.0 0
M  V30 5 C 10.1959 2.5620 0.0 0
M  V30 6 N 5.8445 0.0000 0.0 0
M  V30 7 C 3.4543 3.1885 0.0 0
M  V30 8 C 4.8611 2.5620 0.0 0
M  V30 9 C 2.4237 2.0439 0.0 0
M  V30 10 C 3.2019 4.7075 0.0 0
M  V30 11 C 4.7002 1.0304 0.0 0
M  V30 12 S 3.1937 0.7103 0.0 0
M  V30 13 C 0.8864 2.1360 0.0 0
M  V30 14 C 1.8568 5.4575 0.0 0
M  V30 15 C 0.0000 3.3953 0.0 0
M  V30 16 C 0.4318 4.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5,6,7,8,9-Hexahydro-4H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-one
C11H12N2OS
40106-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.5863 2.9874 0.0 0
M  V30 3 C 3.0800 2.6673 0.0 0
M  V30 4 C 4.7472 4.5191 0.0 0
M  V30 5 C 5.6834 1.9067 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 S 3.3404 5.1454 0.0 0
M  V30 9 C 6.0451 5.3481 0.0 0
M  V30 10 C 7.2123 2.0906 0.0 0
M  V30 11 N 0.7700 4.0011 0.0 0
M  V30 12 N 0.7700 1.3336 0.0 0
M  V30 13 C 7.5024 4.8504 0.0 0
M  V30 14 C 8.0219 3.4006 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 8
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40106-13-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40106-31-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7677966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of some thienopyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM El-Baih, Fatma E. M.; Al-Blowy, Hanan A. S.; Al-Hazimi, Hassan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2006), 11(7), 498-513

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-(trifluoromethyl)benzene
C7H4BrF3
402-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 Br 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzonitrile
C8H4F3N
455-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 9.2400 1.5400 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 455-18-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26128049
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cyanation of Aryl Halides Using Formamide and
Cyanuric Chloride as a New "CN" Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niknam, Esmaeil; Panahi, Farhad; Khalafi-Nezhad, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(18), 2699-2707

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diethyl 1-amino-3-methyl-1H-pyrrole-2,4-dicarboxylate
C11H16N2O4
427878-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6445 4.0287 0.0 0
M  V30 2 O 9.9782 3.2587 0.0 0
M  V30 3 O 8.6445 5.5687 0.0 0
M  V30 4 C 11.3120 4.0287 0.0 0
M  V30 5 C 12.6456 3.2587 0.0 0
M  V30 6 C 5.5838 5.3914 0.0 0
M  V30 7 C 3.3420 2.9015 0.0 0
M  V30 8 O 2.4368 1.6557 0.0 0
M  V30 9 O 2.7156 4.3085 0.0 0
M  V30 10 C 0.9052 1.8166 0.0 0
M  V30 11 C 0.0000 0.5707 0.0 0
M  V30 12 N 5.0172 0.0000 0.0 0
M  V30 13 C 7.3109 3.2587 0.0 0
M  V30 14 C 5.9039 3.8850 0.0 0
M  V30 15 C 7.1499 1.7271 0.0 0
M  V30 16 C 4.8735 2.7406 0.0 0
M  V30 17 N 5.6435 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-methyl-4-oxopyrrolo[2,1-f][1,2,4]triazine-6-carboxylate
C10H11N3O3
427878-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 N 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 4.5865 1.6538 0.0 0
M  V30 13 N 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 427878-69-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 427878-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12311961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [0374] To a solution of compound a. (2 g) in formamide (8 mL) was added
acetic acid (20% by weight), and the mixture was heated at 120° C. for 24
h. The reaction mixture was cooled and water added (32 mL) to precipitate
the product. The solids were collected by filtration and washed with
EtOAc to furnish to the compound b. as a yellow solid (90%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing salts of
4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide
and novel stable forms produced therein and their use as antiinflammatory
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Soojin; Malley, Mary F.; Shi, Zhongping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060235020 A1 2006-10-19

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diethyl 1-amino-3-methyl-1H-pyrrole-2,4-dicarboxylate
C11H16N2O4
427878-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6445 4.0287 0.0 0
M  V30 2 O 9.9782 3.2587 0.0 0
M  V30 3 O 8.6445 5.5687 0.0 0
M  V30 4 C 11.3120 4.0287 0.0 0
M  V30 5 C 12.6456 3.2587 0.0 0
M  V30 6 C 5.5838 5.3914 0.0 0
M  V30 7 C 3.3420 2.9015 0.0 0
M  V30 8 O 2.4368 1.6557 0.0 0
M  V30 9 O 2.7156 4.3085 0.0 0
M  V30 10 C 0.9052 1.8166 0.0 0
M  V30 11 C 0.0000 0.5707 0.0 0
M  V30 12 N 5.0172 0.0000 0.0 0
M  V30 13 C 7.3109 3.2587 0.0 0
M  V30 14 C 5.9039 3.8850 0.0 0
M  V30 15 C 7.1499 1.7271 0.0 0
M  V30 16 C 4.8735 2.7406 0.0 0
M  V30 17 N 5.6435 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-methyl-4-oxopyrrolo[2,1-f][1,2,4]triazine-6-carboxylate
C10H11N3O3
427878-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 N 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 4.5865 1.6538 0.0 0
M  V30 13 N 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 427878-69-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 427878-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8820806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step B: [0253] To a solution of Compound 2A (2 g) in formamide (8 mL) was
added acetic acid (20% by weight), and the mixture was heated at
120&#x00B0;C. for 24 h. The reaction mixture was cooled, and water was
added (32 mL) to precipitate the product. The solids were collected by
filtration and washed with EtOAc to furnish Compound 2B as a yellow solid
(90%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolopyrrolotriazines as p38 kinase inhibitors.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, James; Wrobleski, Stephen T.; Liu, Chunjian; Leftheris, Katerina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060019928 A1 2006-01-26

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diethyl 1-amino-3-methyl-1H-pyrrole-2,4-dicarboxylate
C11H16N2O4
427878-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6445 4.0287 0.0 0
M  V30 2 O 9.9782 3.2587 0.0 0
M  V30 3 O 8.6445 5.5687 0.0 0
M  V30 4 C 11.3120 4.0287 0.0 0
M  V30 5 C 12.6456 3.2587 0.0 0
M  V30 6 C 5.5838 5.3914 0.0 0
M  V30 7 C 3.3420 2.9015 0.0 0
M  V30 8 O 2.4368 1.6557 0.0 0
M  V30 9 O 2.7156 4.3085 0.0 0
M  V30 10 C 0.9052 1.8166 0.0 0
M  V30 11 C 0.0000 0.5707 0.0 0
M  V30 12 N 5.0172 0.0000 0.0 0
M  V30 13 C 7.3109 3.2587 0.0 0
M  V30 14 C 5.9039 3.8850 0.0 0
M  V30 15 C 7.1499 1.7271 0.0 0
M  V30 16 C 4.8735 2.7406 0.0 0
M  V30 17 N 5.6435 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-methyl-4-oxopyrrolo[2,1-f][1,2,4]triazine-6-carboxylate
C10H11N3O3
427878-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 N 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 4.5865 1.6538 0.0 0
M  V30 13 N 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 427878-69-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 427878-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6759476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for the preparation of pyrrolotriazine compounds useful as kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Godfrey, Jollie Duaine; Hynes, John; Dyckman, Alaric J.; Leftheris,
Katerina; Shi, Zhongping; Wrobleski, Stephen T.; Doubleday, Wendel
William; Grosso, John A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030186982 A1 2003-10-02

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diethyl 1-amino-3-methyl-1H-pyrrole-2,4-dicarboxylate
C11H16N2O4
427878-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6445 4.0287 0.0 0
M  V30 2 O 9.9782 3.2587 0.0 0
M  V30 3 O 8.6445 5.5687 0.0 0
M  V30 4 C 11.3120 4.0287 0.0 0
M  V30 5 C 12.6456 3.2587 0.0 0
M  V30 6 C 5.5838 5.3914 0.0 0
M  V30 7 C 3.3420 2.9015 0.0 0
M  V30 8 O 2.4368 1.6557 0.0 0
M  V30 9 O 2.7156 4.3085 0.0 0
M  V30 10 C 0.9052 1.8166 0.0 0
M  V30 11 C 0.0000 0.5707 0.0 0
M  V30 12 N 5.0172 0.0000 0.0 0
M  V30 13 C 7.3109 3.2587 0.0 0
M  V30 14 C 5.9039 3.8850 0.0 0
M  V30 15 C 7.1499 1.7271 0.0 0
M  V30 16 C 4.8735 2.7406 0.0 0
M  V30 17 N 5.6435 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 17
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-methyl-4-oxopyrrolo[2,1-f][1,2,4]triazine-6-carboxylate
C10H11N3O3
427878-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 O 7.4148 3.1854 0.0 0
M  V30 5 O 6.0811 5.4955 0.0 0
M  V30 6 C 8.7486 3.9554 0.0 0
M  V30 7 C 10.0823 3.1854 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 N 3.0801 1.3337 0.0 0
M  V30 10 C 3.3405 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 4.5865 1.6538 0.0 0
M  V30 13 N 2.3101 0.0000 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 N 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 427878-69-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 427878-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10742728
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM B. To a solution of Compound A (2 g) in formamide (8 mL) was added acetic
acid (20% by weight), and the mixture was heated at 120°C for 24h. The
reaction mixture was cooled and water added (32 mL) to precipitate the
product. The solids were collected by filtration and washed with EtOAc.
Compound B as a yellow solid (90%).
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolo[2,1-f][1,2,4]triazine carboxylic acid derivatives
for use in treating p38 kinase-associated conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leftheris, Katerina; Barrish, Joel; Hynes, John; Wrobleski, Stephen T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002040486 A2 2002-05-23

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6-Diamino-2,4-dihydroxypyrimidine sulfate
C4H6N4O2.H2O4S
42965-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0800 8.4149 0.0 0 VAL=6
M  V30 2 O 1.5400 8.4149 0.0 0
M  V30 3 O 4.6200 8.4149 0.0 0
M  V30 4 O 3.0800 6.8749 0.0 0
M  V30 5 O 3.0800 9.9549 0.0 0
M  V30 6 N 0.0000 2.6674 0.0 0
M  V30 7 N 1.5400 0.0000 0.0 0
M  V30 8 O 1.5400 5.3349 0.0 0
M  V30 9 O 6.1600 2.6674 0.0 0
M  V30 10 C 1.5400 2.6674 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 N 3.8500 1.3338 0.0 0
M  V30 14 N 3.8500 4.0011 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 6 10
M  V30 6 1 7 11
M  V30 7 2 8 12
M  V30 8 2 9 15
M  V30 9 2 10 11
M  V30 10 1 10 12
M  V30 11 1 11 13
M  V30 12 1 12 14
M  V30 13 1 13 15
M  V30 14 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Xanthine
C5H4N4O2
69-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7036 0.0000 0.0 0
M  V30 2 O 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42965-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 69-89-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-10923202
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Xanthine (IV). A suspension of 150 g of
5,6-diamino-2,4-dihydroxypyrimidine sulfate in 750 ml of formamide in a
3-1 flask was heated for 90 min at 180°C. The mixture was cooled, and the
precipitate was filtered off and thoroughly washed with water and cold
ethanol. Yield 80 g (90%). Mp >300°C. IR spectrum, ν, cm-1: 3065, 1572,
1491, 1392, 1320, 1233, 989, 635, 605.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Purine Antiviral Agents, Hypoxanthine and 6-Mercaptopurine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sariri, R.; Khalili, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (Translation of Zhurnal
Organicheskoi Khimii) (2002), 38(7), 1053-1055

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-ethylthiophene-3-carboxylate
C9H13NO2S
4507-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.7106 0.0 0
M  V30 2 O 2.3100 4.0442 0.0 0
M  V30 3 O 2.3100 1.3769 0.0 0
M  V30 4 C 0.7700 4.0442 0.0 0
M  V30 5 C 0.0000 5.3780 0.0 0
M  V30 6 N 5.0494 0.0000 0.0 0
M  V30 7 C 8.2358 4.3858 0.0 0
M  V30 8 C 9.6426 3.7595 0.0 0
M  V30 9 C 4.6200 2.7106 0.0 0
M  V30 10 C 5.5252 1.4647 0.0 0
M  V30 11 C 5.5252 3.9564 0.0 0
M  V30 12 S 6.9898 1.9406 0.0 0
M  V30 13 C 6.9898 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Ethylthieno[2,3-d]pyrimidin-4(1H)-one
C8H8N2OS
18593-51-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0010 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 C 7.4150 3.1854 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 S 4.5865 1.6538 0.0 0
M  V30 7 N 2.3101 0.0000 0.0 0
M  V30 8 C 3.3406 3.8119 0.0 0
M  V30 9 C 0.7700 2.6673 0.0 0
M  V30 10 C 4.7475 3.1854 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4507-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18593-51-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15931218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5-diethoxybenzoate
C13H19NO4
460750-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 O 2.6673 3.8501 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 8.0022 6.9302 0.0 0
M  V30 8 O 9.3360 6.1601 0.0 0
M  V30 9 O 8.0022 8.4702 0.0 0
M  V30 10 C 10.6697 6.9302 0.0 0
M  V30 11 C 12.0033 6.1601 0.0 0
M  V30 12 N 5.3348 8.4702 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 4.0012 6.1601 0.0 0
M  V30 17 C 6.6685 6.1601 0.0 0
M  V30 18 C 5.3348 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 17
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Diethoxyquinazolin-4-one
C12H14N2O3
179246-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 6.1601 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 O 6.6684 3.8500 0.0 0
M  V30 6 C 8.0022 4.6201 0.0 0
M  V30 7 C 9.3359 3.8500 0.0 0
M  V30 8 C 2.6675 6.1601 0.0 0
M  V30 9 C 4.0011 6.9301 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 6.9301 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0
M  V30 13 N 4.0011 8.4701 0.0 0
M  V30 14 C 4.0011 3.8500 0.0 0
M  V30 15 N 1.3337 8.4701 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 2.6675 9.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 460750-27-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 179246-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12501982
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 554-68-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-phenylaminoquinazoline derivatives as fructose
1,6-bisphosphatase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bauer, Paul H.; Wright, Stephen W.; Schnur, Rodney C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030144308 A1 2003-07-31

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate
C14H21NO6
476168-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 4.6200 0.0 0
M  V30 2 C 4.0009 3.8500 0.0 0
M  V30 3 C 4.0009 2.3100 0.0 0
M  V30 4 O 2.6673 1.5400 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 8.0020 6.1600 0.0 0
M  V30 7 C 9.3358 6.9300 0.0 0
M  V30 8 C 10.6694 6.1600 0.0 0
M  V30 9 O 12.0031 6.9300 0.0 0
M  V30 10 C 13.3367 6.1600 0.0 0
M  V30 11 C 2.6673 9.2400 0.0 0
M  V30 12 O 1.3336 8.4700 0.0 0
M  V30 13 O 2.6673 10.7800 0.0 0
M  V30 14 C 0.0000 9.2400 0.0 0
M  V30 15 N 5.3347 10.7800 0.0 0
M  V30 16 C 5.3347 6.1600 0.0 0
M  V30 17 C 6.6684 6.9300 0.0 0
M  V30 18 C 4.0009 6.9300 0.0 0
M  V30 19 C 6.6684 8.4700 0.0 0
M  V30 20 C 4.0009 8.4700 0.0 0
M  V30 21 C 5.3347 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 1 15 21
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,7-Bis(2-methoxyethoxy)quinazolin-4(3H)-one
C14H18N2O5
179688-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 1.3336 0.0 0
M  V30 2 O 4.6200 6.6684 0.0 0
M  V30 3 C 3.0800 6.6684 0.0 0
M  V30 4 C 2.3100 8.0021 0.0 0
M  V30 5 O 0.7700 8.0021 0.0 0
M  V30 6 C 0.0000 9.3358 0.0 0
M  V30 7 O 7.7000 6.6684 0.0 0
M  V30 8 C 9.2400 6.6684 0.0 0
M  V30 9 C 10.0100 8.0021 0.0 0
M  V30 10 O 11.5500 8.0021 0.0 0
M  V30 11 C 12.3200 9.3358 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 4.6200 1.3336 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 N 7.7000 1.3336 0.0 0
M  V30 18 C 5.3900 5.3347 0.0 0
M  V30 19 N 5.3900 0.0000 0.0 0
M  V30 20 C 6.9300 5.3347 0.0 0
M  V30 21 C 6.9300 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476168-17-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 179688-29-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9766838
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of allenic quinazolines using
palladium-catalyzed hydride-transfer reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nakamura, Hiroyuki; Onagi, Shinya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2006), 47(15), 2539-2542

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-carboethoxy-5-methyl-4-phenylthiophene
C14H15NO2S
4815-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6421 3.0177 0.0 0
M  V30 2 O 7.1485 3.3379 0.0 0
M  V30 3 O 5.1662 1.5530 0.0 0
M  V30 4 C 8.1790 2.1935 0.0 0
M  V30 5 C 9.6853 2.5136 0.0 0
M  V30 6 C 0.9473 5.7283 0.0 0
M  V30 7 N 6.3386 6.2949 0.0 0
M  V30 8 C 3.0801 4.0012 0.0 0
M  V30 9 C 4.6116 4.1621 0.0 0
M  V30 10 C 2.4536 5.4080 0.0 0
M  V30 11 C 4.9318 5.6686 0.0 0
M  V30 12 S 3.5981 6.4386 0.0 0
M  V30 13 C 2.3101 2.6675 0.0 0
M  V30 14 C 0.7700 2.6675 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 17 C 2.3101 0.0000 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-5-phenylthieno[2,3-d]pyrimidin-4(1H)-one
C13H10N2OS
35978-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9553 0.0000 0.0 0
M  V30 2 O 4.0011 6.0812 0.0 0
M  V30 3 C 3.8118 2.7406 0.0 0
M  V30 4 C 2.6673 3.7712 0.0 0
M  V30 5 C 3.1853 1.3338 0.0 0
M  V30 6 C 1.3336 3.0012 0.0 0
M  V30 7 C 2.6673 5.3112 0.0 0
M  V30 8 S 1.6538 1.4947 0.0 0
M  V30 9 N 0.0000 3.7712 0.0 0
M  V30 10 N 1.3336 6.0812 0.0 0
M  V30 11 C 0.0000 5.3112 0.0 0
M  V30 12 C 5.3181 3.0607 0.0 0
M  V30 13 C 5.7939 4.5254 0.0 0
M  V30 14 C 6.3486 1.9164 0.0 0
M  V30 15 C 7.3004 4.8456 0.0 0
M  V30 16 C 7.8549 2.2365 0.0 0
M  V30 17 C 8.3308 3.7012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35978-38-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15862991
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-carboethoxy-5-methyl-4-phenylthiophene
C14H15NO2S
4815-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6421 3.0177 0.0 0
M  V30 2 O 7.1485 3.3379 0.0 0
M  V30 3 O 5.1662 1.5530 0.0 0
M  V30 4 C 8.1790 2.1935 0.0 0
M  V30 5 C 9.6853 2.5136 0.0 0
M  V30 6 C 0.9473 5.7283 0.0 0
M  V30 7 N 6.3386 6.2949 0.0 0
M  V30 8 C 3.0801 4.0012 0.0 0
M  V30 9 C 4.6116 4.1621 0.0 0
M  V30 10 C 2.4536 5.4080 0.0 0
M  V30 11 C 4.9318 5.6686 0.0 0
M  V30 12 S 3.5981 6.4386 0.0 0
M  V30 13 C 2.3101 2.6675 0.0 0
M  V30 14 C 0.7700 2.6675 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 17 C 2.3101 0.0000 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-5-phenylthieno[2,3-d]pyrimidin-4(1H)-one
C13H10N2OS
35978-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9553 0.0000 0.0 0
M  V30 2 O 4.0011 6.0812 0.0 0
M  V30 3 C 3.8118 2.7406 0.0 0
M  V30 4 C 2.6673 3.7712 0.0 0
M  V30 5 C 3.1853 1.3338 0.0 0
M  V30 6 C 1.3336 3.0012 0.0 0
M  V30 7 C 2.6673 5.3112 0.0 0
M  V30 8 S 1.6538 1.4947 0.0 0
M  V30 9 N 0.0000 3.7712 0.0 0
M  V30 10 N 1.3336 6.0812 0.0 0
M  V30 11 C 0.0000 5.3112 0.0 0
M  V30 12 C 5.3181 3.0607 0.0 0
M  V30 13 C 5.7939 4.5254 0.0 0
M  V30 14 C 6.3486 1.9164 0.0 0
M  V30 15 C 7.3004 4.8456 0.0 0
M  V30 16 C 7.8549 2.2365 0.0 0
M  V30 17 C 8.3308 3.7012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4815-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35978-38-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4868707
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME96 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-(mercaptomethyl)-2-phenylethyl]carbamate
C17H19NO2S
676457-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0011 0.0 0
M  V30 2 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 3 N 6.9301 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7001 4.0011 0.0 0
M  V30 6 S 5.3901 0.0000 0.0 0
M  V30 7 O 9.2401 4.0011 0.0 0
M  V30 8 O 6.9301 5.3348 0.0 0
M  V30 9 C 10.0101 5.3348 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 2.3100 2.6675 0.0 0
M  V30 13 C 0.7700 5.3348 0.0 0
M  V30 14 C 0.7700 2.6675 0.0 0
M  V30 15 C 0.0000 4.0011 0.0 0
M  V30 16 C 11.5501 5.3348 0.0 0
M  V30 17 C 12.3201 4.0011 0.0 0
M  V30 18 C 12.3201 6.6686 0.0 0
M  V30 19 C 13.8602 4.0011 0.0 0
M  V30 20 C 13.8602 6.6686 0.0 0
M  V30 21 C 14.6302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 16
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C19H22N2O3S
2602313-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 8.0021 0.0 0 CFG=1
M  V30 2 C 4.6201 9.3359 0.0 0
M  V30 3 N 6.9301 8.0021 0.0 0
M  V30 4 C 4.6201 6.6684 0.0 0
M  V30 5 C 7.7001 9.3359 0.0 0
M  V30 6 S 5.3901 5.3348 0.0 0
M  V30 7 O 9.2401 9.3359 0.0 0
M  V30 8 O 6.9301 10.6695 0.0 0
M  V30 9 C 4.6201 4.0011 0.0 0
M  V30 10 C 10.0101 10.6695 0.0 0
M  V30 11 N 5.3901 2.6673 0.0 0
M  V30 12 C 4.6201 1.3337 0.0 0
M  V30 13 O 5.3901 0.0000 0.0 0
M  V30 14 C 3.0800 9.3359 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 2.3100 10.6695 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 18 C 0.7700 10.6695 0.0 0
M  V30 19 C 0.0000 9.3359 0.0 0
M  V30 20 C 11.5501 10.6695 0.0 0
M  V30 21 C 12.3201 12.0032 0.0 0
M  V30 22 C 12.3201 9.3359 0.0 0
M  V30 23 C 13.8602 12.0032 0.0 0
M  V30 24 C 13.8602 9.3359 0.0 0
M  V30 25 C 14.6302 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 20
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 676457-77-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2602313-16-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-23165127
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on catalyst, solvent and stoichiometry of
reactant, catalyst, scalable, paraformaldehyde used, Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Nβ-Protected Amino Sulfenyl Methyl Formamides and Sulfonyl
Methyl Formamides: A Simple Protocol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasulu, Chinthaginjala; Sagar, Nagamangala R.; Vishwanatha,
Thimmalapura M.; Durgamma, Suram; Sureshbabu, Vommina V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2021), 6(7), 4680-4686

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-6-methoxynaphthalene
C11H9BrO
5111-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 Br 0.0000 0.0000 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 C 5.3348 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-naphthalenecarbonitrile
C12H9NO
67886-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 1.3337 0.0 0
M  V30 2 N 10.7802 1.3337 0.0 0
M  V30 3 O 0.7700 2.6673 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 C 6.9302 2.6673 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 5.3901 0.0000 0.0 0
M  V30 11 C 7.7002 1.3337 0.0 0
M  V30 12 C 3.0801 4.0010 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 14 C 6.9302 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5111-65-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67886-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25328484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 366-18-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3264-82-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed vessel used, aerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Mediated Generation of "CN" Unit from Formamide and Its Catalysis in
the Cyanation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Luo; Liu, Yu-Ting; Park, Yoonsu; Park, Sung-Woo; Chang, Sukbok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2019), 9(4), 3360-3365

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl-3-pyridinylmethanone
C12H9NO
5424-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 N 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzoyl-2-pyridinecarboxamide
C13H10N2O2
82465-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 N 9.3359 6.1601 0.0 0
M  V30 5 O 10.6695 3.8500 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 6.6684 1.5400 0.0 0
M  V30 9 C 6.6684 4.6201 0.0 0
M  V30 10 N 8.0022 2.3100 0.0 0
M  V30 11 C 8.0022 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5424-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82465-57-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24659168
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Minisci reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A study of Minisci reaction by changing Fe2+ equivalency: Preparation of
arylpyridinyl methanol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ozgeris, Bunyamin; Tumer, Ferhan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Communications (2019), 12(3), 143-148

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
2-Bromo-N-2-naphthalenylbenzamide
C17H12BrNO
571165-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 4.0011 0.0 0
M  V30 2 C 7.7001 2.6675 0.0 0
M  V30 3 O 6.9301 1.3338 0.0 0
M  V30 4 Br 9.2401 0.0000 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 3.0800 5.3348 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 6.6686 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 0.0000 5.3348 0.0 0
M  V30 13 C 5.3901 4.0011 0.0 0
M  V30 14 C 0.7700 6.6686 0.0 0
M  V30 15 C 9.2401 2.6675 0.0 0
M  V30 16 C 10.0101 1.3338 0.0 0
M  V30 17 C 10.0101 4.0011 0.0 0
M  V30 18 C 11.5501 1.3338 0.0 0
M  V30 19 C 11.5501 4.0011 0.0 0
M  V30 20 C 12.3201 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2-Naphthalenyl)-4(3H)-quinazolinone
C18H12N2O
1172640-56-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 N 5.3900 2.6674 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 N 3.0800 1.3338 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 7.7000 1.3338 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 1.3338 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 10.0100 0.0000 0.0 0
M  V30 19 C 11.5500 2.6674 0.0 0
M  V30 20 C 11.5500 0.0000 0.0 0
M  V30 21 C 12.3200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 7
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 1 16 17
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 571165-08-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1172640-56-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7378049
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51-35-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for CuI-catalyzed formation
of 3-substituted-4-quinazolines and 2,3-disubstituted-4(3H )-quinazolines
from 2-bromo-N-phenylbenzamide. For 3-substituted-4-quinazoline
(11a-11r). A Schlenk tube was charged with N-substituted 2-bromobenzamide
(0.25 mmol), CuI (5 mg, 0.025 mmol), trans-4-hydroxy-L-proline (3 mg,
0.025 mmol), and Cs2CO3 (163 mg, 0.5 mmol). The tube was evacuated and
backfilled with argon before formamide (20 µL, 0.5 mmol) and 1 mL DMF was
added. The reaction mixture was stirred at 80 o C (or 90 o C for
substrate 7l) for 24 h. After the reaction mixture was cooled to room
temperature, 5 mL of saturated NH4Cl solution was added. The mixture was
extracted with EtOAc and the organic layer was washed with water, brine
and dried over Na2SO4. After concentration in vacuo, the residue was
purified by column chromatography on silica gel. The desired
3-substituted 4-quinazoline. 3-(Naphthalen-2-yl)quinazolin-4(3H)-one
(11r). 61 mg, 90% yield; 1H NMR (400 MHz, CDCl3) δ 1H NMR (400 MHz,
CDCl3) δ 8.41 (d, J = 7.6 Hz, 1H), 8.23 (s, 1H), 8.04-7.80 (m, 6H),
7.59-7.53 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 161.07, 148.01, 146.34,
135.19, 134.73, 133.45, 133.13, 129.68, 128.23, 127.98, 127.80, 127.73,
127.36, 127.27, 127.17, 125.73, 124.74, 122.49. HRMS-ESI: m/z calcd for
C18H13N2O [M + H]+: 273.1028, found 273.1001.
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst formed in-situ; Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Substituted and 2,3-Disubstituted Quinazolinones via
Cu-Catalyzed Aryl Amidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Lanting; Jiang, Yongwen; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(4), 1150-1153

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-5-(3-chloropropoxy)-4-methoxybenzoic acid
C11H14ClNO4
574738-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 C 8.4700 5.3347 0.0 0
M  V30 4 C 9.2400 6.6685 0.0 0
M  V30 5 Cl 10.7800 6.6685 0.0 0
M  V30 6 O 4.6200 1.3336 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 1.5400 6.6685 0.0 0
M  V30 9 O 0.0000 6.6685 0.0 0
M  V30 10 O 2.3100 8.0021 0.0 0
M  V30 11 N 0.0000 4.0011 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(3-Chloropropoxy)-7-methoxy-4(3H)-quinazolinone
C12H13ClN2O3
574738-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 8.0021 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 C 7.7000 5.3347 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 C 10.0100 6.6685 0.0 0
M  V30 6 Cl 11.5500 6.6685 0.0 0
M  V30 7 O 5.3900 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 3.0800 5.3347 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 2.3100 6.6685 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 N 0.7700 4.0011 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 N 0.7700 6.6685 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 574738-84-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 574738-93-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3113398
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 4: Preparation of 6-(3-chloropropoxy)-7-methoxyquinazoline-4-one
(formula V) 2-amino-4-methoxy-5-(3-chloropropoxy)benzoic acid (450gm),
formamide (2250 ml) and ammonium formate (200 gm) were heated to
170-180°C for 3-4 hours. The reaction mass was concentrated under reduced
pressure at 140-150°C. The residue was stirred in methanol (1000 ml) at
45-50°C and cooled to 5-10°C. The solid obtained was filtered to yield
the title compound (420 gm, 90% yield).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of gefitinib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rao, Dharmaraj Ramachandra; Kankan, Rajendra Narayanrao; Pathi, Srinivas
Laxminarayan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008125867 A2 2008-10-23

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromoanisole
C7H7BrO
578-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Methoxyphenyl)formamide
C8H9NO2
23896-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 O 6.9300 5.3349 0.0 0
M  V30 4 O 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 578-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23896-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-3754958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-99-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand free open air copper(II) mediated aryl formamidation and amination
of aryl halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Komati, Rajesh; Jursic, Branko S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(9), 1523-1527

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-(2-phenylhydrazinylidene)acetate
C9H9ClN2O2
58131-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 Cl 6.6685 0.0000 0.0 0
M  V30 6 O 9.3360 1.5400 0.0 0
M  V30 7 O 8.0023 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-1,2,4-Triazole-3-carboxylic acid, 1-phenyl-, methyl ester
C10H9N3O2
57226-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2356 1.5317 0.0 0
M  V30 2 O 9.6426 2.1580 0.0 0
M  V30 3 O 8.0747 0.0000 0.0 0
M  V30 4 C 10.8884 1.2528 0.0 0
M  V30 5 N 4.6200 3.2067 0.0 0
M  V30 6 N 5.5252 1.9609 0.0 0
M  V30 7 C 5.5252 4.4528 0.0 0
M  V30 8 C 6.9898 2.4367 0.0 0
M  V30 9 N 6.9898 3.9767 0.0 0
M  V30 10 C 3.0800 3.2067 0.0 0
M  V30 11 C 2.3100 4.5405 0.0 0
M  V30 12 C 2.3100 1.8731 0.0 0
M  V30 13 C 0.7700 4.5405 0.0 0
M  V30 14 C 0.7700 1.8731 0.0 0
M  V30 15 C 0.0000 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58131-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 57226-96-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29315259
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study (optimized on time and temperature)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-nitrobenzene
C6H4BrNO2
586-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzonitrile
C7H4N2O2
619-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-78-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 619-72-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26443360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cyanation of Aryl Halides Using Formamide and
Cyanuric Chloride as a New "CN" Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niknam, Esmaeil; Panahi, Farhad; Khalafi-Nezhad, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(18), 2699-2707

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Thiophenedicarboxylic acid, 5-amino-3-methyl-, 4-ethyl 2-methyl ester
C10H13NO4S
61320-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7394 1.5400 0.0 0
M  V30 2 O 9.0732 2.3100 0.0 0
M  V30 3 O 7.7394 0.0000 0.0 0
M  V30 4 C 10.4069 1.5400 0.0 0
M  V30 5 C 11.7406 2.3100 0.0 0
M  V30 6 C 4.6786 0.1773 0.0 0
M  V30 7 N 7.3892 4.8720 0.0 0
M  V30 8 C 2.4368 2.6672 0.0 0
M  V30 9 O 1.5316 3.9131 0.0 0
M  V30 10 O 1.8105 1.2602 0.0 0
M  V30 11 C 0.0000 3.7520 0.0 0
M  V30 12 C 6.4058 2.3100 0.0 0
M  V30 13 C 4.9989 1.6836 0.0 0
M  V30 14 C 6.2448 3.8416 0.0 0
M  V30 15 C 3.9683 2.8281 0.0 0
M  V30 16 S 4.7384 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,4-dihydro-5-methyl-4-oxothieno[2,3-d]pyrimidine-6-carboxylate
C9H8N2O3S
457911-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6079 0.3695 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 C 6.5771 3.0800 0.0 0
M  V30 4 O 7.3471 4.4137 0.0 0
M  V30 5 O 7.3471 1.7464 0.0 0
M  V30 6 C 8.8871 4.4137 0.0 0
M  V30 7 C 2.6673 3.8500 0.0 0
M  V30 8 C 2.6673 2.3100 0.0 0
M  V30 9 S 4.1320 4.3259 0.0 0
M  V30 10 N 1.3337 4.6201 0.0 0
M  V30 11 C 4.1320 1.8342 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 5.0371 3.0800 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61320-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 457911-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4253002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Iodophenyl)acetamide
C8H8INO
622-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 C 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 I 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyanophenyl)acetamide
C9H8N2O
35704-19-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 2.3100 0.0000 0.0 0
M  V30 4 O 0.0000 1.3337 0.0 0
M  V30 5 C 8.4701 2.6673 0.0 0
M  V30 6 N 10.0101 2.6673 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 6.1601 4.0010 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 C 6.9301 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 622-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35704-19-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25824203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 366-18-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3264-82-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed vessel used, aerobic, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Mediated Generation of "CN" Unit from Formamide and Its Catalysis in
the Cyanation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Luo; Liu, Yu-Ting; Park, Yoonsu; Park, Sung-Woo; Chang, Sukbok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2019), 9(4), 3360-3365

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzonitrile
C7H4BrN
623-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 N 7.7000 1.3336 0.0 0
M  V30 3 Br 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Cyanophenyl)formamide
C8H6N2O
6321-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3336 0.0 0
M  V30 2 C 1.5400 2.6673 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 C 8.4700 1.3336 0.0 0
M  V30 5 N 10.0100 1.3336 0.0 0
M  V30 6 C 3.8500 1.3336 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 6.1600 0.0000 0.0 0
M  V30 10 C 6.1600 2.6673 0.0 0
M  V30 11 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6321-94-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-8032393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12168-54-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, Buchwald-Hartwig type
amination, nickel ferrite nanoparticles used as catalyst, catalyst
prepared and used, recyclable and reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM C-N Bond Formation Using Highly Effective and Reusable Nickel Ferrite
Nanoparticles in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Firouz Matloubi; Tavakoli, Ghazal; Moafi, Atiyeh; Saberi,
Vahid; Rezvani, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2014), 6(12), 3474-3481

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Diethyl 1-amino-3-(1-methylethyl)-1H-pyrrole-2,4-dicarboxylate
C13H20N2O4
651744-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5839 5.3915 0.0 0
M  V30 2 C 6.7284 6.4219 0.0 0
M  V30 3 C 4.1193 5.8674 0.0 0
M  V30 4 C 8.6447 4.0287 0.0 0
M  V30 5 O 9.9783 3.2587 0.0 0
M  V30 6 O 8.6447 5.5688 0.0 0
M  V30 7 C 11.3122 4.0287 0.0 0
M  V30 8 C 12.6458 3.2587 0.0 0
M  V30 9 C 3.3420 2.9016 0.0 0
M  V30 10 O 2.4368 1.6557 0.0 0
M  V30 11 O 2.7157 4.3084 0.0 0
M  V30 12 C 0.9052 1.8166 0.0 0
M  V30 13 C 0.0000 0.5707 0.0 0
M  V30 14 N 5.0173 0.0000 0.0 0
M  V30 15 C 5.9040 3.8850 0.0 0
M  V30 16 C 7.3110 3.2587 0.0 0
M  V30 17 C 4.8736 2.7406 0.0 0
M  V30 18 C 7.1501 1.7271 0.0 0
M  V30 19 N 5.6436 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 19
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,4-dihydro-5-(1-methylethyl)-4-oxopyrrolo[2,1-f][1,2,4]triazine-6-carb...
C12H15N3O3
651744-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 C 1.5557 5.7941 0.0 0
M  V30 3 C 4.1649 6.3486 0.0 0
M  V30 4 O 0.0000 4.0010 0.0 0
M  V30 5 C 6.0811 3.9554 0.0 0
M  V30 6 O 7.4148 3.1854 0.0 0
M  V30 7 O 6.0811 5.4955 0.0 0
M  V30 8 C 8.7486 3.9554 0.0 0
M  V30 9 C 10.0823 3.1854 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 3.3405 3.8119 0.0 0
M  V30 12 N 3.0801 1.3337 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 4.7475 3.1854 0.0 0
M  V30 15 C 4.5865 1.6538 0.0 0
M  V30 16 N 2.3101 0.0000 0.0 0
M  V30 17 N 0.0000 1.3337 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 2 4 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 15
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 651744-39-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 651744-40-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7257136
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Ethyl 5-Isopropyl-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]-
triazine-6-carboxylate (5). A solution of 4 (4.8 g, 18 mmol) in formamide
(18 mL) was heated to 165 °C for 6 h and cooled to room temperature. The
resulting precipitate was filtered, washed with water, and dried
overnight to afford 5 (4.0 g, 90%) as a white solid: Anal. RP-HPLC tR =
1.56 min (column A, purity 99%). Ethyl
5-Isopropyl-4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]-triazine-6-carboxylate
(5). Yield 90% 1H NMR (500 MHz, DMSO-d6) δ 11.68 (s, 1H), 7.90 (s, 1H),
7.86 (d, 1H, J = 4.0 Hz), 4.24 (q, 2H, J = 7.1 Hz), 4.20 (m, 1H), 1.31
(d, 6H, J = 7.2 Hz), 1.29 (t, 3H, J = 7.1 Hz); 13C NMR (125 MHz, DMSO-d6)
δ 163.8, 155.0, 140.4, 134.7, 124.5, 117.6, 114.1, 60.1, 24.3, 21.8,
14.6; HRMS for C12H15N3O3 (M + H)+ calcd 250.1113, found 250.1102. Anal.
(C12H15N3O3) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of Orally Active
4-(2,4-Difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines
as Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast
Growth Factor Receptor-1 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Borzilleri, Robert M.; Zheng, Xiaoping; Qian, Ligang; Ellis, Christopher;
Cai, Zhen-Wei; Wautlet, Barri S.; Mortillo, Steve; Jeyaseelan, Robert;
Kukral, Daniel W.; Fura, Aberra; Kamath, Amrita; Vyas, Viral; Tokarski,
John S.; Barrish, Joel C.; Hunt, John T.; Lombardo, Louis J.; Fargnoli,
Joseph; Bhide, Rajeev S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(12), 3991-4008

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)thiophene-3-carboxylic acid ethyl ester
C13H12ClNO2S
65234-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 Cl 10.3115 4.9318 0.0 0
M  V30 8 C 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 S 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 7.6440 1.8517 0.0 0
M  V30 15 C 6.3103 4.1618 0.0 0
M  V30 16 C 8.9778 2.6218 0.0 0
M  V30 17 C 7.6440 4.9318 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H7ClN2OS
331761-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 Cl 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65234-09-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 331761-45-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15927947
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)thiophene-3-carboxylic acid ethyl ester
C13H12ClNO2S
65234-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 Cl 10.3115 4.9318 0.0 0
M  V30 8 C 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 S 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 7.6440 1.8517 0.0 0
M  V30 15 C 6.3103 4.1618 0.0 0
M  V30 16 C 8.9778 2.6218 0.0 0
M  V30 17 C 7.6440 4.9318 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H7ClN2OS
331761-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 Cl 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65234-09-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 331761-45-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14391308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-chlorophenyl)thiophene-3-carboxylic acid ethyl ester
C13H12ClNO2S
65234-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 Cl 10.3115 4.9318 0.0 0
M  V30 8 C 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 S 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 7.6440 1.8517 0.0 0
M  V30 15 C 6.3103 4.1618 0.0 0
M  V30 16 C 8.9778 2.6218 0.0 0
M  V30 17 C 7.6440 4.9318 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Chlorophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H7ClN2OS
331761-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 Cl 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65234-09-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 331761-45-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3567818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodoanisole
C7H7IO
696-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 I 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzonitrile
C8H7NO
874-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 O 0.7700 1.3337 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 696-62-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 874-90-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28059974
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 366-18-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3264-82-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed vessel used, aerobic, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ni-Mediated Generation of "CN" Unit from Formamide and Its Catalysis in
the Cyanation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Luo; Liu, Yu-Ting; Park, Yoonsu; Park, Sung-Woo; Chang, Sukbok
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2019), 9(4), 3360-3365

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5-(4-nitrophenyl)-3-thiophenecarboxylate
C13H12N2O4S
722461-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7844 2.9016 0.0 0
M  V30 2 O 2.1580 4.3086 0.0 0
M  V30 3 O 1.8791 1.6557 0.0 0
M  V30 4 C 0.6265 4.4695 0.0 0
M  V30 5 C 0.0000 5.8763 0.0 0
M  V30 6 N 4.4596 0.0000 0.0 0
M  V30 7 N 12.0882 6.3388 0.0 0 VAL=5
M  V30 8 O 13.4220 5.5688 0.0 0
M  V30 9 O 12.0882 7.8788 0.0 0
M  V30 10 C 6.7534 3.2587 0.0 0
M  V30 11 C 5.3465 3.8850 0.0 0
M  V30 12 S 6.5924 1.7271 0.0 0
M  V30 13 C 4.3161 2.7406 0.0 0
M  V30 14 C 5.0861 1.4070 0.0 0
M  V30 15 C 8.0872 4.0287 0.0 0
M  V30 16 C 9.4208 3.2587 0.0 0
M  V30 17 C 8.0872 5.5688 0.0 0
M  V30 18 C 10.7545 4.0287 0.0 0
M  V30 19 C 9.4208 6.3388 0.0 0
M  V30 20 C 10.7545 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 15
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Nitrophenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H7N3O3S
2237221-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 0.0000 0.0 0
M  V30 2 N 11.1973 3.0801 0.0 0 VAL=5
M  V30 3 O 11.9673 1.7464 0.0 0
M  V30 4 O 11.9673 4.4137 0.0 0
M  V30 5 C 5.0371 3.0801 0.0 0
M  V30 6 C 4.1321 1.8342 0.0 0
M  V30 7 S 4.1321 4.3260 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 N 1.3337 4.6201 0.0 0
M  V30 12 N 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 6.5772 3.0801 0.0 0
M  V30 15 C 7.3472 4.4137 0.0 0
M  V30 16 C 7.3472 1.7464 0.0 0
M  V30 17 C 8.8872 4.4137 0.0 0
M  V30 18 C 8.8872 1.7464 0.0 0
M  V30 19 C 9.6572 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 19
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 722461-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2237221-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19152356
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Surmounting the resistance against EGFR inhibitors through the
development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Milik, Sandra N.; Abdel-Aziz, Amal Kamal; Lasheen, Deena S.; Serya, Rabah
A. T.; Minucci, Saverio; Abouzid, Khaled A. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2018), 155316-336

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-carboline-3-carboxylate
C14H12N2O2
74214-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5289 3.0800 0.0 0
M  V30 2 O 9.8625 2.3100 0.0 0
M  V30 3 O 8.5289 4.6200 0.0 0
M  V30 4 C 11.1962 3.0800 0.0 0
M  V30 5 C 12.5298 2.3100 0.0 0
M  V30 6 C 4.5278 2.3100 0.0 0
M  V30 7 C 3.0631 2.7859 0.0 0
M  V30 8 C 4.5278 0.7700 0.0 0
M  V30 9 C 5.8614 3.0800 0.0 0
M  V30 10 C 2.1579 1.5400 0.0 0
M  V30 11 C 2.4368 4.1928 0.0 0
M  V30 12 N 3.0631 0.2941 0.0 0
M  V30 13 C 5.8614 0.0000 0.0 0
M  V30 14 C 7.1951 2.3100 0.0 0
M  V30 15 C 0.6263 1.7009 0.0 0
M  V30 16 C 0.9052 4.3538 0.0 0
M  V30 17 N 7.1951 0.7700 0.0 0
M  V30 18 C 0.0000 3.1079 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 10 12
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-(aminocarbonyl)-9H-pyrido[3,4-b]indole-3-carboxylate
C15H13N3O3
1356545-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8614 0.7700 0.0 0
M  V30 2 N 4.5278 0.0000 0.0 0
M  V30 3 O 7.1951 0.0000 0.0 0
M  V30 4 C 8.5289 5.3900 0.0 0
M  V30 5 O 9.8625 4.6200 0.0 0
M  V30 6 O 8.5289 6.9300 0.0 0
M  V30 7 C 11.1962 5.3900 0.0 0
M  V30 8 C 12.5298 4.6200 0.0 0
M  V30 9 C 4.5278 4.6200 0.0 0
M  V30 10 C 4.5278 3.0800 0.0 0
M  V30 11 C 3.0631 5.0959 0.0 0
M  V30 12 C 5.8614 5.3900 0.0 0
M  V30 13 C 5.8614 2.3100 0.0 0
M  V30 14 N 3.0631 2.6042 0.0 0
M  V30 15 C 2.1579 3.8500 0.0 0
M  V30 16 C 2.4368 6.5028 0.0 0
M  V30 17 C 7.1951 4.6200 0.0 0
M  V30 18 N 7.1951 3.0800 0.0 0
M  V30 19 C 0.6263 4.0110 0.0 0
M  V30 20 C 0.9052 6.6638 0.0 0
M  V30 21 C 0.0000 5.4179 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 15
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74214-62-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1356545-75-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-4457670
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7720-78-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure In a 150-ml, single-necked,
round-bottomed flask equipped with a magnetic stirrer, β-carboline
derivative 1 or 2 (168 mg or 420 mg, 1.5 mmol), 50mL formamide, and 1mL
concentrated sulfuric acid were placed. The stirred mixture was cooled to
10-15°C. Then a saturated solution of FeSO4· 7H2O and H2O2 (30% solution
in water) were added simultaneously over a period of 10 min, and stirring
continued. The addition of FeSO4·7H2O and H2O2 can be repeated until
there is no starting material left (TLC control). The reaction mixture
was poured into water (150 mL), followed by neutralization with saturated
solution of sodium carbonate and extraction with ethyl acetate (3×100mL).
The combined organic layers were washed with brine (1×100 mL) and dried
with MgSO4, and the solvent was removed under vacuum. The residue was
purified by flash column chromatography. Other compounds were synthesized
similarly, and the spectroscopic data of 1a-1f and 2a-2f are as follows.
1-Carbamoyl-3-ethoxycarbonyl-β-carboline (2a). Yield: 255 mg (90%); pale
yellow solid. mp 189-190°C; IR (KBr) 3446, 3340, 3261, 3186, 2980, 2929,
1683, 1622, 1585, 1340, 1301, 1259, 1116, 1016, 746, 667, 621, 563, 503
cm-1; ESI-MS m/z 284.05 (M+1); 1H NMR (300 MHz, DMSO-d 6) δ12.07 (1H, s,
indole), 9.08 (1H, s, ArH), 8.44 (1H, d, J=7.9 Hz, ArH), 7.98 (2H, m,
-CONH2), 7.86 (1H, d, J=11.0 Hz, ArH), 7.62 (1H, m, ArH), 7.33 (1H, m,
ArH), 4.43 (2H, q, -CH2-), 1.40 (3H, t, J=2.5 Hz, -CH3).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Minisci reaction, incremental addition of H2O2 and FeSO4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile synthesis of 1-substituted β-carboline derivatives via Minisci
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Guowu; Wang, Yue; Zhou, Qingfa; Tang, Weifang; Wang, Jian; Lu, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2011), 41(23), 3541-3550

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydro-6-methylbenzo[b]thiophene-3-carboxylate
C12H17NO2S
76981-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.3321 0.0 0
M  V30 2 O 8.7355 2.8561 0.0 0
M  V30 3 O 6.9506 4.8384 0.0 0
M  V30 4 C 9.8799 3.8867 0.0 0
M  V30 5 C 11.3446 3.4106 0.0 0
M  V30 6 N 7.6210 0.0000 0.0 0
M  V30 7 C 0.0000 2.6217 0.0 0
M  V30 8 C 4.6200 2.6217 0.0 0
M  V30 9 C 6.1264 2.3015 0.0 0
M  V30 10 C 3.8500 1.2881 0.0 0
M  V30 11 C 3.8500 3.9555 0.0 0
M  V30 12 C 6.2874 0.7700 0.0 0
M  V30 13 S 4.8806 0.1437 0.0 0
M  V30 14 C 2.3100 1.2881 0.0 0
M  V30 15 C 2.3100 3.9555 0.0 0
M  V30 16 C 1.5400 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro-7-methyl[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C11H12N2OS
95211-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 8.8070 4.8667 0.0 0
M  V30 3 C 4.5865 2.9876 0.0 0
M  V30 4 C 3.0800 2.6673 0.0 0
M  V30 5 C 4.7474 4.5192 0.0 0
M  V30 6 C 5.8323 2.0824 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 S 3.3404 5.1455 0.0 0
M  V30 10 C 6.1542 5.1455 0.0 0
M  V30 11 C 7.2391 2.7087 0.0 0
M  V30 12 N 0.7700 4.0011 0.0 0
M  V30 13 N 0.7700 1.3336 0.0 0
M  V30 14 C 7.4000 4.2403 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76981-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95211-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15849592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel protein kinase CK2 inhibitors on the base
of 4-aminothieno[2,3-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ostrynska, Olga V.; Balanda, Anatoliy O.; Bdzhola, Volodymyr G.; Golub,
Andriy G.; Kotey, Igor M.; Kukharenko, Olexander P.; Gryshchenko, Andrii
A.; Briukhovetska, Nadiia V.; Yarmoluk, Sergiy M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115148-160

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydro-6-methylbenzo[b]thiophene-3-carboxylate
C12H17NO2S
76981-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.3321 0.0 0
M  V30 2 O 8.7355 2.8561 0.0 0
M  V30 3 O 6.9506 4.8384 0.0 0
M  V30 4 C 9.8799 3.8867 0.0 0
M  V30 5 C 11.3446 3.4106 0.0 0
M  V30 6 N 7.6210 0.0000 0.0 0
M  V30 7 C 0.0000 2.6217 0.0 0
M  V30 8 C 4.6200 2.6217 0.0 0
M  V30 9 C 6.1264 2.3015 0.0 0
M  V30 10 C 3.8500 1.2881 0.0 0
M  V30 11 C 3.8500 3.9555 0.0 0
M  V30 12 C 6.2874 0.7700 0.0 0
M  V30 13 S 4.8806 0.1437 0.0 0
M  V30 14 C 2.3100 1.2881 0.0 0
M  V30 15 C 2.3100 3.9555 0.0 0
M  V30 16 C 1.5400 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro-7-methyl[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C11H12N2OS
95211-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 8.8070 4.8667 0.0 0
M  V30 3 C 4.5865 2.9876 0.0 0
M  V30 4 C 3.0800 2.6673 0.0 0
M  V30 5 C 4.7474 4.5192 0.0 0
M  V30 6 C 5.8323 2.0824 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 S 3.3404 5.1455 0.0 0
M  V30 10 C 6.1542 5.1455 0.0 0
M  V30 11 C 7.2391 2.7087 0.0 0
M  V30 12 N 0.7700 4.0011 0.0 0
M  V30 13 N 0.7700 1.3336 0.0 0
M  V30 14 C 7.4000 4.2403 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76981-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95211-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11261389
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of
N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gryshchenko, A. A.; Bdzhola, V. G.; Balanda, A. O.; Briukhovetska, N. V.;
Kotey, I. M.; Golub, A. G.; Ruban, T. P.; Lukash, L. L.; Yarmoluk, S. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2015), 23(9), 2287-2293

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydro-6-methylbenzo[b]thiophene-3-carboxylate
C12H17NO2S
76981-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.3321 0.0 0
M  V30 2 O 8.7355 2.8561 0.0 0
M  V30 3 O 6.9506 4.8384 0.0 0
M  V30 4 C 9.8799 3.8867 0.0 0
M  V30 5 C 11.3446 3.4106 0.0 0
M  V30 6 N 7.6210 0.0000 0.0 0
M  V30 7 C 0.0000 2.6217 0.0 0
M  V30 8 C 4.6200 2.6217 0.0 0
M  V30 9 C 6.1264 2.3015 0.0 0
M  V30 10 C 3.8500 1.2881 0.0 0
M  V30 11 C 3.8500 3.9555 0.0 0
M  V30 12 C 6.2874 0.7700 0.0 0
M  V30 13 S 4.8806 0.1437 0.0 0
M  V30 14 C 2.3100 1.2881 0.0 0
M  V30 15 C 2.3100 3.9555 0.0 0
M  V30 16 C 1.5400 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro-7-methyl[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C11H12N2OS
95211-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 8.8070 4.8667 0.0 0
M  V30 3 C 4.5865 2.9876 0.0 0
M  V30 4 C 3.0800 2.6673 0.0 0
M  V30 5 C 4.7474 4.5192 0.0 0
M  V30 6 C 5.8323 2.0824 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 S 3.3404 5.1455 0.0 0
M  V30 10 C 6.1542 5.1455 0.0 0
M  V30 11 C 7.2391 2.7087 0.0 0
M  V30 12 N 0.7700 4.0011 0.0 0
M  V30 13 N 0.7700 1.3336 0.0 0
M  V30 14 C 7.4000 4.2403 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76981-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95211-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4384421
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted thienopyrimidines as MKNK inhibitors for
treatment of particularly hyperproliferative an angiogenesis disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kettschau, Georg; Puehler, Florian; Klar, Ulrich; Wortmann, Lars; Lienau,
Philip; Kosemund, Dirk; Suelzle, Detlev; Haegebarth, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014118229 A1 2014-08-07

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4,5,6,7-tetrahydro-6-methylbenzo[b]thiophene-3-carboxylate
C12H17NO2S
76981-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.3321 0.0 0
M  V30 2 O 8.7355 2.8561 0.0 0
M  V30 3 O 6.9506 4.8384 0.0 0
M  V30 4 C 9.8799 3.8867 0.0 0
M  V30 5 C 11.3446 3.4106 0.0 0
M  V30 6 N 7.6210 0.0000 0.0 0
M  V30 7 C 0.0000 2.6217 0.0 0
M  V30 8 C 4.6200 2.6217 0.0 0
M  V30 9 C 6.1264 2.3015 0.0 0
M  V30 10 C 3.8500 1.2881 0.0 0
M  V30 11 C 3.8500 3.9555 0.0 0
M  V30 12 C 6.2874 0.7700 0.0 0
M  V30 13 S 4.8806 0.1437 0.0 0
M  V30 14 C 2.3100 1.2881 0.0 0
M  V30 15 C 2.3100 3.9555 0.0 0
M  V30 16 C 1.5400 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrahydro-7-methyl[1]benzothieno[2,3-d]pyrimidin-4(1H)-one
C11H12N2OS
95211-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 8.8070 4.8667 0.0 0
M  V30 3 C 4.5865 2.9876 0.0 0
M  V30 4 C 3.0800 2.6673 0.0 0
M  V30 5 C 4.7474 4.5192 0.0 0
M  V30 6 C 5.8323 2.0824 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 S 3.3404 5.1455 0.0 0
M  V30 10 C 6.1542 5.1455 0.0 0
M  V30 11 C 7.2391 2.7087 0.0 0
M  V30 12 N 0.7700 4.0011 0.0 0
M  V30 13 N 0.7700 1.3336 0.0 0
M  V30 14 C 7.4000 4.2403 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76981-71-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95211-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3462467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(RS)-7-Methoxy-7-(methoxymethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-ol
A mixture comprising 21.46 g (71.7 mmol) (RS)-ethyl
2-amino-6-methoxy-6-(methoxymethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
(prepared according to intermediate example 16c), 114 mL methanamide and
7.23 g ammonium formate was stirred at 150° C. overnight. The reaction
mixture was cooled in an ice bath, the precipitate was filtered off,
washed with water and ethanol and dried.
(RS)-7-Methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-ol 3.19
g (13.0 mmol) (RS)-ethyl
2-amino-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
(prepared according to intermediate example 17c) were transformed in
analogy to intermediate example 16b to give after working up and
purification. 2.71 g (90%) of the title compound.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzothienopyrimidines useful in treating or
preventing hyper-proliferative and/or angiogenesis disorder
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Klar, Ulrich; Kettschau, Georg; Kosemund, Dirk; Puehler, Florian; Eis,
Knut; Lienau, Philip; Boemer, Ulf; Suelzle, Detlev; Wortmann, Lars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013174735 A1 2013-11-28

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Fenchone
C10H16O
7787-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.8391 0.0 0
M  V30 2 O 4.6188 0.1820 0.0 0
M  V30 3 C 0.8644 0.9862 0.0 0
M  V30 4 C 2.5798 0.0000 0.0 0
M  V30 5 C 4.6200 2.8413 0.0 0 CFG=1
M  V30 6 C 3.8503 1.5166 0.0 0
M  V30 7 C 3.0798 3.3130 0.0 0
M  V30 8 C 3.8497 4.1756 0.0 0
M  V30 9 C 2.3103 1.5161 0.0 0
M  V30 10 C 1.5400 2.8404 0.0 0 CFG=2
M  V30 11 C 2.3097 4.1751 0.0 0
M  V30 12 H 0.0000 2.8374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 1 3 9
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=3
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 10 7 CFG=3
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2R,4S)-1,3,3-Trimethylbicyclo[2.2.1]hept-2-yl]formamide
C11H19NO
131348-04-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3275 3.0716 0.0 0
M  V30 2 C 6.6611 2.3016 0.0 0
M  V30 3 O 7.9949 3.0716 0.0 0
M  V30 4 C 5.3300 0.0000 0.0 0
M  V30 5 C 1.6756 4.2568 0.0 0
M  V30 6 C 3.6542 4.2509 0.0 0
M  V30 7 C 3.9939 2.3016 0.0 0 CFG=1
M  V30 8 C 3.9962 0.7697 0.0 0 CFG=1
M  V30 9 C 2.6614 3.0736 0.0 0
M  V30 10 C 2.4270 1.1333 0.0 0
M  V30 11 C 2.6609 0.0009 0.0 0
M  V30 12 C 1.3313 2.3138 0.0 0 CFG=1
M  V30 13 C 1.3285 0.7731 0.0 0
M  V30 14 H 0.0000 3.0879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 9
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10 CFG=1
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 10 CFG=1
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7787-20-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 131348-04-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14306380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 98:2 endo:exo
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Influence of the bridgehead substituent on the stereoselective Leuckart
reaction of 2-norbornanones - skeletal rearrangement versus structural
retention
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garcia Martinez, Antonio; Teso Vilar, Enrique; Garcia Fraile, Amelia;
Martinez-Ruiz, Paloma
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2001), (15), 2805-2808

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-cyclohexyl-3-pyridinamine
C11H15ClN2
793675-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 Cl 1.3336 0.0000 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 C 1.3336 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 N 0.0000 2.3100 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6685 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 4
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclohexyl-1H-imidazo[4,5-b]pyridine
C12H15N3
1365094-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4196 1.8517 0.0 0
M  V30 2 C 3.0127 2.4782 0.0 0
M  V30 3 C 4.2587 0.3202 0.0 0
M  V30 4 C 1.9823 1.3336 0.0 0
M  V30 5 C 2.5368 3.9427 0.0 0
M  V30 6 N 2.7523 0.0000 0.0 0
M  V30 7 N 0.4760 1.6538 0.0 0
M  V30 8 C 1.0306 4.2629 0.0 0
M  V30 9 C 0.0000 3.1185 0.0 0
M  V30 10 C 5.7533 2.6217 0.0 0
M  V30 11 C 7.0869 1.8517 0.0 0
M  V30 12 C 5.7533 4.1617 0.0 0
M  V30 13 C 8.4207 2.6217 0.0 0
M  V30 14 C 7.0869 4.9317 0.0 0
M  V30 15 C 8.4207 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 793675-33-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365094-43-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7634426
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 29154-12-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1160861-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 1-(4-Methoxybenzyl)-1H-imidazo[4,5-b]pyridine
(3a) To an oven-dried 25 mL Schlenk-tube equipped with a stirbar was
added Pd2(dba)3 · CHCl3 (20.8 mg, 0.02 mmol),
2-Di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl
(L1) (48 mg, 0.1 mmol), K3PO4 (639 mg, 3.01 mmol) and
2-Chloro-N-(4-methoxybenzyl)pyridin-3-amine (2a) (500 mg, 2.01 mmol) (if
solid). The tube was evacuated and refilled with Ar(g). Formamide (0.12
mL, 3.01 mmol) was added via syringe as a single portion, followed by the
chloropyridine (if liquid) in 4 mL of tert-butanol. The reaction mixture
was degassed with 3 x vacuum / Ar(g) purge cycles. The reaction vessel
was then equipped with a cold-finger under a positive pressure of argon
gas and immersed in a 110°C pre-heated oil-bath for 4h at which time TLC
showed consumption of the chloro-pyridine. The reaction was cooled to
room temperature, diluted with MeOH (4 mL) filtered through a Celite plug
and concentrated to give a dark brown oil. The crude product was purified
on a silica gel column (4.5 cm x 12 cm), eluting with 4% MeOH in CH2Cl2.
1-Cyclohexyl-1H-imidazo[4,5-b]pyridine (3g) Following the general
experimental; 2-Chloro-N-cyclohexylpyridin-3-amine (2g) (84.3 mg, 0.4
mmol), Pd2(dba)3·CHCl3 (4.14 mg, 0.004 mmol), t-BuBrettPhos (9.7 mg, 0.02
mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) were
combined with 2 mL tert-butanol in a 25 mL Schlenk flask. After 4h the
reaction was complete, the reaction cooled to RT, filtered through
Celite, concentrated and purified on a silica gel column (2.5 cm x 12
cm), eluting with 4% MeOH / CH2Cl2. 3g as 69 mg of a white solid (90%).
1H NMR (300 MHz, CDCl3) δ = 8.54 (dd, J = 4.8 Hz, 1.5 Hz, 1H), 8.18 (s,
1H), 7.75 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.18 (dd, J = 8.1 Hz, 4.8 Hz,
1H), 4.18 (tt, J = 12 Hz, 3.9 Hz, 1H), 2.24-2.13 (m, 2H), 2.02-1.92 (m,
2H), 1.88-1.72 (m, 3H), 1.49 (qt, J = 12.9 Hz, 3.3 Hz, 2H), 1.30 (qt, J =
12.6 Hz, 3.0 Hz, 1H); 13C NMR (75.4 MHz, CDCl3) δ = 156.6, 145.0, 142.8,
125.6, 118.4, 117.8, 56.2, 33.3, 25.7, 25.4; FT-IR (NaCl, thin film) ν =
2935, 2858, 1607, 1486, 1414, 1281, 1219, 786 cm-1. HRMS (ESI) Calc
(C12H15N3): 201.1265, Found: 201.1266; MP: 151-153°C; Rf (4% MeOH /
CH2Cl2): 0.25.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Imidazo[4,5-b]pyridines and Imidazo[4,5-b]pyrazines by
Palladium Catalyzed Amidation of 2-Chloro-3-amino-heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosenberg, Adam J.; Zhao, Jinbo; Clark, Daniel A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(7), 1764-1767

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2,3′-Bithiophene]-4′-carboxylic acid, 5′-amino-5-bromo-, ethyl ester
C11H10BrNO2S2
844500-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9963 3.7711 0.0 0
M  V30 2 O 8.5364 3.7711 0.0 0
M  V30 3 O 6.2263 5.1047 0.0 0
M  V30 4 C 9.3064 5.1047 0.0 0
M  V30 5 C 10.8464 5.1047 0.0 0
M  V30 6 N 8.3591 0.7103 0.0 0
M  V30 7 Br 0.0000 4.9869 0.0 0
M  V30 8 C 4.6948 2.2763 0.0 0
M  V30 9 C 6.2263 2.4374 0.0 0
M  V30 10 C 4.3746 0.7700 0.0 0
M  V30 11 C 6.8528 1.0304 0.0 0
M  V30 12 S 5.7083 0.0000 0.0 0
M  V30 13 C 3.6643 3.4209 0.0 0
M  V30 14 S 2.1328 3.2598 0.0 0
M  V30 15 C 3.9845 4.9272 0.0 0
M  V30 16 C 1.5063 4.6667 0.0 0
M  V30 17 C 2.6509 5.6972 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(5-Bromo-2-thienyl)thieno[2,3-d]pyrimidin-4(1H)-one
C10H5BrN2OS2
1929574-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 5.1455 0.0 0
M  V30 2 Br 9.5389 4.3629 0.0 0
M  V30 3 C 4.5865 2.1579 0.0 0
M  V30 4 C 3.0800 2.4780 0.0 0
M  V30 5 C 4.7474 0.6263 0.0 0
M  V30 6 C 2.3100 1.1444 0.0 0
M  V30 7 C 2.3100 3.8119 0.0 0
M  V30 8 S 3.3405 0.0000 0.0 0
M  V30 9 N 0.7700 1.1444 0.0 0
M  V30 10 N 0.7700 3.8119 0.0 0
M  V30 11 C 0.0000 2.4780 0.0 0
M  V30 12 C 5.7309 3.1885 0.0 0
M  V30 13 C 5.5699 4.7200 0.0 0
M  V30 14 S 7.2373 2.8683 0.0 0
M  V30 15 C 6.9767 5.3463 0.0 0
M  V30 16 C 8.0073 4.2019 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 844500-41-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929574-63-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-736467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(1,3-benzodioxol-5-yl)-3-thiophenecarboxylate
C14H13NO4S
849659-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3096 3.4207 0.0 0
M  V30 2 O 8.8159 3.1006 0.0 0
M  V30 3 O 6.8336 4.8854 0.0 0
M  V30 4 C 9.8464 4.2451 0.0 0
M  V30 5 C 11.3528 3.9249 0.0 0
M  V30 6 N 8.0062 0.1435 0.0 0
M  V30 7 C 4.7475 2.4373 0.0 0
M  V30 8 C 6.2790 2.2763 0.0 0
M  V30 9 C 4.1211 1.0304 0.0 0
M  V30 10 C 6.5992 0.7700 0.0 0
M  V30 11 S 5.2655 0.0000 0.0 0
M  V30 12 C 3.9774 3.7711 0.0 0
M  V30 13 C 2.4374 3.7711 0.0 0
M  V30 14 C 4.7475 5.1048 0.0 0
M  V30 15 C 1.6674 5.1048 0.0 0
M  V30 16 C 3.9774 6.4384 0.0 0
M  V30 17 C 2.4374 6.4384 0.0 0
M  V30 18 O 0.1611 5.4249 0.0 0
M  V30 19 O 1.4070 7.5828 0.0 0
M  V30 20 C 0.0000 6.9565 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 2 16 17
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1,3-Benzodioxol-5-yl)thieno[2,3-d]pyrimidin-4(1H)-one
C13H8N2O3S
1056054-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 5.1454 0.0 0
M  V30 2 C 4.5864 2.1578 0.0 0
M  V30 3 C 3.0800 2.4780 0.0 0
M  V30 4 C 4.7474 0.6263 0.0 0
M  V30 5 C 2.3100 1.1444 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 S 3.3406 0.0000 0.0 0
M  V30 8 N 0.7700 1.1444 0.0 0
M  V30 9 N 0.7700 3.8118 0.0 0
M  V30 10 C 0.0000 2.4780 0.0 0
M  V30 11 C 5.7308 3.1884 0.0 0
M  V30 12 C 7.1955 2.7124 0.0 0
M  V30 13 C 5.4106 4.6947 0.0 0
M  V30 14 C 8.3399 3.7430 0.0 0
M  V30 15 C 6.5550 5.7251 0.0 0
M  V30 16 C 8.0197 5.2492 0.0 0
M  V30 17 O 9.8714 3.5819 0.0 0
M  V30 18 O 9.3533 6.0192 0.0 0
M  V30 19 C 10.4979 4.9888 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 2 15 16
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849659-34-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1056054-64-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4723460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-[4-(trifluoromethyl)phenyl]-3-thiophenecarboxylate
C14H12F3NO2S
849659-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9847 0.0 0
M  V30 2 O 1.7849 4.4606 0.0 0
M  V30 3 O 4.3940 5.0151 0.0 0
M  V30 4 C 1.4647 5.9669 0.0 0
M  V30 5 C 0.0000 6.4429 0.0 0
M  V30 6 N 1.0076 1.4948 0.0 0
M  V30 7 C 10.3115 4.9320 0.0 0
M  V30 8 F 9.5414 6.2656 0.0 0
M  V30 9 F 11.6451 5.7020 0.0 0
M  V30 10 F 11.0815 3.5983 0.0 0
M  V30 11 C 4.9766 1.8519 0.0 0
M  V30 12 C 3.5696 2.4782 0.0 0
M  V30 13 C 4.8155 0.3203 0.0 0
M  V30 14 C 2.5392 1.3338 0.0 0
M  V30 15 S 3.3092 0.0000 0.0 0
M  V30 16 C 6.3103 2.6219 0.0 0
M  V30 17 C 6.3103 4.1619 0.0 0
M  V30 18 C 7.6440 1.8519 0.0 0
M  V30 19 C 7.6440 4.9320 0.0 0
M  V30 20 C 8.9778 2.6219 0.0 0
M  V30 21 C 8.9778 4.1619 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 21
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 16
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[4-(Trifluoromethyl)phenyl]thieno[2,3-d]pyrimidin-4(1H)-one
C13H7F3N2OS
1321618-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0872 0.0 0
M  V30 2 C 9.7546 4.9318 0.0 0
M  V30 3 F 8.9846 6.2655 0.0 0
M  V30 4 F 11.0882 5.7018 0.0 0
M  V30 5 F 10.5246 3.5981 0.0 0
M  V30 6 C 4.4197 1.8517 0.0 0
M  V30 7 C 3.0128 2.4781 0.0 0
M  V30 8 C 4.2587 0.3202 0.0 0
M  V30 9 C 1.9823 1.3337 0.0 0
M  V30 10 C 2.5369 3.9428 0.0 0
M  V30 11 S 2.7523 0.0000 0.0 0
M  V30 12 N 0.4759 1.6538 0.0 0
M  V30 13 N 1.0304 4.2630 0.0 0
M  V30 14 C 0.0000 3.1186 0.0 0
M  V30 15 C 5.7534 2.6218 0.0 0
M  V30 16 C 7.0871 1.8517 0.0 0
M  V30 17 C 5.7534 4.1618 0.0 0
M  V30 18 C 8.4208 2.6218 0.0 0
M  V30 19 C 7.0871 4.9318 0.0 0
M  V30 20 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 20
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849659-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1321618-65-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5984489
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-4-(4-hydroxyphenyl)-3-thiophenecarboxylate
C13H13NO3S
849659-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 3.9845 0.0 0
M  V30 2 O 1.7849 4.4604 0.0 0
M  V30 3 O 4.3940 5.0150 0.0 0
M  V30 4 C 1.4647 5.9667 0.0 0
M  V30 5 C 0.0000 6.4426 0.0 0
M  V30 6 N 1.0076 1.4946 0.0 0
M  V30 7 O 10.3115 4.9318 0.0 0
M  V30 8 C 4.9766 1.8517 0.0 0
M  V30 9 C 3.5696 2.4781 0.0 0
M  V30 10 C 4.8157 0.3202 0.0 0
M  V30 11 C 2.5392 1.3337 0.0 0
M  V30 12 S 3.3092 0.0000 0.0 0
M  V30 13 C 6.3103 2.6218 0.0 0
M  V30 14 C 7.6440 1.8517 0.0 0
M  V30 15 C 6.3103 4.1618 0.0 0
M  V30 16 C 8.9778 2.6218 0.0 0
M  V30 17 C 7.6440 4.9318 0.0 0
M  V30 18 C 8.9778 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Hydroxyphenyl)thieno[2,3-d]pyrimidin-4(1H)-one
C12H8N2O2S
1929574-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.5673 5.0873 0.0 0
M  V30 2 O 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 7.0871 1.8517 0.0 0
M  V30 14 C 5.7534 4.1618 0.0 0
M  V30 15 C 8.4208 2.6218 0.0 0
M  V30 16 C 7.0871 4.9318 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849659-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1929574-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3194091
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 540-69-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 4-Oxothienopyrimidinyl Propanoic Acid Derivatives as AMPActivated
Protein Kinase (AMPK) Activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sasmal, Pradip K.; Jaleel, Mahaboobi; Rao, P. Tirumala; Munikumar, M.;
Bhattacharya, Megha; Kumar, Nutakki Ravi; Neelima, Poondla.; Abdul
Rawoof, Khaji; Rao, P. Narasimha; Abbineni, Chandrasekhar; Roshaiah, M.;
Sridhar, S.; Kumar, Thammera Ranjith; Vinu, Menon C. A.; Potluri, Vijay;
Misra, Parimal; Talwar, Rashmi; Das, Saibal Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Letters in Drug Design & Discovery (2014), 11(6), 778-785

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-(Aminomethyl)-3-(2-chlorophenyl)-2-propenenitrile
C10H9ClN2
853195-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 N 5.3347 5.3900 0.0 0
M  V30 7 Cl 1.3336 0.0000 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 3 4 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2Z)-3-(2-Chlorophenyl)-2-cyano-2-propen-1-yl]formamide
C11H9ClN2O
1009375-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 5.3348 1.5400 0.0 0
M  V30 5 N 8.0023 3.0801 0.0 0
M  V30 6 N 5.3348 0.0000 0.0 0
M  V30 7 C 9.3360 3.8501 0.0 0
M  V30 8 O 10.6697 3.0801 0.0 0
M  V30 9 Cl 1.3337 5.3901 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 3 4 6
M  V30 7 1 5 7
M  V30 8 2 7 8
M  V30 9 1 9 11
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 853195-03-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1009375-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-15484649
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (Z)-2-Cyano-3-phenylprop-2-enylformamide (5a);
Typical Procedre A mixture of 3a (2.0 mmol, 0.32 g) and formamide (6.3
mmol, 0.25 mL) was heated at a temperature between 110-120 °C for 1.5 h.
The mixture was cooled and partitioned between EtOAc (30 mL) and H2O (30
mL). The organic layer was separated and the aqueous layer was further
extracted with EtOAc (2 × 15 mL). The organic layers were combined dried
(Na2SO4) and concentrated on a rotavapor. The reside was purified via
silica gel column chromatography with hexane-EtOAc (1:2) as eluent to
yield 5a. The prodct 5a was recrystallized from EtOAc-hexane mixture of
analytically pure 5a. (Z)-3-(2-Chlorophenyl)-2-cyanoprop-2-enylformamide
(5d) Hexane-EtOAc (1:2); yield: 90%; white solid. Mp 96-98 °C. IR (KBr):
1674 (NHCHO), 2214 (C≡N), 3266 cm-1 (NH). 1H NMR (CDCl3, 200 MHz): δ =
4.21 (d, J = 6.9 Hz, 2 H, CH2), 4.28 (d, J = 6.3 Hz, 2 H, CH2), 6.17 (br
s, 1 H, NH), 7.31-7.54 (m, 8 H, 2×3 ArH and2×=CH), 7.92-7.97 (m, 2 H,
2×ArH), 8.21 (d, J = 11.7 Hz, 1 H, CHO), 8.34 (s, 1 H, CHO). 1H NMR
(CDCl3+D2O, 200 MHz): δ = 4.20 (s, 2 H, CH2), 4.27 (s, 2 H, CH2),
7.33-7.54 (m, 8 H, 2×3 ArH and2×=CH), 7.92-7.96 (m, 2 H, 2×ArH), 8.20 (s,
1 H, CHO), 8.33 (s, 1 H, CHO). 13C NMR (CDCl3, 75 MHz): δ = 41.5, 45.4,
110.7, 116.9, 127.1, 129.1, 129.8, 131.2, 131.5, 131.8, 134.2, 141.4,
141.9, 161.4, 164.5. MS (ES+): m/z = 243.0 (M++23). Anal. Calcdfor
C11H9ClN2O (220.04): C, 59.88; H, 4.11; N, 12.70. Found C, 60.11; H,
4.26; N, 12.63.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of primary allylamine derivatives of Baylis-Hillman adducts
to heterocyclic synthesis: generation of 5-benzyl-4(3H)-pyrimidinones and
2-benzylidene-2,3-dihydropyrrolizin-1-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nag, Somnath; Madapa, Sudharshan; Batra, Sanjay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2008), (1), 101-109

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-(4-methylphenyl)-3-thiophenecarbonitrile
C12H10N2S
86604-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 1.4647 0.0 0
M  V30 2 N 3.6623 0.0000 0.0 0
M  V30 3 N 0.0000 2.5000 0.0 0
M  V30 4 C 9.7756 4.1752 0.0 0
M  V30 5 C 3.6156 4.1752 0.0 0
M  V30 6 C 2.7104 2.9292 0.0 0
M  V30 7 C 2.7104 5.4211 0.0 0
M  V30 8 C 1.2459 3.4052 0.0 0
M  V30 9 S 1.2459 4.9452 0.0 0
M  V30 10 C 5.1556 4.1752 0.0 0
M  V30 11 C 5.9256 5.5089 0.0 0
M  V30 12 C 5.9256 2.8415 0.0 0
M  V30 13 C 7.4656 5.5089 0.0 0
M  V30 14 C 7.4656 2.8415 0.0 0
M  V30 15 C 8.2356 4.1752 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-amine
C13H11N3S
900465-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.5673 5.0873 0.0 0
M  V30 2 C 9.7546 4.9318 0.0 0
M  V30 3 C 4.4197 1.8517 0.0 0
M  V30 4 C 3.0128 2.4782 0.0 0
M  V30 5 C 4.2587 0.3202 0.0 0
M  V30 6 C 1.9823 1.3337 0.0 0
M  V30 7 C 2.5369 3.9428 0.0 0
M  V30 8 S 2.7523 0.0000 0.0 0
M  V30 9 N 0.4759 1.6540 0.0 0
M  V30 10 N 1.0306 4.2631 0.0 0
M  V30 11 C 0.0000 3.1186 0.0 0
M  V30 12 C 5.7534 2.6218 0.0 0
M  V30 13 C 5.7534 4.1618 0.0 0
M  V30 14 C 7.0871 1.8517 0.0 0
M  V30 15 C 7.0871 4.9318 0.0 0
M  V30 16 C 8.4208 2.6218 0.0 0
M  V30 17 C 8.4208 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86604-37-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 900465-97-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37447679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and anticancer evaluation of novel
imidazo[1,2-c]thieno[3,2-e]pyrimidin derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alizadeh-Bami, Farzaneh; Mehrabi, Hossein; Safari, Fatemeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2023), 144133594

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Acetylthiophene
C6H6OS
88-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 C 5.1048 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 2.4374 2.3100 0.0 0
M  V30 5 C 1.0306 1.6835 0.0 0
M  V30 6 S 2.2764 3.8416 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2-Thienyl)pyrimidine
C8H6N2S
19084-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3698 1.3337 0.0 0
M  V30 2 C 1.4646 0.0878 0.0 0
M  V30 3 S 1.4646 2.5795 0.0 0
M  V30 4 C 0.0000 0.5636 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 3.9098 1.3337 0.0 0
M  V30 7 C 4.6798 0.0000 0.0 0
M  V30 8 N 4.6798 2.6673 0.0 0
M  V30 9 C 6.2198 0.0000 0.0 0
M  V30 10 C 6.2198 2.6673 0.0 0
M  V30 11 N 6.9898 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19084-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12284510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-78-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal (second stage), in vacuo first stage
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidinium ylides. IX The synthesis and the stability of some new
pyrimidinium ylides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iuhas, Paula Cristina; Georgescu, Emilian; Georgescu, Florentina;
Draghici, Constantin; Caproiu, Miron Teodor
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Revue Roumaine de Chimie (2001), 46(1), 55-62

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-6-(trifluoromethyl)-3-pyridinecarboxylate
C9H9F3N2O2
890302-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0
M  V30 2 O 8.4700 4.0011 0.0 0
M  V30 3 O 8.4700 1.3338 0.0 0
M  V30 4 C 10.0100 4.0011 0.0 0
M  V30 5 C 10.7800 5.3349 0.0 0
M  V30 6 N 6.1600 0.0000 0.0 0
M  V30 7 C 1.5400 2.6674 0.0 0
M  V30 8 F 1.5400 4.2074 0.0 0
M  V30 9 F 0.0000 2.6674 0.0 0
M  V30 10 F 1.5400 1.1274 0.0 0
M  V30 11 C 6.1600 2.6674 0.0 0
M  V30 12 C 5.3900 1.3338 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 N 3.8500 1.3338 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 3.0800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Trifluoromethyl)pyrido[2,3-d]pyrimidin-4(3H)-one
C8H4F3N3O
890301-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 C 6.9300 2.6673 0.0 0
M  V30 3 F 6.9300 4.2073 0.0 0
M  V30 4 F 8.4700 2.6673 0.0 0
M  V30 5 F 6.9300 1.1273 0.0 0
M  V30 6 C 3.0800 1.3336 0.0 0
M  V30 7 C 2.3100 2.6673 0.0 0
M  V30 8 N 4.6200 1.3336 0.0 0
M  V30 9 N 2.3100 0.0000 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 5.3900 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 N 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 890302-01-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890301-90-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15618711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel triazole/isoxazole functionalized
7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising
anticancer and antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naresh Kumar, R.; Jitender Dev, G.; Ravikumar, N.; Krishna Swaroop, D.;
Debanjan, B.; Bharath, G.; Narsaiah, B.; Nishant Jain, S.; Gangagni Rao,
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(12), 2927-2930

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Quinoline
C9H7N
91-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 N 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Quinolinecarboxamide
C10H8N2O
5382-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 1.5400 0.0 0
M  V30 2 N 8.0022 2.3100 0.0 0
M  V30 3 O 6.6686 0.0000 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 N 4.0011 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 4.0011 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-22-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5382-42-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-095-CAS-12960572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7722-84-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, alternative reaction conditions gave lower yield, sunlight
used, yield depends on catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sunlight induced functionalization of some heterocyclic bases in the
presence of polycrystalline TiO2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Caronna, T.; Gambarotti, C.; Palmisano, L.; Punta, C.; Recupero, F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2003), (18),
2350-2351

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloroadamantane
C10H15Cl
935-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.5321 3.0179 0.0 0
M  V30 2 C 4.1957 2.2463 0.0 0
M  V30 3 C 2.9051 3.0867 0.0 0
M  V30 4 C 4.2781 0.7086 0.0 0
M  V30 5 C 2.4986 2.2355 0.0 0
M  V30 6 C 1.6969 2.3891 0.0 0
M  V30 7 C 3.0699 0.0111 0.0 0
M  V30 8 C 1.2906 1.5379 0.0 0
M  V30 9 C 0.0000 2.3780 0.0 0
M  V30 10 C 1.7794 0.8513 0.0 0
M  V30 11 C 1.3730 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 9
M  V30 13 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-1-Adamantylformamide
C11H17NO
3405-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5317 3.0177 0.0 0
M  V30 2 C 6.8681 2.2463 0.0 0
M  V30 3 O 8.2043 3.0177 0.0 0
M  V30 4 C 4.1955 2.2463 0.0 0
M  V30 5 C 2.9049 3.0866 0.0 0
M  V30 6 C 4.2779 0.7085 0.0 0
M  V30 7 C 2.4985 2.2355 0.0 0
M  V30 8 C 1.6968 2.3890 0.0 0
M  V30 9 C 3.0697 0.0111 0.0 0
M  V30 10 C 1.2904 1.5379 0.0 0
M  V30 11 C 0.0000 2.3779 0.0 0
M  V30 12 C 1.7794 0.8513 0.0 0
M  V30 13 C 1.3729 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 935-56-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3405-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-6145373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10170-69-1
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, hermetically closed stainless-steel high-pressure
microreactor or sealed glass ampoule used, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-(adamantan-1-yl)amides by reaction of carboxylic acid
amides with 1-bromo(chloro)adamantane catalyzed by manganese compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khusnutdinov, R. I.; Shchadneva, N. A.; Khisamova, L. F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2015), 51(4), 476-479

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoyl chloride
C7H5ClO
98-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide
C7H7NO
55-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-88-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2896337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Typical Procedure for Amination All the experiments were carried out in a
parallel synthesizer from REDLEYS Discovery Technologies, UK. A solution
of acid chloride 1a (1.0 gm 7.11 mmol) in formamide (10 ml) was heated to
100-120 °C and maintained at same temperature for 5 to 6 hours, the
reaction mixture was cooled to room temperature. The reaction mass
quenched in excess water and extracted with dichloromethane. The combined
organic solvent was washed with saturated NaHCO3 aqueous solution and
dried over anhydrous Na2SO4. The solvent was evaporated under reduced
pressure to give the residue which was purified by column chromatography
using silica gel and EtOAc= hexane as eluent. An amount of 0.77 g (6.4
mmol, 90%) of 2a was obtained as crystals. Compound 2a, Yield 0.77 g (6.4
mmol, 90%). Mp in °C (Lit): 128-129; Mp in °C (Obs.): 128-129
$DTYPE RXN:VAR(1):NOTES
$DATUM excess water used in stage 2, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formamide as an ammonia synthon in amination of acid chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivasan, S.; Manisankar, P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2010), 40(23), 3538-3543

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Chloroacetophenone
C8H7ClO
99-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Acetylphenyl)formamide
C9H9NO2
41656-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 O 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99-91-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41656-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-044-CAS-5616400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12168-54-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, Buchwald-Hartwig type
amination, nickel ferrite nanoparticles used as catalyst, catalyst
prepared and used, recyclable and reusable catalyst, alternative
preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM C-N Bond Formation Using Highly Effective and Reusable Nickel Ferrite
Nanoparticles in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Firouz Matloubi; Tavakoli, Ghazal; Moafi, Atiyeh; Saberi,
Vahid; Rezvani, Hamid Reza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2014), 6(12), 3474-3481

$RFMT $RIREG SCHEME127 STEP1
$RXN



  1  1
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, N-formyl-
C2H3NO2
18197-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 C 4.0010 0.0000 0.0 0
M  V30 4 O 0.0000 0.7700 0.0 0
M  V30 5 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18197-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29097594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Diformamide NH(CHO)2. The literature procedure was modified.2 5.70 g
(0.248 mol) of sodium was added to 50 ml of methanol. In the end of
solution, 19.7 ml of formamide was added and the mixture was refluxed for
30 min, until white precipitate was formed. After this, solvent was
evaporated in vacuo and the residue was heated until dry solid was
formed. Sodium diformamide thus obtained was cooled and 14 ml of glacial
acetic acid was added, the flask was shaken for a few minutes (the
mixture warm up, cool under cold stream). After this, 200 ml of dry
acetone or ethyl acetate was added and the mixture was stirred for 10
minutes. Precipitate was filtered off and washed with a few portions of
the solvent. Filtrate was filtered through a short SiO2 column and
evaporated to yield diformamide as a solid or colorless liquid due to
presence of free formamide. Yield is ~90 %. Diformamide is soluble in
acetone, ethyl acetate, slightly soluble in ether.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nonracemizable Isocyanoacetates for Multicomponent Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhdanko, Alexander G.; Nenajdenko, Valentine G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(2), 884-887

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  2
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-naphthalenecarboxylate
C18H21NO4
1824676-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 5.3347 0.0 0
M  V30 2 O 2.3100 5.3347 0.0 0
M  V30 3 O 4.6200 6.6685 0.0 0
M  V30 4 C 1.5400 6.6685 0.0 0
M  V30 5 C 0.0000 6.6685 0.0 0
M  V30 6 N 6.9300 5.3347 0.0 0
M  V30 7 C 8.4700 5.3347 0.0 0
M  V30 8 O 9.2400 6.6685 0.0 0
M  V30 9 O 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 6.6685 0.0 0
M  V30 11 C 10.7800 5.1285 0.0 0
M  V30 12 C 12.3200 6.6685 0.0 0
M  V30 13 C 10.7800 8.2085 0.0 0
M  V30 14 C 3.8500 2.6674 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 4.6200 1.3338 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 C 6.1600 1.3338 0.0 0
M  V30 20 C 3.8500 0.0000 0.0 0
M  V30 21 C 1.5400 1.3338 0.0 0
M  V30 22 C 6.9300 2.6674 0.0 0
M  V30 23 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 2 19 22
M  V30 23 2 20 23
M  V30 24 1 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzo[f]quinazolin-1(2H)-one
C12H8N2O
7066-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 C 5.3900 1.3338 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 4.6200 5.3349 0.0 0
M  V30 9 C 6.9300 4.0011 0.0 0
M  V30 10 C 6.9300 1.3338 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 N 0.7700 4.0011 0.0 0
M  V30 13 N 0.7700 1.3338 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 4 9
M  V30 9 2 5 10
M  V30 10 2 6 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 8 11
M  V30 14 2 9 14
M  V30 15 1 10 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzo[f]quinazoline-1,3(2H,4H)-dione
C12H8N2O2
7066-24-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 0.0000 0.0 0
M  V30 2 O 9.2400 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 C 5.3900 1.3338 0.0 0
M  V30 9 C 3.0800 5.3349 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 N 6.9300 4.0011 0.0 0
M  V30 14 N 6.9300 1.3338 0.0 0
M  V30 15 C 0.0000 2.6674 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 16
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 2 6 11
M  V30 11 2 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 12
M  V30 15 2 10 15
M  V30 16 1 11 15
M  V30 17 1 13 16
M  V30 18 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1824676-62-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7066-19-5
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 7066-24-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4542043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 28
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzoquinazolinones. Part 2: Synthesis of amino-, and
sulfanyl-derivatives of benzo[f]- and benzo[h]quinazolinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nowak, Monika; Malinowski, Zbigniew; Fornal, Emilia; Jozwiak, Andrzej;
Parfieniuk, Ewa; Gajek, Gabriela; Kontek, Renata
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2015), 71(50), 9463-9473

$RFMT $RIREG SCHEME129 STEP1
$RXN



  1  2
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-Bis(formamide-κO)diiodocadmium
C2H6CdI2N2O2
108631-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cd 4.0012 1.5400 0.0 0 CHG=2 VAL=4
M  V30 2 O 2.6675 2.3101 0.0 0 VAL=3
M  V30 3 O 5.3348 0.7700 0.0 0 VAL=3
M  V30 4 I 4.7712 2.8737 0.0 0 CHG=-1 VAL=1
M  V30 5 I 3.2311 0.2064 0.0 0 CHG=-1 VAL=1
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 6.6687 0.0000 0.0 0
M  V30 8 N 0.0000 2.3101 0.0 0
M  V30 9 N 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 2 6 CFG=2
M  V30 6 2 3 7 CFG=2
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-22)-Tetrakis(cyanato-κO)diiodocadmium
C4H12CdI2N4O4
1547297-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cd 5.1959 2.9202 0.0 0 CHG=2 VAL=6
M  V30 2 O 7.7254 1.4621 0.0 0 VAL=3
M  V30 3 O 2.6664 1.4621 0.0 0 VAL=3
M  V30 4 O 5.1959 5.8444 0.0 0 VAL=3
M  V30 5 O 2.6664 4.3823 0.0 0 VAL=3
M  V30 6 I 7.7254 4.3823 0.0 0 CHG=-1 VAL=1
M  V30 7 I 5.1959 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 8 C 8.9902 2.1911 0.0 0
M  V30 9 C 1.4017 2.1911 0.0 0
M  V30 10 C 6.4607 6.5734 0.0 0
M  V30 11 C 1.4017 3.6533 0.0 0
M  V30 12 N 10.2549 1.4621 0.0 0
M  V30 13 N 0.1329 1.4621 0.0 0
M  V30 14 N 7.7254 5.8444 0.0 0
M  V30 15 N 0.0000 4.4588 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 2 2 8 CFG=2
M  V30 8 2 3 9 CFG=2
M  V30 9 2 4 10 CFG=2
M  V30 10 2 5 11 CFG=2
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 108631-63-6
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 1547297-43-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-10165301
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 8
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7790-80-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Zinc and cadmium iodide complexes with (thio)amides: Transformations of
formamide complexes and effects of substitution on structure and bonding
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savinkina, Elena V.; Zamilatskov, Ilya A.; Kuzovlev, Andrey S.; Albov,
Dmitry V.; Golubev, Denis V.; Chernyshev, Vladimir V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2014), 6968-76

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  2
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-2-(2-phenylhydrazinylidene)acetate
C9H9ClN2O2
58131-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 Cl 6.6685 0.0000 0.0 0
M  V30 6 O 9.3360 1.5400 0.0 0
M  V30 7 O 8.0023 3.8501 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3 CFG=2
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-1H-1,2,4-triazole
C8H7N3
13423-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3698 1.3337 0.0 0
M  V30 2 C 1.4646 0.0878 0.0 0
M  V30 3 N 1.4646 2.5795 0.0 0
M  V30 4 N 0.0000 0.5636 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 3.9098 1.3337 0.0 0
M  V30 7 C 4.6798 0.0000 0.0 0
M  V30 8 C 4.6798 2.6673 0.0 0
M  V30 9 C 6.2198 0.0000 0.0 0
M  V30 10 C 6.2198 2.6673 0.0 0
M  V30 11 C 6.9898 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 2 3 5
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-1,2,4-Triazole-3-carboxylic acid, 1-phenyl-, methyl ester
C10H9N3O2
57226-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2356 1.5317 0.0 0
M  V30 2 O 9.6426 2.1580 0.0 0
M  V30 3 O 8.0747 0.0000 0.0 0
M  V30 4 C 10.8884 1.2528 0.0 0
M  V30 5 N 4.6200 3.2067 0.0 0
M  V30 6 N 5.5252 1.9609 0.0 0
M  V30 7 C 5.5252 4.4528 0.0 0
M  V30 8 C 6.9898 2.4367 0.0 0
M  V30 9 N 6.9898 3.9767 0.0 0
M  V30 10 C 3.0800 3.2067 0.0 0
M  V30 11 C 2.3100 4.5405 0.0 0
M  V30 12 C 2.3100 1.8731 0.0 0
M  V30 13 C 0.7700 4.5405 0.0 0
M  V30 14 C 0.7700 1.8731 0.0 0
M  V30 15 C 0.0000 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58131-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13423-60-4
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 57226-96-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29314472
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 4
$DTYPE RXN:VAR(1):PRO(2):YIELD
$DATUM 90
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10025-87-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile One-Pot Synthesis of Methyl
1-Aryl-1H-1,2,4-triazole-3-carboxylates from Nitrilimines with Vilsmeier
Reagent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsai, Shuo-En; Chiang, Kun-Heng; Tseng, Ching-Chun; Chen, Nai-Wei; Chern,
Ching-Yuh; Wong, Fung Fuh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(8), 1754-1762

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  4
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Levulinic acid
C5H8O3
123-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 O 6.6685 1.5400 0.0 0
M  V30 8 O 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl-2-pyrrolidone
C5H9NO
108-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 N 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
γ-Valerolactone
C5H8O2
108-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 O 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-5-methyl-2H-pyrrol-2-one
C5H7NO
48086-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 N 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-5-oxo-1-pyrrolidinecarboxaldehyde
C6H9NO2
82524-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.7700 0.0 0
M  V30 2 O 1.3769 0.0000 0.0 0
M  V30 3 C 0.0000 2.7392 0.0 0
M  V30 4 O 5.4211 2.7392 0.0 0
M  V30 5 N 2.7106 2.3100 0.0 0
M  V30 6 C 1.4647 3.2152 0.0 0
M  V30 7 C 3.9564 3.2152 0.0 0
M  V30 8 C 1.9406 4.6798 0.0 0
M  V30 9 C 3.4806 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 2 4 7
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 108-27-0
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 108-29-2
$DTYPE RXN:PRO(3):CAS_RN
$DATUM 48086-68-6
$DTYPE RXN:PRO(4):CAS_RN
$DATUM 82524-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20622985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile Direct Route to N-(Un)substituted Lactams by Cycloamination of
Oxocarboxylic Acids without External Hydrogen
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hu; Wu, Hongguo; Zhang, Heng; Su, Yaqiong; Yang, Song; Hensen, Emiel
J. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemSusChem (2019), 12(16), 3778-3784

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  4
$MOL
Formamide
CH3NO
75-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 O 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Levulinic acid
C5H8O3
123-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 O 6.6685 1.5400 0.0 0
M  V30 8 O 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl-2-pyrrolidone
C5H9NO
108-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6218 0.0 0
M  V30 2 O 5.3026 1.4946 0.0 0
M  V30 3 N 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-5-oxo-1-pyrrolidinecarboxaldehyde
C6H9NO2
82524-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.7700 0.0 0
M  V30 2 O 1.3769 0.0000 0.0 0
M  V30 3 C 0.0000 2.7392 0.0 0
M  V30 4 O 5.4211 2.7392 0.0 0
M  V30 5 N 2.7106 2.3100 0.0 0
M  V30 6 C 1.4647 3.2152 0.0 0
M  V30 7 C 3.9564 3.2152 0.0 0
M  V30 8 C 1.9406 4.6798 0.0 0
M  V30 9 C 3.4806 4.6798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 2 4 7
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formylamino)pentanoic acid
C6H11NO3
1339051-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 C 5.3348 3.8501 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 9.3360 1.5400 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Formylamino)pentanamide
C6H12N2O2
2319580-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0
M  V30 4 C 5.3348 3.8501 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 9.3360 1.5400 0.0 0
M  V30 9 N 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-76-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 108-27-0
$DTYPE RXN:PRO(2):CAS_RN
$DATUM 82524-59-2
$DTYPE RXN:PRO(3):CAS_RN
$DATUM 1339051-45-4
$DTYPE RXN:PRO(4):CAS_RN
$DATUM 2319580-39-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20223919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, Teflon lined autoclave used, no solvent, alternative
reaction conditions shown, optimization study, optimized on stoichiometry
of reactant, optimized on stoichiometry of reagents, optimized on
temperature, optimized on time, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quasi-Catalytic Approach to N-Unprotected Lactams via Transfer
Hydro-amination/Cyclization of Biobased Keto Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Hongguo; Dai, Wenshuai; Saravanamurugan, Shunmugavel; Li, Hu; Yang,
Song
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sustainable Chemistry & Engineering (2019), 7(12), 10207-10213

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Formamide, acetate (1:1)
C2H4O2.CH3NO
64392-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.8501 0.0 0
M  V30 2 N 0.0000 4.6201 0.0 0
M  V30 3 O 2.6673 4.6201 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 O 2.6673 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 4 5
M  V30 4 1 4 6
M  V30 5 2 4 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-fluoro-5-iodobenzoic acid
C7H5FINO2
231278-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6675 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 N 2.3100 0.0000 0.0 0
M  V30 5 I 5.3901 5.3349 0.0 0
M  V30 6 F 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-6-iodo-4(3H)-quinazolinone
C8H4FIN2O
231278-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3338 0.0 0
M  V30 2 I 5.3900 0.0000 0.0 0
M  V30 3 F 6.9300 2.6674 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 2.3100 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 64392-62-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 231278-08-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 231278-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21219629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-86-4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An alternative synthesis of the non-small cell lung carcinoma drug
afatinib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kovacevic, Tatjana; Mesic, Milan; Avdagic, Amir; Zegarac, Miroslav
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2018), 59(47), 4180-4182

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
1-Bromo-4-nitrobenzene
C6H4BrNO2
586-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formamide, compd. with 2,4,6-trichloro-1,3,5-triazine (1:1)
C3Cl3N3.CH3NO
2415121-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 6.9300 0.0 0
M  V30 2 Cl 5.3349 6.9300 0.0 0
M  V30 3 Cl 2.6674 2.3100 0.0 0
M  V30 4 N 2.6674 6.9300 0.0 0
M  V30 5 C 1.3338 6.1600 0.0 0
M  V30 6 C 4.0011 6.1600 0.0 0
M  V30 7 N 1.3338 4.6200 0.0 0
M  V30 8 N 4.0011 4.6200 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 N 1.3338 0.7700 0.0 0
M  V30 12 O 4.0011 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzonitrile
C7H4N2O2
619-72-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 586-78-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2415121-39-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 619-72-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26442643
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 92
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-12-7
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Cyanation of Aryl Halides Using Formamide and
Cyanuric Chloride as a New "CN" Source
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niknam, Esmaeil; Panahi, Farhad; Khalafi-Nezhad, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(18), 2699-2707

